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Abstract
Randomised controlled trial evaluating the effectiveness and
cost-effectiveness of ‘Families for Health’, a family-based
childhood obesity treatment intervention delivered in a
community setting for ages 6 to 11 years
Wendy Robertson,* Joanna Fleming, Atiya Kamal, Thomas Hamborg,
Kamran A Khan, Frances Griffiths, Sarah Stewart-Brown,
Nigel Stallard, Stavros Petrou, Douglas Simkiss, Elizabeth Harrison,
Sung Wook Kim and Margaret Thorogood
Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK
*Corresponding author w.robertson@warwick.ac.uk
Background: Effective programmes to help children manage their weight are required. ‘Families for
Health’ focuses on a parenting approach, designed to help parents develop their parenting skills to support
lifestyle change within the family. Families for Health version 1 showed sustained reductions in mean body
mass index (BMI) z-score after 2 years in a pilot project.
Objective: The aim was to evaluate its effectiveness and cost-effectiveness in a randomised controlled
trial (RCT).
Design: The trial was a multicentre, investigator-blind RCT, with a parallel economic and process
evaluation, with follow-up at 3 and 12 months. Randomisation was by family unit, using a 1 : 1 allocation
by telephone registration, stratified by three sites, with a target of 120 families.
Setting: Three sites in the West Midlands, England, UK.
Participants: Children aged 6–11 years who were overweight (≥ 91st centile BMI) or obese (≥ 98th centile
BMI), and their parents/carers. Recruitment was via referral or self-referral.
Interventions: Families for Health version 2 is a 10-week, family-based community programme with
parallel groups for parents and children, addressing parenting, lifestyle, social and emotional development.
Usual care was the treatment for childhood obesity provided within each locality.
Main outcome measures: Joint primary outcome measures were change in children’s BMI z-score and
incremental cost per quality-adjusted life-year (QALY) gained at 12 months’ follow-up (QALYs were
calculated using the European Quality of Life-5 Dimensions Youth version). Secondary outcome measures
included changes in children’s waist circumference, percentage body fat, physical activity, fruit/vegetable
consumption and quality of life. Parents’ BMI and mental well-being, family eating/activity, parent–child
relationships and parenting style were also assessed. The process evaluation documented recruitment,
reach, dose delivered, dose received and fidelity, using mixed methods.
Results: The study recruited 115 families (128 children; 63 boys and 65 girls), with 56 families randomised
to the Families for Health arm and 59 to the ‘usual-care’ control arm. There was 80% retention of families
at 3 months (Families for Health, 46 families; usual care, 46 families) and 72% retention at 12 months
(Families for Health, 44 families; usual care, 39 families). The change in BMI z-score at 12 months was not
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significantly different in the Families for Health arm and the usual-care arm [0.114, 95% confidence
interval (CI) –0.001 to 0.229; p= 0.053]. However, within-group analysis showed that the BMI z-score was
significantly reduced in the usual-care arm (–0.118, 95% CI –0.203 to –0.034; p= 0.007), but not in the
Families for Health arm (–0.005, 95% CI –0.085 to 0.078; p= 0.907). There was only one significant
difference between groups for secondary outcomes. The economic evaluation, taking a NHS and Personal
Social Services perspective, showed that mean costs 12 months post randomisation were significantly
higher for Families for Health than for usual care (£998 vs. £548; p< 0.001). The mean incremental
cost-effectiveness of Families for Health was estimated at £552,175 per QALY gained. The probability that
the Families for Health programme is cost-effective did not exceed 40% across a range of thresholds.
The process evaluation demonstrated that the programme was implemented, as planned, to the intended
population and any adjustments did not deviate widely from the handbook. Many families waited more
than 3 months to receive the intervention. Facilitators’, parents’ and children’s experiences of Families for
Health were largely positive and there were no adverse events. Further analysis could explore why some
children show a clinically significant benefit while others have a worse outcome.
Conclusions: Families for Health was neither effective nor cost-effective for the management of obesity in
children aged 6–11 years, in comparison with usual care. Further exploration of the wide range of
responses in BMI z-score in children following the Families for Health and usual-care interventions is
warranted, focusing on children who had a clinically significant benefit and those who showed a worse
outcome with treatment. Further research could focus on the role of parents in the prevention of obesity,
rather than treatment.
Trial registration: Current Controlled Trials ISRCTN45032201.
Funding: This project was funded by the National Institute for Health Research (NIHR) Health Technology
Assessment programme and will be published in full in Health Technology Assessment; Vol. 21, No. 1.
See the NIHR Journals Library website for further project information.
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Glossary
Data Monitoring and Ethics Committee An independent committee, the roles of which are to monitor
the data from the trial; to safeguard the safety, rights and well-being of trial participants; to assess ethical
and safety issues; and, on the basis of their assessment, to make recommendations to the Trial Steering
Committee on whether or not the trial should continue.
Logic model A diagrammatic representation of an intervention, describing anticipated delivery
mechanisms, intervention components, the mechanisms through which an intervention is proposed to
work and intended outcomes.
Process evaluation An assessment conducted during the implementation of an intervention including
components of whether or not it is reaching the intended participants; if the intervention is being provided
and delivered as intended; and how the intervention is being received by the participants.
Trial Steering Committee A committee responsible for the overall supervision and progress of a trial on
behalf of the trial sponsor and trial funder. Its role is to ensure that the trial is conducted in accordance
with the Guidelines for Good Clinical Practice and relevant regulatory requirements.
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Plain English summary
One-third of children aged 10–11 years in England are overweight. The NHS needs programmes thatwork and offer good value for money for helping children who are overweight.
In this study we wanted to find out whether or not a programme called ‘Families for Health’ could help
families with children, aged 6–11 years, who are overweight. This is a group-based programme, 10 weeks
long, involving children and their parents. The programme was delivered across three areas in the West
Midlands and aimed to help parents develop their parenting skills to enable them to bring about lifestyle
change within the family. Four facilitators, two for the children’s group and two for the parents’ group,
ran each programme. The facilitators included people with experience in nursing, teaching, youth work,
physical activity and nutrition, who had attended a 4-day training course to run the programme.
Approximately half of our 115 families with at least one child who was overweight were invited to attend
the Families for Health programme and the other half were invited to attend the usual care that was already
available locally for the treatment of children who were overweight. The Families for Health programme
was implemented almost as desired, with most families’ experiences of the programme being positive,
although some families had to wait to receive the intervention. After 12 months there were no differences
in the average change in weight (as measured by the body mass index of the children), in physical activity,
in fruit and vegetable consumption or in health-related quality of life (as measured by the European Quality
of Life-5 Dimensions Youth version) between the Families for Health group and the usual-care group.
The Families for Health intervention was also more expensive than the care available locally.
In conclusion, the Families for Health programme was found to be neither effective nor cost-effective in
helping families to manage the weight of overweight children.
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Scientific summary
Background
Childhood obesity, both in the UK and internationally, is a major public health burden. One-third of
children in year 6 (aged 10–11 years) in England were classified as either overweight or obese in 2013/14.
Obesity in childhood increases the risk of poor physical and mental health in childhood, and there
is evidence that childhood obesity also affects adult health.
The prevention and management of childhood obesity is now a public health priority. Effective
interventions are needed to treat children who are obese, in order to reduce ill health in children and
to reduce the proportion whose obesity continues into adulthood. A Cochrane systematic review of
interventions to treat obesity identified 64 randomised controlled trials (RCTs) and, of these, only two were
from the UK. They concluded that it is difficult to recommend any particular intervention, but indicated
that family-based lifestyle interventions combining dietary, physical activity and behavioural components
can produce ‘a significant and clinically meaningful reduction in overweight’ (Oude Luttikhuis H, Baur L,
Jansen H, Shrewsbury VA, O’Malley C, Stolk RP, Summerbell CD. Interventions for treating obesity in
children. Cochrane Database Syst Rev 2009;1:CD001872). Parental involvement was identified as useful
with children aged < 12 years. Although family-based interventions for the treatment of childhood obesity
have become more common, the focus on parenting skills within a programme is less so. A review of the
limited research on interventions focusing on parenting to treat childhood obesity shows a small to
moderate effect on weight-related outcomes, meriting further investigation.
‘Families for Health’ is a family-based group intervention for the treatment of children aged 6–11 years who
are overweight or obese. The programme puts greater emphasis on parenting skills, relationship skills and
emotional and social development than other similar interventions, and combines this with information
about lifestyle. A pre–post pilot of Families for Health in 27 children showed that mean reductions in
children’s body mass index (BMI) z-scores from baseline were sustained at 9 months [–0.21, 95%
confidence interval (CI) –0.35 to –0.07; p= 0.007] and 2 years (–0.23, 95% CI –0.42 to –0.03; p= 0.027).
There were also other health-related improvements. As Families for Health was a promising new childhood
obesity intervention, definitive evaluation of its clinical effectiveness by RCT was now required.
Aim and objectives
Our aim was to assess the effectiveness and cost-effectiveness at 12 months of the Families for Health
programme using a RCT methodology.
Our objectives were to:
l assess the effectiveness of the Families for Health programme in reducing BMI z-scores in children
aged 6–11 years who are overweight or obese
l evaluate the cost-effectiveness of the Families for Health programme [expressed in terms of incremental
cost per quality-adjusted life-year (QALY) gained]
l investigate parents’ and children’s views of the programme and their observations on approaches to
maximising impact
l investigate facilitators’ views of the programme and their observations on approaches to
maximising impact.
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Methods
A multicentre, investigator-blind RCT, randomised at family level, in which Families for Health version 2
was compared with usual care, was carried out. Families for Health version 2 is a 10-week, family-based
programme run in a community venue, with parallel groups for parents and children, addressing
parenting, lifestyle change and social and emotional development. ‘Usual care’ was the usual support for
the treatment of childhood obesity that was currently provided within each NHS locality. Alongside the
evaluation of effectiveness, a parallel economic evaluation and process evaluation were carried out.
Recruitment of families
Participants were recruited from three sites (NHS primary care trusts) within the West Midlands, England, UK,
using both active and passive recruitment methods. Active recruitment methods are those where eligible
participants were identified and targeted, such as with a letter following measurement in the National Child
Measurement Programme or by referral from a health-care professional. Passive methods are those where
the community was informed using flyers, posters, public events and media, and then participants identified
themselves as potential participants.
The inclusion criteria were families with at least one child aged 6–11 years who was overweight
(≥ 91st centile BMI) or obese (≥ 98th centile BMI), with at least one parent or guardian and the overweight
child willing to take part. Exclusion criteria were if the parent or child had insufficient command of English
and would find it difficult to participate in the group; the child had a metabolic or other recognised
medical cause of obesity; or the child had severe learning difficulties and/or behavioural problems,
and would find it difficult to participate in a group-based programme.
Sample size
Power calculations assumed a residual standard deviation in the BMI z-score of 0.22, a standard deviation
of the random family effects of 0.14 (corresponding to a within-family intracluster correlation of 0.27),
an intracluster correlation of 0.1 in the intervention groups, a two-sided significance of 5% and that
60% of participating families have one overweight/obese child and 40% have two. Allowing for clustering
effects by family and for group effects in the intervention arm, a sample size of six groups of 10 families
(60 families) in the intervention arm and 60 families in the control arm gives a power of 94% to detect an
intervention effect of 0.2 in BMI z-scores. If 30% of families drop out, the study retains a power of 88%.
Randomisation
Randomisation was carried out after all baseline measurements had been obtained. Randomisation was by
family unit using a 1 : 1 allocation, with a target of 120 families, and carried out by a central telephone
registration and randomisation service at the Warwick Clinical Trials Unit. Randomisation was stratified by
the three sites using a biased-coin (p= 2/3) minimisation method within each site to ensure approximately
equal numbers of families were randomised to the Families for Health programme and control.
Interventions
Families for Health version 2 was run in a community venue, with parallel groups for parents and children,
addressing parenting, lifestyle change, and social and emotional development. Usual care was the usual
support for the treatment of childhood obesity that was currently provided within each NHS locality. Usual
care varied by site, being group based in site A, one-to-one support in site B, and either group-based or
one-to-one support in site C. Usual care had evolved from virtually nothing to reasonably high-level
provision in the time between the pilot and the implementation of the trial.
Outcome measures
Measurements with children and parents were taken at home at baseline, and at 3 and 12 months’
follow-up. The primary outcome measure of effectiveness was change in children’s BMI z-score at the
12 months’ follow-up compared with the change in the control group. Secondary outcome measures
included changes in children’s waist circumference; percentage body fat; physical activity using an
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accelerometer; fruit and vegetable consumption; and health-related quality of life as measured using the
European Quality of Life-5 Dimensions Youth version (EQ-5D-Y). Parents’ BMI and mental well-being,
family eating and activity, parent–child relationships and parenting style were also assessed. The primary
statistical analysis was carried out on an intention-to-treat basis.
Economic evaluation
A trial-based economic evaluation was conducted from a NHS and Personal Social Services perspective
(and separately, for the purposes of a sensitivity analysis, from a societal perspective). Economic components
encompassed measurement and valuation of service utilisation, including the costs of running Families for
Health and usual care, and broader resource utilisation provided via researcher-administered interviews at
each follow-up point, as well as EQ-5D-Y health outcomes that measured QALYs. Cost-effectiveness was
expressed in terms of incremental cost per QALY gained (baseline outcome for the cost-effectiveness
analysis) and incremental cost per change in BMI z-score at 12 months’ follow-up. A range of sensitivity and
subgroup analyses were performed. The primary analysis was carried out on an intention-to-treat basis.
Process evaluation
Process evaluation documented recruitment, reach, dose delivered, dose received and fidelity, using mixed
methods. Interviews were carried out with parents and children from both trial arms and focus groups were
carried out with the facilitators of each of the Families for Health groups. Interviews and focus groups were
digitally recorded, transcribed verbatim and coded using NVivo 10 (QSR International, Melbourne, VIC,
Australia). Coding was thematic based on the interview schedules with the addition of emergent themes.
Results
Recruitment
The study recruited 115 families, including 128 children (63 boys and 65 girls), between March 2012 and
February 2014. A total of 56 families were randomised to Families for Health version 2 intervention arm
and 59 families to the usual-care control arm. Passive recruitment methods resulted in a higher proportion
of the total number of families recruited [passive (72/115) vs. active (43/115); p< 0.007].
Baseline characteristics were similar across the two arms, with the exception of socioeconomic status, with
the Families for Health arm having a higher proportion of families from managerial and professional
occupations than the control arm.
Follow-up
There was 80% retention of families in the study at 3 months and 72% retention at 12 months.
Follow-up was lower for usual care at 12 months [Families for Health (78.6%) vs. usual care (66.1%)].
Clinical outcomes
The primary analysis was prespecified to be a comparison of the change in children’s BMI z-score from
baseline to 12 months’ follow-up conducted on an intention-to-treat basis. The analysis allowed
for clustering within the family and adjusted for the child baseline BMI z-score, sex and locality. The
primary analysis did not find any difference in the BMI z-score at the 12-month follow-up between
the usual-care arm and the Families for Health arm (0.114, 95% CI –0.001 to 0.229; p= 0.053, model 1).
The within-group analysis showed that the BMI z-score was significantly reduced in the usual-care arm
(–0.118, 95% CI –0.203 to –0.034; p= 0.007), whereas there was no significant change in the Families for
Health arm (–0.005, 95% CI –0.085 to 0.078; p= 0.907). Apart from a significant improvement in activity
level in parents in the usual care arm compared with the Families for Health arm, there were no other
significant differences between groups for the other secondary outcomes. Although imputation analysis
suggests that these results are robust, the possibility that the findings are attributable to differential loss to
follow-up cannot be ruled out.
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Economic evaluation
The economic evaluation showed that mean costs for the 12-month post-randomisation period were
significantly higher in the Families for Health arm than in the usual-care arm (£998 vs. £548), with a cost
difference of £450 (95% CI £249 to £650; p< 0.001). This was mainly driven by the higher cost of the
Families for Health programme, which was more expensive than all the various usual-care provision.
There was no significant difference in mean QALYs over the 12-month post-randomisation period between
the Families for Health arm and the usual-care arm (0.83 vs. 0.83; mean difference 0.0009). The mean
incremental cost-effectiveness of Families for Health was estimated at £552,175 per QALY gained, and the
probability that Families for Health is cost-effective is approximately 28% at a £20,000 cost-effectiveness
threshold. When health outcomes were measured in terms of longitudinal change in BMI z-score, the
mean incremental cost-effectiveness of Families for Health was dominated by usual care in health
economic terms, and the probability that Families for Health is cost-effective did not exceed 2% across a
range of cost-effectiveness thresholds.
Process evaluation
Seven Families for Health groups were run across the three trial sites. The proportion of families that
attended at least one session was higher in the Families for Health arm (42/56, 75%) than in the usual
care arm (24/59, 40.7%) (p= 0.001). There were 62.5% of families who completed at least five sessions of
Families for Health, and were defined as completers. Families for Health was delivered broadly, as planned,
but challenges included families waiting more than 3 months to receive the intervention, delivering the
programme with an insufficient number of families and tailoring a manualised programme to meet
individual family needs. Key aspects received well by families were better understanding of food labelling,
informing food choices, positive influence on parenting skills, support from others and raising their child’s
awareness of health. Based on the quantity and quality of what was delivered, the process evaluation
indicates that the intervention was implemented reasonably well, probably as well as could be expected
when scaled up over three sites.
Conclusions
Families for Health was neither clinically effective nor cost-effective for the management of obesity in
children aged 6–11 years, in comparison with usual care.
Implications for public health
Usual care for obesity management evolved from nothing to a reasonably high level of provision in the
time between the pilot evaluation of Families for Health and the implementation of the trial. Usual care
differed in different sites and may have evolved to suit local needs, making the best of local practitioner
skills and local resources, which may explain why it is more effective than Families for Health. However, at
least 47.5% of families did not receive the usual-care intervention, and so informing parents of their child’s
weight may actually be the effective component.
Childhood obesity is hard to treat. Even treatment interventions that are shown to be effective may only
have a modest impact.
Further research implications
Broader reporting of adverse events, including the negative effect of treatment on primary outcomes, is
required. In the current study, the wide range of responses in BMI z-scores in children at the 12-month
follow-up ranged from a difference from baseline of –0.746 to 0.895 across the two groups, indicating
that some children had a clinically significant benefit, whereas others showed a worse outcome with
treatment. Exploration of these extreme cases by treatment group and engagement in the intervention is
warranted from this trial.
SCIENTIFIC SUMMARY
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Rather than a focus on the treatment of obesity, shifting attention to the role of parents in the prevention
of obesity, alongside school-based prevention initiatives, may be worthy of future research. The
‘whole-systems approach’ to tackle obesity advocated by Public Health England is also a very important
new research programme.
Trial registration
This study is registered as ISRCTN45032201.
Funding
Funding for this study was provided by the Health Technology Assessment programme of the National
Institute for Health Research.
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Chapter 1 Introduction
Scientific background
Childhood obesity, both in the UK and internationally, is known to be a major public health burden.
The most recent Health Survey for England found that between 1995 and 2005 obesity in children aged
2–10 years in England rose from 10% to 17% in boys and from 11% to 17% in girls.1 However, the trend
may now be reversing, with 13% of boys and 12% of girls found to be obese in 2013.1 Analysis of
general practice data found a similar trend, with the prevalence of childhood overweight and obesity
stabilising from 2004 to 2013 in children aged 2–10 years.2 This prevalence is still too high, with over
one-third (33.5%) of children in year 6 (aged 10–11 years) in England classified as either overweight or
obese in the 2013/14 school year.3 This translates to over 172,000 children in year 6 alone who are
overweight or obese.
Childhood overweight and obesity have been linked to a number of long-term and immediate
physiological and psychological health risks,4,5 with associations between childhood body mass index
(BMI) and type 2 diabetes, hypertension and coronary heart disease in adulthood.6 This means that the
prevention and management of childhood obesity is a public health priority. Effective interventions to treat
children who are obese, to reduce ill health in children and to reduce the proportion of children whose
obesity continues into adulthood are needed.
In 2008, there were an estimated 314–375 weight management programmes for children in operation in
England at any one time.7 These lifestyle interventions focused on diet, physical activity, behaviour change
or any combination of these factors, and included programmes, courses or clubs, and online services.
They could include programmes that were designed for overweight or obese children and young people,
or for their parents, carers or families; designed primarily for adults but that accept, or may be used by,
children and young people; or provided by the public, private or voluntary sector, in the community or in
(or via) primary care organisations. Aicken et al.7 noted that some were small local schemes, whereas
others were available on a regional or national basis.
Care pathway for weight management of children and young people
Government guidelines describe a three-tier pyramid model for weight management, with three levels of
service, from universal services, offered to everybody, through to specialist services, provided to those with
particular needs.8 Level 1 represents the core preventative services that all children, young people and
their families should have access to, while level 2 represents targeted weight management services. The
Families for Health intervention fits into level 2. This level of intervention is often aimed at children and
young people with a BMI between the 91st and 98th centile, and services typically take the form of
multicomponent family-based interventions, often taking place in community settings. They may also be
called ‘early intervention services’. Level 3 is specialist support, offered to children with a BMI ≥ 99.6th
centile, with a medical cause of obesity, significant comorbidity or complex needs. The Department of
Health has recommended that overweight or obese children should be referred to appropriate weight
management services.9
Evidence for effectiveness of level 2 child obesity interventions
A Cochrane systematic review of interventions to treat obesity identified 64 randomised controlled trials
(RCTs).10 Thirty-seven studies were lifestyle interventions for children aged < 12 years (four dietary, nine
physical activity and 24 behavioural). The authors concluded that it is difficult to recommend any particular
intervention, but indicated that family-based lifestyle interventions combining dietary, physical activity and
behavioural components can produce a significant and clinically meaningful reduction in overweight.
Parental involvement was identified as useful with children aged < 12 years.
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Recent UK-based trials of interventions targeting children who are obese have covered a variety of
approaches. A RCT of the 9-week family-based community programme MEND (Mind, Exercise, Nutrition
. . . Do it!; Mytime Active, Bromley, UK) with 116 children (aged 8–12 years) showed a between-group
difference in the BMI z-score at the 6-month follow-up of –0.24 [95% confidence interval (CI) –0.34 to
–0.13; p< 0.0001; n= 82] in favour of MEND over the waiting list control.11 A further RCT compared
paediatric dietitians using a one-to-one behavioural approach (5 hours) with standard dietetic care
(1.5 hours) in 134 children (aged 5–11 years).12 No significant differences in BMI z-scores were found at
6 or 12 months. A feasibility RCT that compared the community-based Watch It programme (delivered by
health trainers) with a waiting list control, in 70 children and adolescents, found no significant change in
BMI z-score and treatment.13 A RCT of Epstein’s family-based behavioural treatment in a UK hospital, with
72 participants, found that there was no significant difference between the intervention and waiting list
groups in BMI z-score, although both treatment and control groups showed significant reductions.14
A National Institute for Health and Care Excellence (NICE) guideline on managing overweight and obesity
among children and young people suggested that targeting both parents and children, or whole families,
is effective in reducing BMI z-scores.15 By the end of a programme, evidence on interventions involving
families showed no negative effect on well-being and, in some cases, showed positive effects. Similarly, a
review of the limited research on interventions focusing on parenting to treat childhood obesity shows a
small positive effect on weight-related outcomes.16
Family-based interventions rooted in behaviour theory have been shown to achieve better treatment
effectiveness than those rooted in family systems theory.17 A recent review of published studies18
investigating family-based childhood obesity interventions in the UK included 10 studies. The majority of
programmes reviewed lasted 12 weeks, with only three studies providing follow-up data at 12 months or
longer. Change in adiposity was a short-term benefit of participation, but there was insufficient robust
evidence to suggest that this benefit was long-lasting and many studies were methodologically weak
with limited internal validity. The authors concluded that there was insufficient evidence on how the
inclusion of parents and the wider family may impact on the effectiveness of UK community-based weight
management programmes for children and young people.18
Evidence for cost-effectiveness of child obesity interventions
Oude Luttikhuis et al.10 point to a paucity of cost-effectiveness studies in this area. A recent US study of
families in which both children and parents were overweight or obese found that the cost per unit weight
lost by parents and children was lower for family-based group treatment than for an intervention that
treated the parent and child separately.19 Evidence from seven short-term health economic analyses
suggests that, in the short term, lifestyle weight management programmes will result in an increased cost
to the NHS in terms of BMI z-score gains when compared with routine care. However, overall small (and in
some cases non-significant) improvements in BMI z-scores can be achieved.15 Interventions that lead to
even small reductions in BMI can be cost-effective in the long term at conventional cost-effectiveness
thresholds, provided that the short-term effects on BMI can be sustained into adulthood. The NICE
guidance suggested that evidence from these studies is directly applicable, but there were some potentially
serious limitations to the studies.15
From randomised controlled trial to practice
Two recent studies have investigated the roll-out of an intervention tested in a RCT into the
community.20,21 Both were based on the multicomponent family-based weight management intervention,
MEND, which addresses diet and physical activity through education, skills training and motivational
enhancement. When delivered at scale, the rolled-out intervention resulted in the improvement of BMI and
psychosocial outcomes but worked less well for some groups of children (certain ethnic groups and those
from more deprived areas). This was not because of variations in uptake of the programme, which was
good in deprived groups, but because of differing experiences in completing, with more disadvantaged
groups being less likely to complete the programme. The intervention, therefore, had the potential to
widen inequalities. The authors suggested that further research should investigate how completion rates
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could be improved for particular groups.21 They felt that the intervention should be implemented in such a
way as to achieve sustained impact for all groups by modifying content, training and implementation.20
Parenting programmes
It has been argued that parenting programmes have potential to improve the mental health and
well-being of children, as well as improve family relationships and benefit the community as whole.22
A public health approach to parenting is needed to ensure that more parents benefit and that a
societal-level impact is achieved.22 The effectiveness of parenting interventions in the treatment and
prevention of childhood obesity has shown a small positive effect on weight-related outcomes,16 but this
approach has not been investigated in a RCT in the UK.
Development of the Families for Health intervention
‘Families for Health’ is a manualised group-based family intervention for the treatment of children aged
6–11 years who are overweight or obese, which could be an option in the care pathway as a targeted
‘early-intervention’ service. The programme was developed at Warwick University and supported by a
Department of Health career development award to the principal investigator. The programme differs from
other interventions for childhood obesity being used or tested in the UK by offering a greater emphasis on
parenting skills, relationship skills and emotional and social development, combined with information
about lifestyle. Parents and children attend separate groups, meeting mid-way for a healthy snack and
activity. The groups are led by two trained facilitators.
The development and evaluation of the Families for Health programme has followed the Medical Research
Council (MRC)’s framework for complex interventions.23 A pre–post pilot study in Coventry of 27 children
showed that a mean reduction in children’s BMI z-scores from baseline was sustained at 9 months (–0.21,
95% CI –0.35 to –0.07; p= 0.007) and 2 years (–0.23, 95% CI –0.42 to 0.03; p= 0.027).24,25 There were
also other health-related improvements. Interview data showed that parents found the parenting approach
helpful, providing the tools for them to become ‘agents of change’ in the family. The NHS costs to deliver
the programme were £517 per family or £402 per child.25 The process evaluation of the pilot study
showed the need for minor modifications to the programme including more physical activity, removal of
some unnecessary material, a reduction in the number of sessions and addition of follow-up sessions.
These changes to the intervention might increase effectiveness.
The materials for version 1 of this programme were developed by Candida Hunt and the University of
Warwick team, including investigators in this trial (WR and SS-B).26 Following development and evaluation
of the original programme Families for Health version 1,24,25 changes were made including shortening the
delivery from 12 to 10 sessions, adding two follow-up sessions and enhancing the information given to
families on healthy eating and pedometers. The programme combines information on parenting skills,
social and emotional development, as well as lifestyle change. The parenting aspects are based on the
Nurturing Programme from Family Links (Family Links, Oxford, UK),27 and the circle time elements in the
children’s programme have parallels with the Family Links Nurturing Programme for schools.28
Delivery is group based involving 8–12 families, with children and parents attending parallel groups.
The intervention is delivered in a community setting (e.g. a leisure centre or school), to enhance access and
ensure adequate space and facilities for physical activity. The parents’ group covers both support with parenting
skills and family lifestyle, which are integrated in the weekly sessions. The approaches include facilitated
discussion, role-play, goal-setting, skill practice, a solution-focused approach and homework. The children’s
programme includes a focus on healthy eating using the ‘Eatwell plate’ (Food Standards Agency, London, UK)
as the basis; circle time to discuss emotional aspects of their lives and enhancing self-esteem; and physical
activity aimed at increasing activity levels by participation in games, the use of pedometers and introduction to
new physical activities. The parents and children meet mid-way in each session for a healthy snack and an
active game. This gives facilitators an opportunity to act as role models, for example showing parents how they
might reward or praise their children, and to introduce ways in which children and parents can interact at
home. It also provides an opportunity for children to prepare healthy snacks and to try new foods.
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The main principles underpinning the Families for Health intervention are that the parents are identified as
the agents of change responsible for implementing lifestyle change in the family.29 The parenting aspects
aim to support and increase parental capacity to implement and maintain the lifestyle changes that they
would like to try each week. The focus is on healthy eating (not dieting) and activity for the whole family
(that is, not just for the child who is overweight), with an emphasis on children growing into their weight
rather than weight loss. The programme aims to promote a sustainable, healthy approach to family-wide
lifestyle change. The programme puts greater emphasis on parenting skills, relationship skills, and
emotional and social development than other similar interventions, and combines this with information
about lifestyle. These form a core theme throughout and are integrated alongside topics in each
weekly session.
Rationale for research
Although family-based interventions for the treatment of childhood obesity have become more common,
the inclusion of parenting skills within a programme is less so. Such a programme may be effective in the
treatment and prevention of childhood obesity,16,24,25 and so it is important to investigate the impact on
families with overweight and obese children.
This RCT provides evidence of the effectiveness and cost-effectiveness of the Families for Health
programme, which emphasises parenting alongside a healthy lifestyle as an alternative approach for the
treatment of obesity in 6- to 11-year-olds.
Aims and objectives
The aim of the trial was to assess the effectiveness and cost-effectiveness of the Families for Health
programme delivered within the NHS.
The objectives were to:
l assess the effectiveness of the Families for Health programme in reducing the BMI z-score in children
aged 6–11 years who are overweight or obese
l evaluate the cost-effectiveness of the Families for Health programme [expressed in terms of incremental
cost per quality-adjusted life-year (QALY) gained]
l investigate parents’ and children’s views of the programme and their observations on approaches to
maximising impact
l investigate facilitators’ views of the programme and their observations on approaches to
maximising impact.
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Chapter 2 Trial design and methods
Study design
The ‘Families for Health’ trial evaluated the effectiveness of the Families for Health programme in
comparison with usual care in children aged 6–11 years who were overweight or obese. The trial was a
multicentre RCT with parallel economic and process evaluations. Families were randomised (1 : 1) to one of
two arms: Families for Health (target 60 families) or usual care (target 60 families). Further details of the
interventions are described in Treatment groups.
The primary outcome measure was the change in children’s BMI z-score at 12 months. All primary and
secondary outcomes were assessed at baseline, the end of the programme (3 months) and 12 months post
randomisation, to evaluate both the short- and long-term effects.
Study settings
The Families for Health study agreed collaborations with three West Midlands primary care trusts. These
primary care trusts offered Families for Health as part of their care pathway for the treatment of childhood
obesity, alongside their usual care. The three sites are referred to as site A, site B and site C in this report.
In sites A and C, the Families for Health intervention was run in a leisure centre (local authority) and in
site B it was run in a community centre with a sports hall.
Ethical approval and research governance
Ethical approval for the study was obtained from the National Research Ethics Service (NRES) West
Midlands – Coventry and Warwickshire (reference number 11/WM/0290) on 3 October 2011.
The trial was sponsored by the University of Warwick. NHS Research and Development approvals were
obtained with the participating NHS trusts. The trial was conducted in accordance with the standard
operating procedures of the Warwick Clinical Trials Unit.30
A Trial Steering Committee (TSC) was convened every 6 months, comprising four independent members
[chairperson, topic expert, statistician and parent (service user)] who advised on changes to the protocol,
the analyses plans and oversaw the management of the trial. A Data Monitoring and Ethics Committee
(DMEC) was convened annually, comprising three independent members (chairperson/topic expert,
statistician and health economist). The DMEC considered any ethical issues and adverse events, and
reviewed the interim analyses including BMI z-score, European Quality of Life-5 Dimensions Youth version
(EQ-5D-Y) and European Quality of Life-5 Dimensions (EQ-5D) (presented blind) data.
All data were stored securely and anonymised in accordance with the Data Protection Act,31 and the trial
was conducted in compliance with the principles of MRC’s Good Clinical Practice guidelines,32 the
Declaration of Helsinki33 and other requirements as appropriate. All research staff were trained in good
clinical practice in a paediatric setting and child protection awareness training.
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Informed consent
Informed consent was obtained in three steps, giving parents and children time to consider whether or
not they wished to participate. Each potential participant was given, or sent by post, information sheets
about the trial (child and parent versions). After a minimum of 3 days, parents were contacted by
telephone to ask whether or not they were interested in taking part in the trial and to answer any
questions. A researcher then visited the parent(s) and child(ren) at their home, and obtained the parent’s
written consent and the child’s written assent. All research staff were trained in informed consent,
including methods for assessing competence for consent, agreement to participate and obtaining assent
from children.
User involvement
Parents
A parent who had been a participant in the pilot of the Families for Health intervention was a member of
the TSC. She attended seven of the eight TSC meetings and contributed to discussions on the intervention
and study design.
Children
The aim for user involvement, as stated in the protocol, was met using the following approach. Claire
Callens and Carly Tibbins, from the user involvement team of the West Midlands Medicines for Children’s
Research Network carried out patient and public involvement consultation exercises with children from
the West Midlands prior to recruitment from January to February 2012, comprising two stages: stage 1,
two focus groups with hospital-based young person’s advisory groups (aged 8–18 years), which aimed
to develop and pilot questions for the second stage, and also included obtaining views on the acceptability
of wearing accelerometers to measure physical activity; and stage 2, consultation on the proposed
intervention and the research measurements (including accelerometers) with children in the target age
range for the trial (key stage 2, aged 7–11 years) from two primary schools from the areas in which the
trial was to be delivered.
A specific area of inquiry in the second stage of consultation was about the types of activities children
most enjoyed, which was used to inform the ‘activity tasters’ within the Families for Health intervention.
Older children (years 5 and 6) completed a questionnaire and younger children (years 3 and 4) voted, by
show of hands, on the options given for physical activity. Once they understood the concept of a children’s
gym, all children felt that they would like to attend one to see what it was like.
Across the two stages of consultation, 35 young people aged 7–18 years were consulted on
accelerometers in five focus groups. Prior to participation in the focus group discussion, 18 children were
given the opportunity to wear an accelerometer (GT1M ActiGraph; ActiGraph LLC, Pensacola, FL, USA).
First impressions of the acceptability of the accelerometer were often negative relating to comfort and
unwanted attention from friends, indicating that this may be a difficult tool to use. Others felt that an
increased attention from others would be positive. Ways to increase use by participants were suggested
as presenting the accelerometer in a very positive way, include a trial wearing period and providing
incentives.34 A full report of the user involvement consultation with children is available.35
Changes to project protocol
Some parts of the original protocol were changed, as can be seen in Table 1, which also shows where
appropriate approval was obtained.
TRIAL DESIGN AND METHODS
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Treatment groups
The intervention: Families for Health
Families for Health version 2 is a family-based programme aimed at the treatment of children (aged 6–11 years)
who are overweight or obese. Delivery is group based, and the aim was to recruit groups of 8–12 families, with
children and parents attending parallel groups. In families randomised to this arm, both parents were invited,
together with all overweight and non-overweight siblings in the target age range. Where necessary, the start
of a programme was delayed so that viable attendance numbers could be obtained. The programme was
manualised, with detailed handbooks available to facilitators, parents and children. Groups were run on a
Saturday morning or afternoon for 2.5 hours each week for 10 weeks. Follow-up sessions were planned for
1 and 3 months post intervention.
The main principles underpinning the Families for Health intervention were that the parents were identified
as the agents of change responsible for implementing lifestyle change in the family.29 A solution-focused
approach was employed, focusing on solutions rather than the problem. The programme emphasises
parenting skills, relationship skills, and emotional and social development, and combines this with
information about lifestyle, all of which are key to implementing and maintaining behaviour change.
Table 2 shows an outline of the main content of the parallel parents’ and children’s groups for the
10 weeks. The weekly topics in the Families for Health programme were broadly the same for both
parents’ and children’s groups, in order to promote greater understanding and discussion at home.
The parents and children met mid-way each week for a healthy snack and an active game, with an aim of
introducing ways in which children and parents could interact at home.
TABLE 1 Summary of changes to original FFH protocol approved by the NRES West Midlands: Coventry and
Warwickshire Research Ethics Committee and/or HTA programme
Change to protocol Approval Type and date approved
The CSRI was developed and given ethical approval prior
to piloting
NRES Substantial amendment 1, 17 January 2012
The inclusion criterion was changed from children aged
7–11 years to 6–11 years (parents of 6-year-old children were
coming forward requesting to participate)
NRES/HTA
programme
Amendment 2, 27 April 2012
The formatting of CSRI was changed after piloting, the
poster for recruitment was revised and the letter used for
recruitment via the NCMP was changed
NRES Amendment 3, 21 May 2012
Interviews were originally just going to be with families
in the FFH arm, but the protocol was changed to include
interviews with UC families as well in order to improve
comparison with UC
NRES Substantial amendment 4, 6 August 2012
HTA
programme
11 July 2012
Recruitment rates were slower than initially anticipated.
The emphasis on the type of recruitment method used
changed along with the study timelines as the study
progressed. Approval was given for GP databases to be
searched for potential overweight/obese children, who, once
identified, were contacted via letter
NRES Substantial amendment 5, 8 May 2013
Addition of a seventh FFH programme in order to reach
sufficient study participant numbers. This required a 9-month
no-cost extension (to 31 August 2015) to the study to enable
the 12-month follow-up of participants
HTA
programme
Approved by HTA on 19 June 2014
CSRI, Client Services Receipt Inventory; FFH, Families for Health; GP, general practitioner; HTA, Health Technology
Assessment; NCMP, National Child Measurement Programme; UC, usual care.
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The parents programme of the Families for Health programme shared some of parenting skills topics from
the Nurturing Programme from Family Links,27 and included both behavioural (e.g. positive discipline,
family rules) and relationship (e.g. giving praise, raising self-esteem, emotional health) approaches to
parent training. The support with parenting skills were integrated with family lifestyle topics around
healthy eating and physical activity in the weekly sessions. The approaches include facilitated discussion,
role-play, goal-setting, skill practice, a solution-focused approach and homework.
TABLE 2 Content of parents’ and children’s parallel groups for Families for Health (version 2)
Week Parents’ programme Children’s programme
1 Let’s get started
l What is health?
l Balancing act 1: energy in, energy out
l Let’s look after ourselves
Let’s get started
l Why be healthy?
l Balancing act 1: energy in, energy out
2 Balancing acts
l Discipline (including setting limits and praise)
l Balancing act 2: food our bodies need –
the Eatwell plate
Balancing acts
l Balancing act 2: what our bodies need to eat –
the Eatwell plate
l The gift of praise
3 Inner power – our ally for health
l Family guidelines and rewards
l Finding our power for health (focus on
physical activity)
Inner power – our health helper
l Our inner power
l Let’s get active
l Introducing the pedometer
4 The question of choice
l Our eating habits
l Children’s choices
Our choices
l Making strong choices
l Let’s go shopping
5 Health is a family affair
l How much we eat (portion sizes)
l Building self-esteem
Liking ourselves
l Glad to be me
l Let’s make a rainbow (of fruit and vegetables)
6 Feelings – a guide to our emotional health
l Thinking about feelings
l Active alternatives to staring at the screen
Getting to know our feelings
l Feeling up, feeling down
l Screen savers: what else can we do?
7 Solutions to stress
l Stress – and what we can do about it
l Coming to our senses
l Surviving at the supermarket
Time to chill out
l What winds us up?
l What calms us down?
l Activity taster
8 A world of labels
l Food labels: what do they mean?
l Labelling our children
Food detectives
l What’s on the label?
l Activity taster
9 Taking charge
l From problem to solution
l A healthy lifestyle or a life of diets?
l Meeting the challenge of special occasions
Living healthily
l Problems, puzzles and solutions
l Activity taster
10 A healthy family future
l Scaling the ladder to health
l We are stars!
l Family party: time to celebrate
(Combined session with parents)
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The children’s programme included a focus on healthy eating using the Eatwell plate as the basis; circle time
to discuss emotional aspects of their lives and enhancing self-esteem; and physical activity aimed to increase
activity levels by participation in games, the use of pedometers and introduction to new physical activities.
Families in the intervention arm were also eligible for usual-care interventions and any usual care they
received was documented.
Training and selection of facilitators: Families for Health
Four facilitators, two for the children’s group and two for the parents’ group, were required to run each
Families for Health programme. Facilitators were identified from the local NHS or other services, and
selected on the basis of personal attributes including empathy for families with overweight children and
previous relevant experience, for example with running groups with parents and children. In site A, a
formal application process was set up, whereas for sites B and C nominations were received through the
leads for obesity. Professional backgrounds of facilitators included community nursing, teaching, youth
work, leisure services and nutritionists.
Nineteen facilitators attended a 4-day training course in February 2012 provided by two trainers from
Family Links. Trainers from Family Links were used to deliver the training because of the close association
of the Families for Health programme with the Nurturing Programme from Family Links.27,28 The training
covered the content, philosophy and logistics of running the programme. For some sessions facilitators
were divided up into subgroups of whether they were facilitating the children’s or parents’ group, and
practised facilitating parts of the programme. Participants completed an evaluation form for each day
of the training, including the level of confidence in delivering the Families for Health programme and
rating the usefulness of the topics covered. Training increased facilitators’ confidence in delivering the
programme and most found the training a positive and useful experience. Further details of the evaluation
of the training of the facilitators are in Appendix 1.
Usual-care control group
Families assigned to the control arm were offered any usual care that was available in their area.
During the duration of the study, usual care for each locality varied.
Site A had the One Body One Life (Coventry City Council, Coventry, UK) 10-week programme, which is
a group-based family intervention that has been subject to published evaluation.36 This was available
throughout the study. The eligibility criteria for the One Body One Life programme was children aged
7–16 years, but was offered to the whole family if one or more member of the family was an ‘unhealthy
weight’. The programme took a solution-focused approach, with the 1.5-hour sessions comprising a
45-minute physical activity workshop and a 45-minute healthy eating workshop.
Site B had Change4Life (Department of Health, London, UK) advisors who offered one-to-one support for
weight management for children aged 4–13 years who were overweight or obese. Recruitment to their
service was via self-referral, referral from school health or other health professionals, and via the National
Child Measurement Programme (NCMP). Visits were mainly undertaken at the child’s home. This service
was available for the majority of the study, though in the final few months of recruitment funding for
Change4Life advisors was withdrawn and a single telephone call was instead being offered.
In site C, usual care was one of the following: (1) a weight management programme for children and young
people aged 7–15 years, comprising a two-step programme, MEND and Choose It (Wolverhampton City
Council, Wolverhampton, UK), focusing on taster sessions for physical activity and healthy eating. Funding
for this programme was withdrawn halfway through the study and so two alternatives were offered as
‘usual care’ in site C, depending on the age of the child; (2) Weight Watchers® (Weight Watchers UK Ltd,
Maidenhead, UK) for young people aged ≥ 10 years, who had to be accompanied by a parent; and (3) a
referral to the school nurse for children aged 6–9 years, where children would be weighed and measured
and offered advice. This type of usual care was not standard at the start of the study and, therefore, did not
always occur as hoped. Table 3 gives further details of the usual-care programmes.
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Participants
The study recruited children aged 6–11 years who were overweight or obese and their parent(s) from the
three primary care trusts.
Inclusion criteria
Families were considered for inclusion if:
l they had at least one overweight (≥ 91st centile for BMI) or obese (≥ 98th centile for BMI) child
aged 6–11 years, based on the UK 1990 BMI37
l at least one parent or guardian and the overweight child was willing to take part.
Exclusion criteria
Families were excluded if:
l the parent or child had an insufficient command of English and would find it difficult to participate in
the group
l the child had a metabolic or other recognised medical cause of obesity
l the child had severe learning difficulties and/or severe behavioural problems, and would find it difficult
to participate in a group-based programme.
TABLE 3 Usual-care programme details
Usual-care programme Delivery Core themes
One Body One Life (site A) Parent and child group based
1.5 hours weekly for 10 weeks
Delivery at school or community venue
Healthy eating
Physical activity
Health checks
Change4Life advisor (site B) Parent and child one to one with
Change4Life advisor
First session ≈ 1.5 hours, subsequent
visits ≈ 45 minutes
Number of visits varies according to
family needs (average 5 visits)
Majority of visits at home, occasionally
at school or clinic
Healthy eating (Eatwell plate; portion
sizes, food labelling)
Increasing physical activity
Self-esteem
Weight management programme for
parents and children (site C)
Parent and child group based
2 hours weekly for 10 weeks
Delivery at community venue
MEND programme and Choose It
(focusing on taster sessions for
physical activity and healthy eating)
Weight Watchers for children aged
≥ 10 years (site C)
Parent and child group based
1 hour weekly for 12 weeks
Delivery at community venue
Healthy eating (portion sizes)
Encourage increased physical activity
(pedometers for sale)
School nurse referral for children aged
6–9 years (site C)
One to one Weighed and measured
Offered advice
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Recruitment
The aim was to recruit 40 families from each of the three primary care trusts. At the time of recruitment,
data from the NCMP 2008/938 showed an abundant pool of potential participants in just one school year
(year 6) (Table 4).
Both active and passive recruitment methods were used. Initially, passive recruitment included advertisements
in newspapers and local radio interviews, whereas active recruitment involved letters to families with an
overweight or very overweight child, who had recently been measured in the NCMP, and referrals from
health-care professionals. However, recruitment was slower than planned so further recruitment strategies
were employed including letters to families from the family’s general practitioner (GP) and approaches from
Change4Life advisors. Flyers and posters were also sent to be displayed in schools, the community, primary
care surgeries and the local hospital, and there were recruitment stands at local public events. As recruitment
continued, word of mouth from families enrolled in the trial became a successful recruitment method.
Randomisation, allocation concealment and blinding
The unit of randomisation was the family. Researchers registered families after confirming eligibility
and obtaining consent, and after completing the baseline data collection in order to ensure allocation
concealment. The term ‘control’ was not used at any time with the families and they were told that they
would be receiving one of two possible programmes, either Families for Health or usual care. After
consent, the family was allocated to intervention or control by the central telephone registration and
randomisation service at the Warwick Clinical Trials Unit. Randomisation was stratified by locality (site A, B
or C) using a biased-coin (p= 2/3) minimisation method within each locality to ensure that approximately
equal numbers of families were randomised to the Families for Health programme and control. The trial
administrator (EH) assigned the participants to the interventions that they were allocated to.
The families could not be blinded to treatment allocation, but every effort was made to ensure that the
research personnel involved with data collection remained blind to treatment allocation until the initial
data collection was complete. Blinding was not an issue at baseline because all data collection was done
before randomisation. A ‘blinding protocol’ recorded the systems in place to keep the researchers blind to
treatment allocation at the 3- and 12-month follow-up visits, which included the following.
1. The family was reminded via letter and telephone call by the trial administrator that they were not to
discuss their allocation with the researcher at the visit until requested.
2. The researcher took all anthropometric measurements first and then the parent(s) and child(ren)
completed their self-administered questionnaires. The Client Services Receipt Inventory (CSRI)
TABLE 4 Prevalence of obesity (≥ 95th centile) in year 6 (aged 10–11 years) for the proposed study recruitment sites
Location
Number
eligible
Number
measured
Participation
rate (%)
Prevalence of obesity,
% (95% CI)
Number of obese
Year 6 children
Site A 3477 3152 90.7 19.4 (18.0 to 21.3) 611
Site B 5548 4584 82.6 15.1 (14.1 to 17.2) 692
Site C 2827 2649 93.7 23.5 (21.9 to 25.5) 623
West Midlands SHA 62,526 55,993 89.6 19.8 (19.5 to 20.8) –
England 558,633 497,680 89.1 18.3 (18.2 to 19.1) –
SHA, Strategic Health Authority.
Source: NHS Information Centre (NCMP 2008/9).38
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questionnaire and the interview (if being carried out) both unblinded the researcher and so these were
administered last.
3. The researcher that conducted the 3-month follow-up visit (who was now unblinded) did not conduct
the 12-month follow-up visit for the same family. A different researcher who was blind to treatment
allocation conducted the 12-month follow-up visit.
In order to ascertain whether or not the assessors were blind to the allocated arm, an ‘unblinding log’
was kept by the trial administrator to record if a researcher was inadvertently unblinded to allocation.
On 21 occasions the follow-up visits were completed by an unblinded researcher who knew the treatment
allocation at the start of the research visit (e.g. because a family mentioned the name of the programme
that they had been on at the start of the home visit).
Statisticians (TH and NS) were blinded for the interim analysis for the DMEC, but neither the statisticians
nor health economists were blinded for the final analysis presented to the combined meeting of the
TSC and DMEC. This policy was agreed by the TSC.
Data collection and management
All members of the research team were trained to use standard operating procedures for each stage of
data collection. Data entry was carried out by the trial administrator and members of the research team
and then checked by a different team member to minimise data entry errors. The software for data entry
was bespoke, in that it was custom made and managed by the University of Warwick Clinical Trials Unit
programming team.
A number of different measures were used to collect information on the impact of the intervention
(see Table 5). All of these were measured in the family home at baseline, at the end of the 10-week
Families for Health programme (or approximately 3 months in the usual-care arm) and at 12 months from
baseline. In families with more than one eligible child who met the inclusion criteria, data were collected
on all participating overweight or obese children. Research visits in the family home took, on average,
between 1 and 3 hours, depending on whether they were baseline or follow-up and whether or not
interviews were carried out.
Baseline assessment
All baseline visits took place between 16 March 2012 and 11 February 2014. A researcher assessed the
family’s eligibility for the trial and obtained the parents’ consent and children’s assent. Parents were
asked to complete a brief baseline questionnaire that included the parent’s date of birth (needed for
randomisation), the child(ren)’s date of birth (age), sex and ethnic group, and primary care contact details.
At the same time, parents were asked whether or not they were consulting anyone else about their child’s
weight, whether the child suffered from any medical conditions or allergies, whether or not either of them
was taking part in any other research project and what the main reasons were for wanting to address
their child’s weight or lifestyle. Family structure was categorised into five groups: (1) two-parent family,
(2) single mother, (3) single father, (4) stepfamily or (5) other. The researcher also asked how the family
heard about the Families for Health programme. Subsequently, the researcher took the parent and child
through all of the questionnaires described in detail below.
For families allocated to the Families for Health programme, the period between the baseline visit and the
start of the intervention was, on average, 94 days, with a minimum waiting time of 1 day and a maximum
waiting time of 346 days. In site A the mean waiting time was 93 days, in site B it was 73 days and in
site C it was 114 days. No equivalent information was available for families allocated to usual care.
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Follow-up
All 3- and 12-month follow-up visits took place between 27 July 2012 and 9 May 2014 and between
12 March 2013 and 11 March 2015, respectively. Follow-up data collection was scheduled at 3 and
12 months post randomisation. The 3-month visit had been planned to coincide with the completion of
the Families for Health intervention. However, some families had to wait until there was a viable number
of families to form a group (a minimum eight families) before starting the intervention. Therefore, some
post-intervention follow-ups were more than 3 months after randomisation. For families receiving usual
care, 3-month follow-up visits were always scheduled for 3 months post randomisation regardless of
whether or not they had accessed a usual-care intervention at that point. All 12-month follow-up visits
were carried out at 12 months from baseline, by a different researcher from the one who carried out the
3-month follow-up, in order the maintain blinding. Where the 3- and 12-month follow-up were too close,
that is, when a family had waited so long for the intervention group to start that there would be less than
1 month between 3 and 12 months, then a combined 3- and 12-month visit was carried out. Separate
one-to-one in-depth interviews with the parent and child were carried out at the 3- and 12-month
follow-up, respectively, with an original plan of carrying out interviews with 24 families from each trial
arm. The following table (Table 5) demonstrates the different measures used in the study, who (child or
parent) this was collected from and at what time point.
Outcomes
Anthropometric
Child weight and height (body mass index)
The primary outcome measure was the change in children’s BMI z-score at 12 months compared with
the change in the control arm. Weight was measured using the Tanita body composition analyser
(model BC-420S MA; Tanita Europe B.V., Amsterdam, the Netherlands) to the nearest 0.1 kg, taken
without shoes and in light, indoor clothing. Children were asked to stand still on the scales with arms by
their side. Height was measured by a Leicester stadiometer (Harlow Healthcare, South Shields, UK) to the
nearest 0.1 cm, without shoes, with feet together and flat on the floor with heels touching the base of the
stadiometer. Children were asked to put their arms by their side and look straight ahead, and then their
head was adjusted if required so that their ear hole was aligned with the bottom of the eye socket
(the Frankfurt plane). The measuring arm of the stadiometer was lowered onto the top of the head to
measure height. BMI was calculated using the following equation:
BMI =
weight (kg)
height2 (m)
, (1)
and then was converted into standard deviation (SD) scores (z) from 1990 UK growth reference curves, giving
a BMI z-score.37 The BMI z-score is used because it takes into account children’s age and sex, and indicates
how many SDs a child’s BMI is above or below the average BMI for their age and sex. This was carried out
using LMSgrowth (version 2.77; Harlow Healthcare, South Shields, UK; www.healthforallchildren.com/
shop-base/shop/software/lmsgrowth), which is a Microsoft Excel® 2010 (Microsoft Corporation, Redmond,
WA, USA) add-in, designed to manipulate growth data using growth references based on the LMS method.
Child waist circumference
Waist circumference was measured to the nearest 0.1 cm using a Seca 200 tape (Seca, Birmingham, UK)
taken at the level of the umbilicus, consistent with the method of Daniel et al.56 Measurements were made
without compressing the skin, taken while standing with feet together, arms hanging by side and looking
straight ahead. Measurements were taken under clothes, unless a child was uncomfortable with this and
then the measurement was taken over a thin layer of clothing. Where this was the case, a note was made
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at the time of data collection. Waist circumference was translated into z-scores for age and sex using 2001
reference data for British children aged 5–16 years.39
Percentage body fat
An indirect measure of percentage body fat was made using the Tanita scales using bioelectrical impedance
analysis.40 An electrical signal (50 kHz, 800 µA) is sent through the body via the pressure-contact electrodes
on which the participant stands, to get a measure of impedance (Ohms). The percentage of body fat is
calculated using an in-built equation based on impedance, height, age, sex and body type.
Parent weight and height (BMI)
Height was recorded using a Leicester stadiometer and weight with Tanita scales, as with children. No
waist circumference measurements were taken for parents. BMI and percentage body fat were calculated.
Physical activity and diet
Accelerometry: time spent in physical activity and intensity
All children on the trial were asked to wear an accelerometer for 7 days following the baseline and
12-month follow-up assessments in order to provide an objective measure of the amount of physical
activity undertaken over a period of 7 days. Accelerometers are able to record the participant’s movement
such that their physical activity level can be translated into a number of different outcomes, including total
step count, bouts of physical activity at specified intensities or energy expenditure. Accelerometry data
were collected using the ActiGraph GT3X, programmed to record using 15-second epochs. Data were
analysed using the Actilife 6 Data Analysis Software (ActiGraph LLC, Pensacola, FL, USA).
Children, with help from parents, were asked to complete an activity diary alongside the accelerometer
for 7 days. This was a pictorial ‘tick-box’ diary recording activities each hour, with a column for free-text
additional comments. There was also a place to record the time the accelerometer was put on and taken
off. The purpose of the diary was to aid interpretation of the accelerometer output.57 Children and parents
were provided with instructions on receiving the accelerometer about how to wear it. Children were fitted
with accelerometers located at the waist at the left-hand side of the body on an elastic belt, with the
open/close button (to connect accelerometer to computer) facing upwards. They were asked to wear the
device under or on their clothes during all waking hours, except when undertaking water-based activities.
Data were collected for 7 consecutive days and thus included both weekdays and weekends. Owing to
previous evidence suggesting that differences in activity levels exist during school time and out of school
time,58 where possible accelerometers were worn during the school term, in order to keep measurements
consistent across participants. If this was not possible (e.g. a child did not feel comfortable in wearing it
during term time) it was worn during holiday time in order that some (rather than no) activity data were
collected. In all circumstances, the 12-month follow-up data collection took place at the same time of year
and consistently in either term time or holiday time. The outcome was measured at baseline and 12 months
in order to minimise seasonal effects.59 The date of wearing the accelerometer was recorded in the project
management file. At the end of the 7-day period, the researcher collected the accelerometer and
accompanying activity diary from the participant’s home.
Children’s fruit and vegetable consumption
Children completed a 24-hour recall using the ‘Day in the Life Questionnaire’.43 This also asked about
transport to and from school and daily activity, but the primary aim was to assess the number of portions
of fruit and vegetables consumed the previous day. The questionnaire was checked and clarification
sought, if necessary, with parents (e.g. orange juice: was this ‘squash’ or ‘fruit juice’?). In line with national
recommendations (NHS Choices60), fruit juice could account for only one portion of fruit and vegetables
per day, regardless of how much was consumed, and how often. Similarly, baked beans were counted
as one portion regardless of how many times they were consumed in a single day. Composite foods
(e.g. curry, pizza) that contained a unknown number portions of fruit and vegetables were excluded.
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The questionnaire has been validated for measuring fruit and vegetable consumption with 7- to 9-year-olds.43
The validation was done with four schools, comparing the questionnaire with observation by a researcher for
fruit and vegetables eaten at lunchtime, achieving a modest kappa of 0.54–0.58. The reliability was assessed
both by a test–retest, which was acceptable, and by inter-rater reliability of two coders assessing the portions
of fruit and vegetables, with a high kappa of 0.85–0.92, indicating high agreement between coders. The
questionnaire was also shown to be sensitive to change following the distribution of free fruit, confirming it as
a good questionnaire to use in the current study, in order to measure any change in fruit and vegetable intake.
Family eating and activity
Eating and activity behaviour in the family was assessed using a modified version of the Family Eating and
Activity Habits Questionnaire (FEAHQ) from Israel.44 Slight modifications were made to make it suitable for
use in the UK. This was principally in the list of snacks in question 5, excluding those not heard of in the
UK (e.g. Chitos, Ruffles) and adding in those that were common in the UK (e.g. crisps). The questionnaire
includes the following four subscales: (1) activity level (four items), to record the balance between physical
activity and sedentary pastimes (e.g. television); (2) stimulus exposure (eight items), for example presence
and visibility of unhealthy snacks kept at home, allowed to eat snacks/sweets without parental permission,
allowed to buy own sweets; (3) eating related to hunger (four items), for example who initiates the eating
in the family or behaviour if the child is not hungry; and (4) eating style/rites (13 items), for example where
and with whom does eating take place and second helpings. Cronbach’s alpha as a measure of internal
consistency reliability was calculated at α= 0.83 for the questionnaire overall and α= 0.82, 0.78, 0.86 and
0.88 for the subscales 1–4, respectively.44 Parents completed the questionnaire and then summary scores
were calculated for the children’s score for the four sections in accordance with the scoring instructions.
Lower scores are classed as ‘better’ on each section.
Physical and mental health
Children’s quality of life
Children’s quality of life was measured using the Pediatric Quality of Life InventoryTM (PedsQL) version 4.0
(UK) for ages 8–12 years.45 Children completed the 23-item self-report version and the parents completed
the almost identical parent-proxy version about their child’s quality of life. This measures four domains of
health-related quality of life: (1) physical health (eight questions), (2) emotional health (five questions),
(3) social functioning (five questions) and (4) school functioning (five questions). All items are rated on a
5-point Likert scale from 0 (never a problem) to 4 (almost always a problem), which are then rescored:
0= 100, 1= 75, 2= 50, 3= 25, 4= 0. Summary scores are then derived for the physical domain
(eight questions), the psychosocial health domain (emotional/social/school) (15 questions) and for a total
scale score (all 23 questions), with the best possible score being 100 (range 0–100).
Varni et al.46 measured the internal consistency reliability of PedsQL using Cronbach’s alpha, with
963 children and 1629 parents in a US sample. The Cronbach’s alpha scores showed that the
questionnaire had internal reliability for the total score (all 23 questions, α= 0.88 for child report, α= 0.90
for parent report), the physical health score (eight questions, α= 0.80 for child-report, α= 0.88 for parent
report) and the psychosocial summary score (15 questions, α= 0.83 for child report, α= 0.86 for parent
report). This study demonstrated the reliability and validity of the PedsQL version 4.0. The reliability of the
UK version of the PedsQL was also assessed in a sample of 1399 children and 970 parents from south
Wales, and was shown to have similar internal reliability with all subscales on both the child and parent
reports, reaching α= 0.70 (minimum standard) and exceeded α= 0.90 for the total score.47 They
recommend the UK version of the PedsQL for assessment of quality of life in UK children.
Parents’ mental health
Parental mental health was measured using the Warwick–Edinburgh Mental Well-Being Scale
(WEMWBS).48 WEMWBS is a measure of mental well-being focusing entirely on positive aspects of mental
health. The scale consists of 14 items, covering aspects of mental health including positive affect (feelings
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of optimism, cheerfulness, relaxation), satisfying interpersonal relationships and positive functioning
(energy, clear thinking, self-acceptance, personal development, competence and autonomy). Individuals
completing the scale are required to tick the box that best describes their experience of each statement
over the past 2 weeks using a 5-point Likert scale (none of the time, rarely, some of the time, often,
or all of the time). The Likert scale represents a score for each item from 1 to 5, respectively, giving a
minimum score of 14 and a maximum score of 70. All items are scored positively. The overall score for the
WEMWBS is calculated by totalling the scores for each item, with equal weights. Therefore, a higher
WEMWBS score indicates a higher level of mental well-being. WEMWBS has shown good content validity.
In addition, WEMWBS has shown high correlations with other mental health and well-being scales, and
partial correlations with scales measuring overall health.48
Family relationships
Relationship between parents and children
Assessment of the quality of the parent–child relationship was made using the Child–Parent Relationship
Scale (CPRS),49 which was self-completed by parents. The CPRS assesses parents’ perceptions of their
relationships with their sons and daughters. The short-form version was used, which has 15 items assessed
on a 5-point Likert scale, with eight of the questions reverse scored. A mean score is derived with the best
possible score being 5 (range 1–5).
The eight-item conflict subscale measures the degree to which a parent feels that his or her relationship with
a particular child is characterised by negativity. In order to test the validity of the CPRS, structured interactions
between parents and study children were videotaped at 54 months and 6–7 years old. The Cronbach’s alpha
for maternal conflict was 0.84 at 54 months and 0.84 at 6–7 years old, whereas the Cronbach’s alpha for
paternal conflict was 0.80 at 54 months and 0.78 at first grade. The seven-item closeness scale assesses the
extent to which a parent feels that the relationship is characterised by warmth, affection and open
communication. The Cronbach’s alpha for maternal closeness was 0.69 at 54 months and 0.64 at first grade,
whereas the Cronbach’s alpha for paternal closeness was 0.72 at 54 months and 0.74 at first grade. The
conflict and closeness scales of the CPRS represent two distinct domains of parent–child relationships, as
evidenced by a relatively low correlation between the scales (r= 0.16).
Parenting style
Parenting style was measured using the Parenting Styles and Dimensions Questionnaire (PSDQ).50
The PSDQ assesses how often a parent exhibits certain behaviours towards his or her child. It has 32 items
contributing to three factors: (1) authoritative parenting style (measuring parent–child warmth and
connection, parental use of reasoning, and inductive parenting and autonomy granting, e.g. ‘I help my
child to understand the impact of behaviour by encouraging my child to talk about the consequences of
his/her own actions’); (2) authoritarian parenting style (measuring physical coercion, verbal hostility and
non-reasoning/punitive disciplinary practices, e.g. ‘When my child asks why he/she has to conform, I state:
because I said so, or I am your parent and I want you to’); and (3) permissive parenting style (measuring
parental indulgence and inconsistency, e.g. ‘I give into my child when the child causes a commotion about
something’). Parents were asked to respond by indicating on a scale of 1–5 (never to always) how
frequently they performed the behaviour in question. The PSDQ has been shown to demonstrate adequate
reliability and validity.50
Economic outcomes
European Quality of Life-5 Dimensions Youth version health-state valuation
of the child
Children completed the descriptive system and the visual analogue scale from the EQ-5D-Y questionnaire
at each visit, with the view to describing their health-related quality of life.51,53 The descriptive system
comprises the following five dimensions: (1) mobility; (2) self-care; (3) usual activities; (4) pain/discomfort;
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and (5) anxiety/depression. Each dimension has three levels: no problems, some problems and extreme
problems. The respondent is asked to indicate their health state by ticking (or placing a cross) in the box
against the most appropriate statement in each of the five dimensions. The 20-cm visual analogue scale is
anchored by the descriptors ‘best possible health’ (100%) and ‘worst possible health’ (0%), with children
placing a mark on how they valued their health on the day of the visit.
European Quality of Life-5 Dimensions Youth version health-state valuation
of the child by parent
Parents also completed the EQ-5D-Y questionnaire describing their child’s health-related quality of life on
the day of each visit. This included the same descriptive questions as those asked of the child (as detailed
in European Quality of Life-5 Dimensions Youth version health-state valuation of the child). On the visual
analogue scale, parents were asked how they thought their child would value their own health.
European Quality of Life-5 Dimensions health-state valuation: parent’s own
Parents completed the EQ-5D questionnaire describing their own health-related quality of life on the day
of each visit.52
Services received by child
A modified version of the CSRI was used to record hospital and community health and social services
received by each child, as well as broader service utilisation (adaptation of CSRI from Beecham and
Knapp54), at baseline, 3 and 12 months. The unit costs of each resource item were valued using both
primary research, based on established accounting methods, and data collated from secondary national
tariff sets.61–64 Further details of the methods used are provided in Chapter 5.
Socioeconomic classification
Families’ socioeconomic classification was measured using details of parental employment. Employment
status and type of employment of the mother and/or father was recorded, including their actual
occupation and whether they were self-employed or an employee. This information was used to code
families into eight socioeconomic classes using the The National Statistics Socio-Economic Classification.55
As the number of families was small, this was subsequently collapsed into three classes, plus a fourth
category of ‘never worked and long-term unemployment’ (Table 6).
TABLE 6 Eight- and three-group versions of The National Statistics Socio-Economic Classification
Eight classes Three classes
1. Higher managerial and professional occupations 1. Managerial and professional occupations
1.1 Large employers and higher managerial occupations
1.2 Higher professional occupations
2. Lower managerial and professional occupations
3. Intermediate occupations 2. Intermediate occupations
4. Small employees and own-account workers
5. Lower supervisory and technical occupations 3. Routine and manual occupations
6. Semiroutine occupations
7. Routine occupations
8. Never worked and long-term unemployed Never worked and long-term unemployed
Source: Office for National Statistics.55
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Sample size
Original sample size justification
Power calculations assumed a residual SD in the BMI z-score of 0.22, a SD of the random family effects of
0.14, an intracluster correlation of 0.1 in the intervention groups, a two-sided significance of 5% and that
60% of participating families have one overweight or obese child and 40% have two with a within-family
intracluster correlation of 0.27. Allowing for clustering effects by family and for group effects in the
intervention arm, a sample size of six groups of 10 families (60 families) in the intervention arm and
60 families in the control arm gives a power of 94% to detect an intervention effect of 0.2 in BMI z-scores
based on pilot study data and relevant literature.24,65 If 30% of families were to drop out, the study retains
a power of 88%. As a check, the power was calculated when no families have more than one overweight
or obese child. In this case, the power is 92% or 83% if 30% of families drop out. Power values were
estimated using a simulation study including 10,000 simulated trials.
Updated sample size calculation
Recruitment to the trial was slower than expected, leading to smaller groups for the Families for Health
programme than planned; therefore, the addition of a seventh Families for Health programme was
proposed. On 19 June 2014 this amendment to the Families for Health protocol was approved by Health
Technology Assessment. The sample size calculation was updated to incorporate the additional
programme and recruitment thus far (all other assumptions of the sample size calculation remained the
same). A sample size of seven groups of eight families (56 families) in the intervention arm and 56 families
in the control arm yields a power of 91% to detect an intervention effect of 0.2 in BMI z-scores if seven
families (one with two children) were providing 12-month follow-up data (12.5% dropout) and 88%
power if six families (one with two children) were providing 12-month follow-up data (25.0% dropout).
If no families had more than one child, then the power would be 89% and 85% for the 12-month
follow-up of seven and six families per programme, respectively.
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Chapter 3 Statistical analysis methods
Analysis of accelerometer data
Accelerometer data were reduced and analysed as follows. Evenson et al.’s41 activity count cut points for
the ActiGraph for physical activity intensities (sedentary, light, moderate or vigorous) were used for the
analysis, as recommended by Trost et al.42 (Table 7). The Evenson cut point associated with moderate to
vigorous physical activity in children is 2296 counts per minute.
Not all the accelerometer records were complete. A child’s record was included in the analysis if there were
at least 3 complete days of data, taken as the minimum needed to obtain a reliable measurement of
habitual physical activity in children, at both baseline and 12-month follow-up. A complete day was defined
as one where there was ≥ 8 hours of data, after excluding periods in the day when the accelerometer
appeared not to have been worn. Although 10 hours of worn time is often used, the reliability between
7 and 10 hours is not substantially different.66 Non-wear time was identified from the data by periods of
≥ 60 minutes of consecutive zero counts, making it unlikely that the monitor was being worn.
At each time point for each child with complete records, the mean daily time spent in moderate and
vigorous physical activity, sedentary time, accelerometer counts per minute and daily step count were
calculated using the Actilife 6 Data Analysis Software.
Statistical methods
A comprehensive statistical analysis for the Families for Health trial was conducted with the aim of
assessing the effectiveness of the Families for Health programme, in comparison with usual care, in the
treatment of overweight and obesity among children aged 6–11 years. The prespecified primary outcome
measure in the statistical analysis was the change in children’s BMI z-score from baseline to 12 months’
follow-up so that clinical effectiveness would be declared based on a reduction in BMI z-score relative to
the comparator. Secondary outcomes in the statistical analysis fell into four categories: (1) anthropometric
measures in children; (2) anthropometric measures in parents; (3) (validated) questionnaires completed by
children; or (4) (validated) questionnaires completed by parents. Table 5 provides an overview of all
outcomes analysed and the time points at which they were measured.
General statistical considerations
The primary outcome analysis as well as all secondary outcome analyses were conducted at the
conventional (two-sided) 5% level and, corresponding to this, all presented CIs are 95% CIs. As specified
TABLE 7 Evenson’s ActiGraph accelerometer cut points for sedentary, light, moderate and vigorous physical activity
for children
Time period
Cut points
Sedentary Light Moderate Vigorous
Per 15 seconds 0–25 26–573 574–1002 ≥ 1003
CPM ≤ 100 101–2295 ≤ 2296 (moderate to vigorous)
CPM, counts per minute.
Source: Evenson et al.41 and Trost et al.42
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in the statistical analysis plan, no formal adjustment for multiple testing among the secondary end points
was used as outcomes are likely to be highly correlated so that standard adjustment techniques, such as
the Bonferroni method, would be conservative. All outcome measures and child/parent characteristics were
summarised by the trial allocation group and for outcome measures by follow-up period. The distribution
of outcome data was investigated and transformations applied, if necessary, before performing statistical
tests and modelling. The main analysis of clinical outcome data was the comparison of change from
baseline between treatment groups. Using the change from baseline has a ‘normalising’ effect so that
standard techniques could generally be used.
Unless otherwise stated, all analyses were performed on an intention-to-treat basis, that is all participants
were analysed in the arm they were allocated to and included regardless of whether or not the treatment
and follow-up schedule was complied with. This reflects the pragmatic nature of the trial and ensures
that conclusions drawn from the analysis will reflect the impact of the Families for Health programme in a
real-world setting.
The statistician conducting the statistical analysis was unblinded for the final statistical analysis and the
analysis presented at the final DMEC/TSC meeting. The multilevel models originally proposed to be
adopted in the analyses (see Primary outcome analysis) consist of two hierarchical levels in the usual-care
arm and three levels in the intervention arm. For these models to be fitted, the participants’ group
affiliation needed to be revealed. Unblinding was agreed to by the TSC.
The entire statistical analysis was conducted using SAS v9.4 TSL1M2 (SAS Institute Inc., Cary, NC, USA)
with the exception of the sample size calculation, which was conducted using R versions 2.10 and 3.0
(R Foundation for Statistical Computing, Vienna, Austria).
Primary outcome analysis
As indicated above, the primary outcome for the statistical analysis was the mean change in child BMI
z-score after 12 months of follow-up compared between treatment arms. It was anticipated that these
data would be correlated within families (if more than one child of a family participates in the trial) and
within delivery groups in the Families for Health intervention arm. The analysis allowed for this clustering in
order to obtain unbiased estimation of the treatment effect and its standard error (SE).67
A three-level hierarchical mixed-effects model was proposed to be fitted in the statistical analysis plan.
At the highest level of the model a random effect for delivery group was intended. Delivery group-level
clustering would have been allowed for in the Families for Health arm only, as usual-care interventions
varied by site, were not necessarily group based and precise details on usual-care treatment received were
generally not available. As the statistical analysis showed, there was no evidence of delivery-group
clustering and models comprising this random effect failed to converge (see Chapter 4, Main primary
outcome analysis). The decision has therefore been made (and been approved by the TSC) to remove this
effect from all hierarchical modelling and to use a two-level hierarchical mixed-effects model instead.
Correlation between measurements of children within family was allowed for in both arms.
The multilevel model was adjusted for the child-level characteristics, baseline BMI z-score and sex, and
family-level variable ‘locality’ as fixed effects. Additionally, adjustment for the family-level characteristic
socioeconomic status (SES) and child-level characteristic ethnicity was explored. Restricted maximum
likelihood estimation was employed for estimating covariance parameters in the multilevel modelling.
The Satterthwaite approximation68 was used for computing the denominator degrees of freedom for the
test of a treatment effect difference between the allocation groups (and for tests of other fixed effects).
The primary analysis is a complete case analysis in the sense that if either the baseline or 12-month
follow-up z-score was missing the subject had to be omitted from the analysis.
STATISTICAL ANALYSIS METHODS
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Sensitivity analyses for the primary outcome
Several sensitivity analyses were undertaken to assess the impact of areas of uncertainty surrounding the
primary outcome analysis and its robustness. These involved re-estimating the treatment effect under the
following scenarios: (1) conducting a per-protocol analysis in which families having participated in five or
more sessions of the Families for Health programme are regarded as ‘programme completers’ (i.e. as having
complied with the protocol sufficiently); and (2) (multiple) imputation of missing primary outcome data.
Three standard imputation techniques were employed to assess the sensitivity of the analysis to the
missing data: first, simple regression imputation, in which missing values are imputed by predicted values
from a linear regression model using the same predictors as the primary outcome analysis; second, multiple
imputation methods Markov chain Monte Carlo;69 and, third, fully conditional specification regression.70
For the two multiple imputation analyses, 200 burn-in iterations were used and estimates averaged over
100 imputed data sets. Baseline BMI z-score, age, sex and site were included as explanatory variables in
the imputation models. Imputations were generated separately for each treatment group.
Subgroup analyses
To explore heterogeneity in the trial population, the following prespecified exploratory subgroup analyses
were conducted with respect to the primary outcome:
l child’s sex (male or female)
l locality (site)
l SES (according to The National Statistics Socio-Economic Classification’s55 four-class standard classifications)
l parent’s BMI at baseline (normal, overweight or obese)
l age of child at baseline (6–8 years or 9–11 years).
The difference in treatment effects by subgroups was initially assessed by interaction tests. These were
performed via significance tests of interaction terms in the hierarchical model utilised for the primary
outcome analysis. Variables that have been categories for subgroup analyses (e.g. age, parent BMI) were
also investigated as covariates on their original scale. Separate models were then fitted for each subgroup
to obtain estimates of the treatment effects within subpopulations.
Repeated measures modelling
An exploratory analysis was performed for the investigation of the difference between arms in terms of
change over time in the primary outcome measure rather than a comparison between arms at either 3- or
12-month follow-up. In this analysis, the time at which follow-up data were provided was fitted as a
continuous variable, accounting for the fact that the actual times varied widely (especially for the 3-month
follow-up). For this purpose a repeated measures mixed model was fitted. This model was based on
the aforementioned hierarchical model for the primary outcome analysis comprising the same effect
(plus time). Model complexity was increased as time became the new first-level (random) factor. The
same model specification, as in the primary outcome multilevel model (restricted maximum likelihood
estimation), was used where possible. An unstructured covariance matrix was assumed for the correlation
between measuring time points.
Analysis of baseline demographic data
Baseline demographic outcomes were obtained on a family level or on a child/parent level. Summary
statistics (mean and SD for continuous variables and absolute number and percentage for categorical
variables) were calculated for all participants recruited to the trial and for the two treatment groups
separately. The characteristics within the two treatment groups were compared using t-tests and
chi-squared tests for continuous and categorical variables, respectively. The statistical comparison of
baseline characteristics was considered exploratory rather than confirmatory and ignored clustering by
delivery group or family. The main intention was to identify baseline variable differences that might be
deemed relevant by the main investigators and would consequently require adjustment in the multilevel
models fitted in the primary and secondary outcome analyses.
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Secondary outcome analyses
All secondary outcomes, including subscales of questionnaires, were summarised by trial allocation group
and follow-up period using mean, SDs and 95% CIs for continuous variables and absolute number,
percentages and 95% CIs for categorical variables. Statistical tests of differences for child secondary
outcomes were performed using the same hierarchical mixed-effects model as the primary outcome
analysis. In addition, child BMI z-score was also compared as change from baseline to 3-month follow-up
and change from baseline to 12-month follow-up using independent group t-tests. Parent outcomes were
compared using t-tests and chi-squared tests, as appropriate, as generally only one parent provided data
and within-family correlation could not be modelled. In case parents and children provided data for the
same outcome, the simpler test was used to ensure comparability. Where the analysis of parent outcomes
was adjusted, hypothesis testing was done within a linear regression model and the adjustment variables
provided in the respective results section.
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Chapter 4 Trial results
Participant flow
In total, 115 families were recruited to the Families for Health trial, with 56 randomly allocated to the
intervention arm and 59 to the usual-care arm. The Consolidated Standards of Reporting Trials (CONSORT)
flow diagram summarises families from enrolment, through eligibility screening and randomisation to the
12-month follow-up (Figure 1). Of the 194 families assessed for eligibility, 79 were excluded. Fourteen
families were not eligible for a variety of reasons including the child not being overweight, being too
young or having behavioural problems. Eight families did not give a reason for not wanting to take part.
Assessed for eligibility 
(n = 194)
Excluded (N = 79)
•  Not meeting inclusion criteria, n = 14
•  Declined to participate, n = 39
•  No reason given, n = 8
•  Unable to contact, n = 18
Allocation
3-month follow-up
12-month follow-up
Randomised 
(n = 115)
Enrolment
Allocated to FFH (N = 56)
•  Received allocated intervention, n = 42
•  Did not receive allocated intervention, n = 14
Allocated to UC (N = 59)
•  Received allocated intervention, n = 24
•  Did not receive allocated intervention, n = 28
•  Unable to determine, n = 7
Followed up (N = 46) (82.1%)
Lost to follow-up (N = 10)
     •  Withdrew consent, n = 0
     •  Unable to contact, n = 9
     •  Index child in care, n = 1
Followed up (N = 46) (78.0%)
Lost to follow-up (N = 13)
     •  Withdrew consent, n = 4
     •  Unable to contact, n = 8
     •  Index child in care, n = 1
Followed up (N = 44) (78.6%)
Lost to follow-up (N = 12)
     •  Withdrew consent at 12 months, n = 2
     •  Unable to contact, n = 9
     •  Index child in care at 3 months, n = 1
Followed up (N = 39) (66.1%)
Lost to follow-up (N = 20)
     •  Withdrew consent at 3 months, n = 4
     •  Unable to contact, n = 15
     •  Index child in care at 3 months, n = 1
FIGURE 1 The CONSORT flow diagram for the Families for Health RCT. FFH, Families for Health; UC, usual care.
Adapted from Robertson W, Fleming J, Kamal A, Hamborg T, Khan KA, Griffiths F, et al. Randomised controlled
trial and economic evaluation of the ‘Families for Health’ programme to reduce obesity in children [published
online ahead of print 21 December 2016]. Arch Dis Child 2016. doi: 10.1136/archdischild-2016-311514. This is an
Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0)
license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided
the original work is properly cited (see http://creativecommons.org/licenses/by/4.0/).71
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A further 18 families were unable to be contacted after their initial referral/interest and 39 families
declined to participate. Reasons given included being unwilling to be randomised, time commitments and
not being able to attend a Saturday intervention.
Of the 56 families allocated to Families for Health arm, 42 (75%) attended at least one session. Of the
59 families allocated to the usual-care arm, 24 (40.7%) families were known to have attended at least one
session. For seven families allocated to usual care, their participation in the usual-care intervention was
classified as ‘unable to determine’ (see Figure 1) because these families were lost to follow-up and their
usual-care provider did not confirm their attendance.
Six families withdrew from the trial, four at 3 months and a further two at 12 months. Reasons for
withdrawal were family illness, a family bereavement, child starting secondary school and feeling could
manage weight on their own, child not liking study measurements being taken and family feeling the
study visit was a waste of their time. One family repeatedly cancelled and rearranged their study visit time
and eventually withdrew with no reason given. In addition to the withdrawal of families, some families
were also lost to follow-up for unknown reasons. Table 8 provides an overview of the number of families
lost at each site and time point, and the number of children retained. There was 80% retention of families
at 3 months and 72% retention at 12 months, but with a lower proportion retained in the usual-care arm
[Families for Health (78.6%) vs. usual care (66.1%), at 12 months] (see Figure 1).
In total, 11 families with more than one child participating in the trial were randomised (see Table 8). This
is a lower proportion of families than anticipated (see Chapter 2, Original sample size calculation). Of these
11 families, one family in the Families for Health treatment group had four participating children and the
other families had two.
Baseline data
Table 9 presents a summary of key descriptive statistics at baseline comparing the randomised groups.
A randomisation procedure with minimisation was used (see Chapter 2) so that the number of families,
parents and children in each group were similar. With the exception of SES, where there was a significant
difference between the Families for Health and usual-care groups, all other baseline characteristics were
similar in both groups with no statistical differences. For the family type and child ethnicity variables,
Fisher’s exact test was used as a result of there being cells with expected values < 5.
Table 10 shows the same variables as Table 9 for families/children provided at least one child completed
the 12-month follow-up. The pattern is very similar, with no significant differences between treatment
TABLE 8 Participant flow by site
Time point
Treatment
group
Number of
families
Number
of families
in site A
Number
of families
in site B
Number
of families
in site C
Number of
children
Number of
families (%) with
≥2 siblingsa
Baseline FFH 56 24 15 17 63 5 (8.9)
UC 59 26 16 17 65 6 (10.2)
3 months FFH 46 22 12 12 48 2 (4.3)
UC 46 18 12 15 50 6 (13.0)
12 months FFH 44 19 11 14 45 1 (2.3)
UC 39 18 9 12 43 4 (10.3)
FFH, Families for Health; UC, usual care.
a Number of families with two or more siblings participating in the RCT.
TRIAL RESULTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
26
TABLE 9 Baseline characteristics of participating families and children
Baseline characteristic
Treatment group
Total
p-value for between-group
differenceFFH UC
Number of families (%) 56 (48.7) 59 (51.3) 115 0.5829
Number of parents/carers (%) 64 (46.7) 73 (53.3) 137
Number of children (%) 63 (49.2) 65 (50.8) 128
Obese 51 (81.0) 55 (84.6) 106 (82.8)
Overweight 12 (19.0) 10 (15.4) 22 (17.2)
Sex of children, n (%)
Male 27 (42.9) 36 (55.4) 63 (49.2) 0.156
Female 36 (57.1) 29 (44.6) 65 (50.8)
Age, years (SD)
Mean age, child 9.46 (1.57) 9.43 (1.61) 9.44 (1.59) 0.893
Mean age, parent/carer 39.60 (5.86) 40.59 (8.87) 40.13 (7.60) 0.456
Family type (N= 115), n (%)
Two-parent family 32 (57.1) 28 (47.5) 60 (52.2) 0.797
Single parent (mother) 20 (35.7) 26 (44.1) 46 (40.0)
Single parent (father) 0 (0) 0 (0) 0 (0)
Stepfamily 3 (5.4) 4 (6.8) 7 (6.1)
Other 1 (1.8) 1 (1.7) 2 (1.7)
Child ethnicity (N= 128), n (%)
White 38 (60.3) 41 (63.1) 79 (61.7) 0.712
Black 4 (6.3) 6 (9.2) 10 (7.8)
Asian 13 (20.6) 9 (13.8) 22 (17.2)
Chinese 0 (0) 0 (0) 0 (0)
Mixed 7 (11.1) 9 (13.8) 16 (12.5)
Other 1 (1.6) 0 (0) 1 (0.8)
BMI
Baseline child weight (kg),
mean (SD)
52.45 (14.22) 52.41 (14.31) 52.43 (14.21) 0.985
Baseline child BMI (kg/m2),
mean (SD)
25.79 (4.44) 25.93 (4.32) 25.86 (4.36) 0.863
Baseline child BMI z-score,
mean (SD)
2.69 (0.67) 2.74 (0.70) 2.71 (0.68) 0.657
Baseline parent/carer BMI (kg/m2),
mean (SD)
31.88 (7.30) 32.01 (8.15) 31.95a (7.74) 0.923
continued
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TABLE 9 Baseline characteristics of participating families and children (continued )
Baseline characteristic
Treatment group
Total
p-value for between-group
differenceFFH UC
SES (N= 115), n (%)
Class 1 (higher managerial,
administrative and professional
occupations)
24 (42.9) 15 (25.4) 39 (33.9) 0.038
Class 2 (intermediate occupations) 12 (21.4) 7 (11.9) 19 (16.5)
Class 3 (routine and manual
occupations)
13 (23.2) 23 (39.0) 36 (31.3)
Class 4 (never worked and
long-term unemployed)
7 (12.5%) 14 (23.7%) 21 (18.3%)
Recruitment method, n (%)
Active 18 (41.7) 25 (58.1) 43 0.701
Passive 38 (52.8) 34 (47.2) 72
FFH, Families for Health; UC, usual care.
a Based on 133 parents.
TABLE 10 Baseline characteristics of families from which at least one child completed 12-month follow-up
Baseline characteristic
Treatment group
Total
p-value for between-group
differenceFFH UC
Number of families (%) 44 (53.0) 39 (47.0) 83 0.9261
Number of parents/carers (%) 50 (50.5) 49 (49.5) 99
Number of children (%) 45 (51.1) 43 (48.9) 88
Obese 38 (84.4) 36 (83.7) 74 (84.1)
Overweight 7 (15.6) 7 (16.3) 14 (15.9)
Sex, n (%)
Boys 19 (42.2) 23 (53.5) 42 (47.7) 0.290
Girls 26 (57.8) 20 (46.5) 46 (52.3)
Age, years (SD)
Mean age child 9.44 (1.47) 9.25 (1.61) 9.35 (1.54) 0.557
Mean age parent/carer 40.19 (6.23) 41.24 (8.48) 40.71 (7.41) 0.484
Family type (N= 83), n (%)
Two-parent family 25 (56.8) 22 (56.4) 47 (56.6) 0.999
Single parent (mother) 15 (34.1) 14 (35.9) 29 (34.9)
Single parent (father) 0 (0) 0 (0) 0 (0)
Stepfamily 3 (6.8) 3 (7.7) 6 (7.2)
Other 1 (2.3) 0 (0) 1 (1.2)
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groups. Comparing the differences between those who completed the 12-month follow-up and those
who did not within each treatment group led to only one significant difference, which was that parents
who dropped out in the usual-care group had a higher baseline BMI than those who remained (p= 0.022).
There is no strong relationship between the presented baseline characteristics and likelihood of a family
dropping out of the study.
Owing to the moderate sample size in this RCT, some of the original eight SES categories were sparsely
populated, leading to problems when applying certain statistical methods. Therefore, families’ SES has
been collapsed into four categories from the original eight-category SES according to Office for National
Statistics guideline55 (see Table 6). Using these four categories, SES is significantly higher in the Families for
Health arm (p= 0.038). Table 11 shows the numbers and proportions in each of the original categories.
The table also shows the number of single mothers in each group. In total, 46 participating families
(40.0%) were single mothers. A TSC member raised the concern that single mothers in class 1 were
TABLE 10 Baseline characteristics of families from which at least one child completed 12-month follow-up
(continued )
Baseline characteristic
Treatment group
Total
p-value for between-group
differenceFFH UC
Child ethnicity (N= 88), n (%)
White 28 (62.2) 25 (58.1) 53 (60.3) 0.839
Black 2 (4.4) 4 (9.3) 6 (6.8)
Asian 9 (20.0) 8 (18.6) 17 (19.3)
Chinese 0 (0) 0 (0) 0 (0)
Mixed 5 (11.1) 6 (14.0) 11 (12.5)
Other 1 (2.2) 0 (0) 1 (1.1)
BMI
Baseline child BMI (kg/m2),
mean (SD)
25.92 (4.57) 25.08 (3.57) 25.51 (4.11) 0.340
Baseline child BMI, z-score (SD) 2.70 (0.63) 2.68 (0.69) 2.71 (0.68) 0.859
Baseline parent/carer BMI (kg/m2),
mean (SD)
32.08 (7.06) 30.24 (6.7)a 31.16b (6.91) 0.195
SES (N= 83), n (%)
Class 1 (higher managerial,
administrative and professional
occupations)
22 (50.0) 12 (30.8) 34 (41.0) 0.102
Class 2 (intermediate occupations) 8 (18.2) 4 (10.3) 12 (14.5)
Class 3 (routine and manual
occupations)
10 (22.7) 16 (41.0) 26 (31.3)
Class 4 (never worked and
long-term unemployed)
4 (9.1) 7 (17.9) 11 (13.3)
Recruitment method, n (%)
Active 14 (41.7) 16 (58.1) 30 (36.1) 0.384
Passive 30 (52.8) 23 (47.2) 53 (63.9)
FFH, Families for Health; UC, usual care.
a p< 0.05 for difference between those who completed the12-month follow-up and those who did not.
b Based on 99 and 96 parents for age and BMI, respectively.
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potentially very different from single mothers in classes 3 and 4 and an adjustment might be needed if the
proportions differed substantially between arms. However, there was no statistical evidence of a difference
in the SES distribution of single mothers between the Families for Health and usual-care group by Fisher’s
exact test (p= 0.451).
Outcomes and estimation
Primary outcome analysis
Exploratory unadjusted analysis
The primary end point for the statistical analysis is the mean change in BMI z-score from baseline to
12 months of follow-up. The primary analysis is a complete-case analysis in the sense that if either
the baseline or 12-month follow-up z-score is missing the subject was omitted from the analysis. In the
subsequent section, the primary end point was compared between treatment arms using a hierarchical
mixed-effect model. Before that, simple unadjusted means are compared in this section. Table 12 shows
the number of children and BMI z-score means at each time point by treatment group. The change over
time of these means is illustrated in Figure 2.
The literature suggests that a change of –0.25 in BMI z-score would be considered clinically significant.65
Seven children (15.6%) in the Families for Health group and 10 children in the usual-care group (23.3%)
achieved a reduction of ≥ 0.25. This difference is non-significant (p= 0.360). No reduction of > 0.5 was
TABLE 11 Socioeconomic status classification of parents at baseline
Feature SES classification details
Eight classes 1.1 1.2 2 3 4 5 6 7 8
Number (%)
in class
1 (0.87) 8 (6.96) 30 (26.09) 5 (4.35) 14 (12.17) 20 (17.39) 11 (9.57) 5 (4.35) 21 (18.26)
Three classes Managerial or professional Intermediate
occupation
Routine and
manual occupation
Never
worked and
long-term
unemployed
Number (%)
in class
39 (33.91) 19 (16.52) 36 (31.30) 21 (18.26)
Single mother
FFH, n (%)
9 (45.0) 1 (5.0) 4 (20.0) 6 (30.0)
Single mother
UC, n (%)
6 (23.1) 2 (7.7) 9 (34.6) 9 (34.6)
FFH, Families for Health; UC, usual care.
TABLE 12 Primary outcome: BMI z-score – sample sizes and unadjusted estimates
Treatment group
Sample size (n) Unadjusted mean z-score (95% CI)
Baseline 3 months 12 months Baseline 3 months 12 months
FFH 63 48 45 2.69
(2.52 to 2.85)
2.62
(2.43 to 2.82)
2.72
(2.54 to 2.89)
UC 65 50 43 2.74
(2.57 to 2.91)
2.65
(2.45 to 2.85)
2.58
(2.37 to 2.79)
FFH, Families for Health; UC, usual care.
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observed in the Families for Health group, whereas three children in the usual-care group had a reduction
of > 0.5. The largest reduction observed was –0.746 and the largest increase was 0.895.
Table 13 presents (unadjusted) mean change from baseline estimates by treatment groups in child BMI and
waist z-scores, and percentage body fat. These are called ‘longitudinal changes’ henceforth. A significant
3.0
FFH
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2.8
2.6
2.4B
M
I z
-s
co
re
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0 3 12
Measurement time point (months)
FIGURE 2 Change over time for primary outcome BMI z-score (unadjusted means and CIs). FFH, Families for Health;
UC, usual care. Adapted from Robertson W, Fleming J, Kamal A, Hamborg T, Khan KA, Griffiths F, et al.
Randomised controlled trial and economic evaluation of the ‘Families for Health’ programme to reduce obesity in
children [published online ahead of print 21 December 2016]. Arch Dis Child 2016. doi: 10.1136/archdischild-2016-
311514. This is an Open Access article distributed in accordance with the terms of the Creative Commons
Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for
commercial use, provided the original work is properly cited (see http://creativecommons.org/licenses/by/4.0/).71
TABLE 13 Primary end point: BMI z-score, waist z-score and percentage fat in children
Measure
Time period
Baseline to 3 months Baseline to 12 months
Treatment group
p-value
Treatment group
p-valueFFH UC FFH UC
BMI z-score,
mean change
(SD) [95% CI]
–0.019 (0.253)
[–0.093 to 0.054]
–0.042 (0.163)
[–0.089 to 0.004]
0.593 0.013 (0.277)
[–0.070 to 0.096]
–0.001 (0.264)
[–0.081 to 0.079]
–0.102 (0.268)
[–0.184 to –0.019]
0.052
0.081
Waist z-score,
mean change
(SD) [95% CI]
–0.111 (0.276)
[–0.191 to –0.031]
–0.048 (0.216)
[–0.110 to 0.013]
0.211 0.002 (0.372)
[–0.110 to 0.113]
–0.011 (0.366)
[–0.122 to 0.101]
–0.145 (0.295)
[–0.235 to –0.054]
0.045
0.065
Percentage
body fat, mean
change (SD)
[95% CI]
0.204 (2.492)
[–0.520 to 0.928]
–0.084 (1.941)
[–0.636 to 0.468]
0.524 0.642 (2.822)
[–0.206 to 1.490]
0.480 (2.633)
[–0.321 to 1.280]
–0.900 (4.381)
[–2.248 to 0.448]
0.055
0.080
FFH, Families for Health; UC, usual care.
Note
Bold text denotes values for the reduced data set without child who had large weight increase.
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reduction from baseline to 12-month follow-up in the BMI z-score is achieved in the usual-care group
with the p-value for the difference in reduction between groups being p= 0.052. The magnitude of the
difference and p-value is consistent with those of the secondary (anthropometric) outcomes. Waist z-score
and percentage body fat are also presented in Table 13.
The Families for Health group comprised one child who gained a large amount of weight between
baseline and 3-month follow-up for reasons unrelated to the intervention. Removing this child from the
analysis (see Table 13, bold values) leads to larger p-values for all outcomes. However, the Families for
Health RCT was specified to use an intention-to-treat analysis; therefore, this child is retained in all
subsequent analyses.
Table 14 shows between-group comparisons of further anthropometric measures for children. All of them
suggest a favourable development in the usual-care group compared with the Families for Health
programme, albeit with small absolute differences.
Main primary outcome analysis (adjusted)
The primary outcome measure was the change in children’s BMI z-score from baseline to the 12-month
follow-up. It was anticipated that the data would be correlated within delivery groups in the Families for
Health intervention arm and within families should more than one child from a family participate in the
trial. It was therefore stipulated that a three-level hierarchical mixed-effects model would be fitted for
the primary outcome analysis. Furthermore, it was decided that this analysis would adjust for child-level
characteristics baseline BMI z-score and sex, and the family-level variable locality (site).
Fitting a model with a random effect for the Families for Health delivery group yielded an estimate of 0
for this effect (Table 15); the model was unable to uniquely estimate any variation from one Families for
Health programme to another, above and beyond the residual variance. This suggests that the responses
of children from the same delivery group were no more similar than children from different groups. Several
checks have been conducted to test this. The decision has therefore been made to remove this effect and
proceed with a two-level hierarchical model.
TABLE 14 Child anthropometric measures
Anthropometric
measure
Time point
Baseline 3 months 12 months
FFH (n= 63) UC (n= 65) FFH (n= 48) UC (n= 50) FFH (n= 45) UC (n= 43)
Mean child age,
years (SD)a
9.46 (1.57) 9.43 (1.61) 10.01 (1.53) 9.56 (1.65) 10.50 (1.49) 10.27 (1.63)
Mean child BMI,
kg/m2 (SD)b
25.79 (4.44) 25.93 (4.32) 26.18 (4.94) 25.60 (4.24) 27.30 (5.02) 25.82 (3.67)
Mean child
percentage body
fat (SD)
36.81 (6.18) 37.46 (6.72) 36.69 (6.63) 36.95 (6.15) 37.58 (6.86) 35.71 (6.74)
Mean child waist
circumference,
cm (SD)
86.17 (11.61) 86.30 (11.88) 86.44 (13.10) 85.62 (12.19) 90.36 (11.86) 86.47 (10.86)
FFH, Families for Health; UC, usual care.
a Based on exact age also used in z-score calculation.
b For estimates without the child in the FFH group who gained a large amount of weight between baseline and 3 months,
the FFH BMI means would be 27.74, 25.97 and 27.10 for baseline, 3 months and 12 months, respectively.
TRIAL RESULTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
32
For the two-level model for the primary outcome the intraclass correlation estimate is:
ICC=
0:0353
0:0353 + 0:0396
= 0:4713, (2)
with a 95% CI of 0.3170 to 0.6256. CI calculation is based on Bonett.72 This suggests that 47.13% of the
observed variation in the dependent variable is attributable to family-level characteristics and 52.87% is
attributable to child-level traits.
Table 16 presents covariate effect estimates in the hierarchical modelling. The estimates for the
prespecified primary analysis model are shown in the upper part of the table (model 1). Expert input by
TSC members recommended exploring additional adjustment for child ethnicity and family SES (model 2).
In both models BMI z-score was the only statistically significant predictor. We therefore continued with
TABLE 15 Random-effects estimation
Covariance parameter Subject Estimate SE p-value
Intercept FFH programme 0 – –
Residual 0.07441 0.01135 < 0.0001
FFH, Families for Health.
TABLE 16 Baseline covariate estimates for the primary outcome, BMI z-score
Model Effect Estimate (SE) p-value 95% CI
Model 1 Baseline BMI z-score –0.108 (0.042) 0.013 –0.192 to –0.023
Sex (male) –0.109 (0.059) 0.069 –0.227 to 0.008
Site A 0.055 (0.068) 0.422 –0.080 to 0.191
Site B –0.088 (0.068) 0.269 –0.245 to 0.007
Model 2 Baseline BMI z-score –0.115 (0.047) 0.022 –0.213 to –0.018
Sex (female) – – –
Sex (male) –0.082 (0.064) 0.199 –0.211 to 0.045
Site C – – –
Site A 0.091 (0.080) 0.257 –0.068 to 0.251
Site B –0.069 (0.093) 0.468 –0.256 to 0.119
SES (unemployed) – – –
SES (managerial) –0.027 (0.109) 0.804 –0.245 to 0.191
SES (intermediate) –0.161 (0.127) 0.211 –0.415 to 0.093
SES (manual) –0.050 (0.105) 0.629 –0.259 to 0.157
Ethnicity (white) – – –
Ethnicity (other) –0.328 (0.281) 0.246 –0.887 to 0.231
Ethnicity (black) –0.010 (0.145) 0.948 –0.298 to 0.279
Ethnicity (mixed) 0.002 (0.092) 0.977 –0.183 to 0.188
Ethnicity (Asian) 0.035 (0.086) 0.687 –0.137 to 0.207
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model 1. F-test statistic p-values for predictor variables are not shown; however, the p-value of the only
significant effect is identical to the p-value in the table (because it is a continuous variable).
The primary outcome analysis estimate of the between-group difference in terms of BMI z-score is 0.114
(95% CI –0.001 to 0.229), that is a non-significant difference in favour of usual-care treatment (Table 17).
This estimate and its p-value are almost identical to the estimate obtained in the unadjusted analysis.
Point estimates of the within-treatment group differences suggest a slightly larger reduction than in the
unadjusted analysis. The different treatment effect estimates obtained for the primary outcome can be
compared in Table 18. Unadjusted values are taken from Table 13, model 1 is the prespecified primary
outcome analysis and model 2 is the analysis including two additional predictors. Treatment effect
estimates and p-values are consistent across analyses.
Imputation analysis for primary outcome
To further investigate the consistency of the treatment effect estimates, an imputation analysis was conducted
to explore the effect of the large number of missing data at 3- and 12-month follow-up. In the Families for
Health group, 28.57% of 12-month primary outcome measures were missing, in the usual-care group
34.20% were missing. This difference in missing data is not significant (p= 0.520) by the chi-squared test.
Estimates presented in Table 19 for the multiple imputation models are averages over the 100 models.
Treatment effect point estimates are, again, similar to the primary outcome analysis with only Markov
chain Monte Carlo imputation reducing the effect size and as a result yielding a non-significant p-value.
Baseline covariates included in the analysis were fully observed and only outcome values were missing.
If the assumption is made that data are ‘missing at random’, then the primary outcome analysis, which
adjusts for baseline BMI z-score (and treatment group), provides an unbiased estimate of treatment effect.
TABLE 17 Primary outcome analysis: change in BMI z-score from baseline to 12 months
Treatment group Estimate (SE) 95% CI p-value
FFH –0.005 (0.041) –0.085 to 0.078 0.907
UC –0.118 (0.042) –0.203 to –0.034 0.007
Treatment effect 0.114 (0.058) –0.001 to 0.229 0.053
FFH, Families for Health; UC, usual care.
TABLE 18 Treatment effect estimates of the primary outcome
Period Treatment group Estimate (SE) 95% CI p-value
Unadjusted FFH 0.013 (0.041) –0.070 to 0.096 0.356
UC –0.102 (0.041) –0.184 to –0.019 0.011
Treatment effect 0.114 (0.058) –0.001 to 0.230 0.052
Model 1 FFH –0.005 (0.041) –0.085 to 0.078 0.907
UC –0.118 (0.042) –0.203 to –0.034 0.007
Treatment effect 0.114 (0.058) –0.001 to 0.229 0.053
Model 2 FFH –0.068 (0.076) –0.221 to 0.084 0.374
UC –0.202 (0.079) –0.359 to –0.045 0.012
Treatment effect 0.134 (0.063) 0.008 to 0.259 0.037
FFH, Families for Health; UC, usual care.
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In this case, multiple imputation could be regarded as unnecessary or an additional sensitivity analysis.
In this scenario the simple regression imputation method also provides unbiased estimates, albeit with
an underestimated variability. This effect can be seen in Table 19, in which point estimates for simple
regression imputation are very similar to the primary outcome analysis, but the p-value is smaller.
Per-protocol analysis
Families that participated in five or more sessions of the Families for Health programme are regarded as
‘programme completers’ (i.e. as having complied with the protocol sufficiently). Improvements in children
from these families, in terms of BMI z-score change from baseline, are compared with improvements in
children from families who attended fewer than five sessions. A comparison is made based on estimates
obtained from the primary analysis multilevel model (model 1). An exploratory analysis comparing families
who attended nine or more sessions (essentially full attendance) with those who attended fewer sessions
can be found in Appendix 2.
Figure 3 presents the number of sessions attended by families and the number of follow-up appointments
completed. The mean number of Families for Health sessions attended was 5.42. For those families who
provided 12 months’ data, the mean number of sessions attended was 6.96. The figure suggests no clear
relationship between sessions attended and the likelihood of being lost to follow-up.
Table 20 shows the difference in BMI and waist z-score between completers and non-completers.
Non-completers achieved a reduction similar to the reduction observed in the usual-care group, while the
mean z-score increased in the completer population. There are several potential explanations for this
TABLE 19 Multiple imputation analysis for longitudinal changes in child BMI z-score from baseline to 12 months
Imputation analysis
Treatment arm, mean change in child BMI z-score
(95% CI)
Treatment effect p-valueFFH UC
Simple regression imputation –0.003 (–0.064 to 0.057) –0.115 (–0.173 to –0.057) 0.112 0.008
FCS imputation 0.001 (–0.069 to 0.070) –0.194 (–0.186 to –0.040) 0.113 0.0256
MCMC imputation –0.016 (–0.096 to 0.062) –0.092 (–0.167 to –0.017) 0.075 0.164
FCS, fully conditional specification; FFH, Families for Health; MCMC, Markov chain Monte Carlo; UC, usual care.
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FIGURE 3 Attendance rate (bar height) and time points at which outcome data were provided (colour/pattern) for
families attending Families for Health.
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including (a) those who achieved a weight reduction felt that they did not need to attend further sessions;
and (b) families were able to access usual care (which appears to yield a better outcome) as well and
non-completers might have been more likely to have accessed usual care. Non-completers also had a
(non-significantly) higher mean baseline BMI z-score (Table 21).
Repeated measures analysis
An exploratory repeated-measures analysis was conducted for the investigation of the difference between
arms in terms of change over time in the primary outcome measure rather than a comparison between
arms at fixed 3- or 12-month follow-up time points. For this purpose, a repeated-measures mixed model
was fitted. The model is based on the hierarchical model used above. Unlike previous models, time is fitted
as a continuous variable here, allowing for the fact that actual measuring time points varied considerably
rather than taking place at exactly 3 and 12 months from baseline. This is illustrated in Figures 4 and 5.
Analysis of the covariance matrix for repeated observations revealed that the baseline and 12 months
observation were more highly correlated than was the 3 months observations and either of the other time
points. An unstructured covariance matrix leads to the best model fit and was therefore used for the
mixed model.
TABLE 21 Differences in baseline characteristics between completers and non-completers (Families for Health)
Characteristic
Treatment group
Completer (n= 39) Non-completer (n= 24)
Mean baseline BMI z-score (95% CI) 2.554 (2.353 to 2.756) 2.860 (2.597 to 3.123)
Mean baseline age, years (95% CI) 9.503 (8.979 to 10.027) 9.580 (8.995 to 10.166)
SES class, n (%)
1 19 (48.7) 7 (29.2)
2 8 (20.5) 6 (25.0)
3 9 (23.1) 5 (20.8)
4 3 (7.7) 6 (25.0)
Note
Fisher’s exact test for SES non-significant (p= 0.221).
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FIGURE 4 Child BMI z-scores and time points (Families for Health).
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The least squares estimates of group BMI z-scores and the treatment effect presented in Table 22 are
averages over time. This includes the baseline time point, which dilutes a difference because of treatment.
Had discrete time points (3 months and 12 months) been used, the differences between arms at different
time points could have been estimated. However, the time by treatment interaction term in the repeated
measures model is significant (see Table 23, bottom row). Consequently, it can be claimed that Families
for Health and usual care have a statistically significantly different effect on children’s BMI z-score, with
Families for Health yielding higher z-scores. Unlike in previous models presented in Primary outcome
analysis, locality and sex are significant predictors of the outcome (Table 23). Note, however, that the
outcome variable in this repeated measures model is z-score change over time [i.e. (slightly) different from
‘change from baseline to 12-month follow-up’ used in the primary outcome analysis].
Secondary outcomes analysis
Children’s total fruit and vegetable consumption
Children completed a 24-hour food recall using the ‘Day in the Life Questionnaire’ to assess the number of
portions of fruit and vegetables consumed the previous day.43
Child-reported fruit and vegetable consumption decreased in both treatment groups from baseline to the
3- and 12-months follow-ups (Table 24). It should be noted that the changes in Table 24 are calculated
for a smaller number of children than the individual means given in Table 25 because of dropouts. There
was no significant difference between the Families for Health and usual-care treatment arms in the
longitudinal change.
TABLE 22 Least squares means estimates for repeated measures model
Characteristic
Time period, averaged over time (95% CI)
p-value
Treatment group
Treatment effectFFH UC
Mean child BMI z-score 2.756 (2.584 to 2.928) 2.661 (2.493 to 2.830) 0.094 (–0.140 to 0.329) 0.427
FFH, Families for Health; UC, usual care.
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FIGURE 5 Child BMI z-scores and time points (usual care).
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Children’s quality of life (Pediatric Quality of Life Inventory)
Children’s health-related quality of life is measured using the PedsQL version 4.0 (UK), for ages 8–12 years.45
Children completed the 23-item self-report version and the parents completed the almost identical
parent-proxy version about their child’s quality of life, with the same number of items.
Table 26 shows that the mean child-reported scores at baseline are 2–3 points higher in the usual-care
group than in the Families for Health group. The differences between the groups are, however, not
significant for any of the change-from-baseline comparisons (Table 27). Results for the parent-reported
PedsQL differ from the child-reported PedsQL. Mean parent-reported scores are consistently 4–8 points
TABLE 24 Sample sizes and longitudinal changes in children’s total fruit and vegetable consumption
Fruit and vegetable consumption
Treatment group
p-valueFFH UC
Sample size (n)
Baseline 63 65
Change from baseline to 3 months 48 50
Change from baseline to 12 months 45 42
Longitudinal changes
Change from baseline to 3 months (95% CI) –0.375 (–1.073 to 0.323) –0.180 (–0.826 to 0.467) 0.681
Change from baseline to 12 months (95% CI) –0.444 (–1.162 to 0.273) –0.195 (–0.902 to 0.511) 0.620
FFH, Families for Health; UC, usual care.
TABLE 23 Covariate effects for the repeated measures mixed models
Effect Estimate 95% CI F-value p-value
Intercept 3.138 2.826 to 3.451 < 0.001
Treatment group (UC) – – 0.12 0.726
Treatment group (FFH) 0.042 –0.195 to 0.279
Sex (male) – – 6.93 0.009
Sex (female) 0.312 –0.546 to –0.08
Site C – – 3.68 0.028
Site A –0.378 –0.068 to 0.251
Site B –0.219 –0.256 to 0.119
SES (unemployed) – – 1.40 0.248
SES (managerial) –0.173 –0.522 to 0.177
SES (intermediate) –0.219 –0.622 to 0.185
SES (manual) 0.075 –0.267 to 0.416
Time –0.102 –0.183 to 0.188 2.63 0.108
Time × treatment (UC) – – 6.13 0.015
Time × treatment (FFH) 0.123 0.025 to 0.221
FFH, Families for Health; UC, usual care.
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TABLE 26 Sample sizes and time point averages in child-reported PedsQL score
PedsQL
subscale
Time point average (95% CI)
Baseline 3 months 12 months
FFH (n= 63) UC (n= 65) FFH (n= 48) UC (n= 50) FFH (n= 45) UC (n= 42)
Overall 75.91
(72.01 to 79.81)
78.07
(74.39 to 81.76)
79.96
(75.74 to 84.18)
77.90
(73.27 to 82.54)
79.93
(75.42 to 84.43)
79.04
(74.13 to 83.95)
Psychosocial 75.00
(70.74 to 79.26)
76.97
(72.97 to 80.97)
79.10
(74.70 to 83.50)
76.61
(71.48 to 81.74)
78.85
(73.85 to 83.86)
79.05
(73.86 to 84.24)
Physical 77.54
(73.07 to 82.01)
80.19
(76.19 to 84.18)
81.57
(76.90 to 86.23)
80.25
(75.59 to 84.91)
81.94
(77.45 to 86.44)
79.02
(74.00 to 84.04)
FFH, Families for Health; UC, usual care.
TABLE 25 Time point averages and longitudinal changes in children’s total fruit and vegetable consumption
Fruit and vegetable consumption
Treatment group
p-valueFFH UC
Time point average, mean (SD)
Baseline 2.13 (2.08) 2.43 (1.94)
3 months 2.13 (2.03) 2.22 (1.64)
12 months 2.22 (1.93) 2.29 (1.75)
Longitudinal changes
Change from baseline to 3 months (SD) –0.375 (2.402) –0.180 (2.274) 0.681
Change from baseline to 12 months (SD) –0.444 (2.389) –0.195 (2.239) 0.620
FFH, Families for Health; UC, usual care.
TABLE 27 Longitudinal changes in child-reported PedsQL
PedsQL subscale
Treatment group
p-valueFFH UC
Overall
Change from baseline to 3 months (95% CI) 1.411 (–1.608 to 4.431) –2.298 (–5.043 to 0.447) 0.070
Change from baseline to 12 months (95% CI) 2.131 (–1.830 to 6.092) 0.254 (–3.712 to 4.220) 0.502
Psychosocial
Change from baseline to 3 months (95% CI) 1.290 (–2.070 to 4.650) –2.452 (–5.396 to 0.493) 0.095
Change from baseline to 12 months (95% CI) 1.966 (–2.614 to 6.545) 1.216 (–3.214 to 5.646) 0.813
Physical
Change from baseline to 3 months (95% CI) 1.739 (–2.526 to 5.986) –2.134 (–5.559 to 1.291) 0.157
Change from baseline to 12 months (95% CI) 2.550 (–2.176 to 7.275) –1.648 (–6.719 to 3.424) 0.225
FFH, Families for Health; UC, usual care.
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lower than child-reported scores (Table 28). Table 29 shows that there were no statistically significant
between-group, or within-group, differences for any of the change-from-baseline comparisons apart from
the change from baseline to 12 months of the psychosocial domain in the usual care group (p= 0.0226).
The children in this trial do seem to have lower mean PedsQL scores than ‘healthy’ children in the UK,
where the mean for the overall score has been reported to be 83.9 (child reported) and 84.6
(parent reported).47
Parent- and child-reported child quality of life (European Quality of Life-5
Dimensions Youth version)
There were no statistically significant differences in suboptimal levels of function, at any follow-up time,
in either child- (Table 30) or parent-reported (Table 31) health-related quality of life, as measured by the
EQ-5D-Y,51,53 between the Families for Health group and the usual-care group. Nor were there any
significant between-group differences, at any follow-up time, in either children’s perception of their overall
health (see Table 30) or parents’ perception of their child’s health (see Table 31) as assessed using a visual
analogue scale. Finally, Table 32 shows that there was no between-group difference in either child- or
parent-reported utility score over each follow-up period. The mean change in child-reported EQ-5D-Y
TABLE 29 Longitudinal changes in parent-reported PedsQL
PedsQL subscale
Treatment group
p-valueFFH UC
Overall
Change from baseline to 3 months (95% CI) 0.922 (–3.885 to 5.729) 2.524 (–2.284 to 7.333) 0.637
Change from baseline to 12 months (95% CI) 3.375 (–1.764 to 8.514) 3.997 (–1.536 to 9.530) 0.868
Psychosocial
Change from baseline to 3 months (95% CI) 1.449 (–3.313 to 6.211) 3.865 (–0.421 to 8.151) 0.449
Change from baseline to 12 months (95% CI) 3.262 (–1.975 to 8.499) 5.350 (0.791 to 9.910) 0.548
Physical
Change from baseline to 3 months (95% CI) –0.027 (–6.724 to 6.671) –0.011 (–6.760 to 6.738) 0.997
Change from baseline to 12 months (95% CI) 3.586 (–2.458 to 9.630) 1.417 (–7.982 to 10.816) 0.697
FFH, Families for Health; UC, usual care.
TABLE 28 Sample sizes and time point averages in parent-reported PedsQL
PedsQL
subscale
Time point average (95% CI)
Baseline 3 months 12 months
FFH (n= 63) UC (n= 65) FFH (n= 47) UC (n= 49) FFH (n= 45) UC (n= 42)
Overall 72.30
(67.42 to 77.19)
60.61
(66.58 to 74.64)
73.72
(67.91 to 79.54)
73.83
(68.34 to 79.31)
76.71
(71.18 to 82.25)
75.98
(71.19 to 80.77)
Psychosocial 71.19
(66.14 to 76.24)
69.35
(65.47 to 73.24)
72.80
(66.82 to 78.77)
73.77
(68.74 to 78.80)
75.11
(69.14 to 81.08)
75.67
(71.09 to 80.24)
Physical 74.45
(64.24 to 79.66)
72.87
(67.19 to 78.56)
75.51
(68.53 to 82.50)
73.93
(66.74 to 81.12)
79.71
(73.68 to 85.74)
76.58
(69.99 to 83.17)
FFH, Families for Health; UC, usual care.
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utility score between baseline and 12 months was estimated at –0.017 (95% CI –0.098 to 0.218;
p= 0.678) for the Families for Health group and –0.040 (95% CI –0.112 to 0.188; p= 0.266) for children
with complete data. The mean change in parent-reported EQ-5D-Y utility score between baseline and
12 months was estimated at 0.012 (95% CI –0.041 to 0.143; p= 0.661) for the Families for Health group
and 0.047 (95% CI –0.005 to 0.137; p= 0.073) for parents with complete data.
Accelerometer data (children)
For a child’s data to be included in the analysis, 3 days with 480 minutes of wear time at both baseline
and 12 months was required. This resulted in pairs of baseline and 12-month follow-up data from only 46
of the 128 children in the trial (36%), 27 in the Families for Health arm and 19 in the usual-care arm.
Table 33 shows the group means of the accelerometer outcomes considered in the analysis. All four
outcomes indicate a favourable development in the usual-care group. This is mirrored in the analysis of
longitudinal changes (Table 34), with the point estimates indicating an improvement in all four outcomes
in the usual-care group and less child physical activity in three out of four outcomes in the Families for
Health arm. Owing to the small sample size in the accelerometer analysis, 95% CIs are wide and there are
no significant differences between groups. The interpretation of the physical activity data must be made
with caution given that paired data were available for only 36% of children.
TABLE 32 Longitudinal changes in EQ-5D-Y quality of life
Change in utility score
Time period
Baseline to 3 months Baseline to 12 months
Treatment group
p-value
Treatment group
p-valueFFH UC FFH UC
Mean child self-reported
EQ-5D-Y (SD)
–0.019 (0.237) –0.021 (0.229) 0.967 –0.017 (0.265) –0.040 (0.229) 0.667
Mean parent-reported
EQ-5D-Y (SD)
–0.002 (0.171) 0.017 (0.216) 0.628 0.012 (0.173) 0.047 (0.166) 0.332
FFH, Families for Health; UC, usual care.
TABLE 33 Sample sizes and time point means in accelerometer variables (children)
Outcome
Time point mean (95% CI)
Baseline 12 months
FFH (n= 27) UC (n= 19) FFH (n= 27) UC (n= 19)
Minutes of moderate
or vigorous activity
per day
46.96
(40.16 to 53.77)
52.60
(40.22 to 64.98)
43.71
(36.58 to 50.85)
57.81
(46.82 to 68.81)
Minutes of sedentary
behaviour per day
454.41
(425.09 to 483.72)
436.68
(400.52 to 472.84)
458.65
(433.90 to 483.40)
427.62
(384.72 to 470.52)
Steps per day 8297.94
(7552.43 to 9043.46)
8316.76
(7214.66 to 9418.87)
8520.24
(7554.70 to 9485.79)
9129.62
(7789.40 to 10,469.85)
Counts per minute 488.93
(435.17 to 542.69)
539.03
(439.18 to 638.87)
462.58
(416.52 to 508.63)
579.92
(493.92 to 665.92)
FFH, Families for Health; UC, usual care.
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Parents’ mental well-being (Warwick–Edinburgh Mental Well-Being scale)
Parental mental health was measured using the WEMWBS.48 The WEMWBS is a measure of mental
well-being focusing entirely on positive aspects of mental health, and a higher score indicates better
mental health. Tables 35 and 36 show the mean WEMWBS scores and changes from baseline by
treatment group. The WEMWBS scores are, on average, higher in the Families for Health group than in
the usual-care group at follow-up time points, but the difference does not reach statistical significance.
Average WEMWBS scores decrease from baseline to 12 months in the usual-care group.
Adjusting the comparison of WEMWBS scores between treatment groups for age and sex did not lead to
any change in treatment effects or p-values for the between-group differences at 12 months (Table 37).
The mean within-group differences are estimated to be slightly higher in both groups; however, neither
change from baseline within a group is statistically significant, as indicated by the CIs overlapping zero in
both cases.
Parenting Styles and Dimensions Questionnaire
Parenting style was measured using the PSDQ.50 The PSDQ is a 32-item, parent-report questionnaire.
The 32 items form three patterns of parenting: authoritative, authoritarian and permissive. Higher scores
indicate more frequent use of the described behaviour. Authoritarian and permissive parenting styles are
considered to be less effective parenting styles than authoritative. Parents are classified according to their
highest score in the three parenting domains.
TABLE 35 Time point averages and longitudinal changes in parents’ WEMWBS
WEMWBS
Treatment group
p-valueFFH UC
Time point average, mean score (SD)
Baseline 47.86 (8.87) 47.74 (9.69)
3 months 50.00 (8.43) 48.09 (11.01)
12 months 50.68 (10.18) 44.98 (11.57)
Longitudinal changes
Change from baseline to 3 months (SD) 1.311 (8.562) 0.419 (10.12) 0.656
Change from baseline to 12 months (SD) 2.409 (8.883) –2.167 (12.548) 0.060
FFH, Families for Health; UC, usual care.
TABLE 34 Change from baseline to 12 months’ follow-up in accelerometer variables with paired t-tests (children)
Outcome
Treatment group
p-valueFFH UC
Minutes of moderate or vigorous activity per day (95% CI) –3.249
(–9.426 to 2.927)
5.213
(–4.971 to 15.397)
0.125
Minutes of sedentary behaviour per day (95% CI) 4.245
(–22.003 to 30.492)
–9.061
(–56.314 to 38.192)
0.611
Steps per day (95% CI) 222.3
(–566.0 to 1000.6)
812.9
(–503.1 to 2128.9)
0.400
Counts per minute (95% CI) –26.352
(–81.830 to 29.127)
40.895
(–49.543 to 131.300)
0.171
FFH, Families for Health; UC, usual care.
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Table 38 shows the mean score for each parenting style at each time point. The authoritative style always
scored higher than the other two styles. For 53 parents in the Families for Health group, authoritative was
the highest scoring parenting pattern at baseline, with the remaining three parents scoring highest on
permissive (5.4%). In the usual-care group, 53 parents endorsed behaviours indicative of a primarily
TABLE 37 Sample sizes and longitudinal changes in parents’ WEMWBS, adjusted for age and sex
WEMWBS
Treatment group
p-valueFFH UC
Sample size (n)
Baseline 56 57
Change from baseline to 3 months 45 43
Change from baseline to 12 months 44 36
Longitudinal changes
Change from baseline to 3 months (95% CI) 0.684 (–4.468 to 5.836) 0.016 (–5.565 to 5.596) 0.754
Change from baseline to 12 months (95% CI) 3.081 (–2.657 to 8.819) –1.373 (–7.701 to 4.949) 0.076
FFH, Families for Health; UC, usual care.
TABLE 36 Sample sizes and longitudinal changes in parents’ WEMWBS
WEMWBS
Treatment group
p-valueFFH UC
Sample size (n)
Baseline 56 57
Change from baseline to 3 months 45 43
Change from baseline to 12 months 44 36
Longitudinal changes
Change from baseline to 3 months (95% CI) 1.311 (–1.261 to 3.883) 0.419 (–2.693 to 3.530) 0.656
Change from baseline to 12 months (95% CI) 2.409 (–0.291 to 5.110) –2.167 (–6.412 to 2.079) 0.060
FFH, Families for Health; UC, usual care.
TABLE 38 Sample sizes and time point averages in parenting style (PSDQ)
Parenting style
Time point average (95% CI)
Baseline 3 months 12 months
FFH (n= 56) UC (n= 59) FFH (n= 45) UC (n= 45) FFH (n= 44) UC (n= 38)
PSDQ authoritative 4.08
(3.92 to 4.23)
4.02
(3.84 to 4.21)
4.13
(3.97 to 4.29)
4.04
(3.82 to 4.26)
4.19
(4.04 to 4.34)
3.97
(3.74 to 4.21)
PSDQ authoritarian 1.70
(1.58 to 1.83)
1.58
(1.47 to 1.69)
1.60
(1.46 to 1.74)
1.56
(1.45 to 1.66)
1.59
(1.45 to 1.72)
1.58
(1.46 to 1.69)
PSDQ permissive 2.34
(2.14 to 2.55)
2.28
(2.07 to 2.50)
2.21
(1.98 to 2.43)
2.19
(1.96 to 2.43)
2.11
(1.90 to 2.32)
2.09
(1.86 to 2.33)
FFH, Families for Health; UC, usual care.
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authoritative parenting style and six parents (10.2%) exhibited permissive styles at baseline. At the 3-month
follow-up, 43 parents scored highest on authoritative style, whereas two parents (4.4%) scored highest on
permissive behaviour in both treatment groups. At the 12-month follow-up, one parent (2.3%) in the
Families for Health group and two parents in the usual-care group (5.3%) scored highest on permissive
style. Authoritarian never emerged as the primary parenting style in this trial. Very few changes of the
primary parenting style occurred over the course of the study, which is desirable as most parents are already
in the preferred group (authoritative). In total, five parents scored higher for a parenting style different from
their primary baseline parenting style over the course of the study: three in the Families for Health group
and two in the usual-care group. Four parents changed from primarily permissive to authoritative, and one
parent in the Families for Health group changed from authoritative to permissive.
There were no significant differences between or within groups for authoritative, authoritarian and
permissive parenting style scores over the course of the study (Table 39). Figure 6 presents the correlation
of reduction in child BMI z-scores and authoritative parenting style scores at baseline and 12 months.
Despite being generally regarded as the most effective parenting style, the correlation was weak
(r= –0.142 and r= –0.128 for baseline and 12 months, respectively).
Relationship between parents and children (Child–Parent Relationship Scale)
Assesment of the quality of the parent–child relationship was made using the CPRS,49 which was
self-completed by parents for each of their participating children. A mean score was derived, with the
best possible score being 5 (range 1–5). Tables 40 and 41 show the results for this secondary outcome,
indicating that there are no significant between- (or within-) group differences for the overall scale, or the
closeness and conflicts subscales.
Family eating and activity (Family Eating and Activity Habits Questionnaire)
Eating and activity behaviour in the familiy was assessed using a modified version of the FEAHQ.44
The questionnaire comprises four subscales:
1. activity level: to record the balance between physical activity and sedentary pastimes
2. stimulus exposure: presence and visibility of unhealthy snacks kept at home, allowed to eat snack/
sweets without parental permission, allowed to buy own sweets
3. eating related to hunger: who initiaties the eating in the family, behaviour if the child is not hungry
4. eating style/rites: where and with whom does eating take place, second helpings.
TABLE 39 Longitudinal changes in parenting style (PSDQ)
Parenting style
Treatment group
p-valueFFH UC
PSDQ authoritative
Change from baseline to 3 months (95% CI) 0.033 (–0.115 to 0.182) 0.085 (–0.074 to 0.244) 0.633
Change from baseline to 12 months (95% CI) 0.106 (–0.042 to 0.254) 0.073 (–0.082 to 0.228) 0.756
PSDQ authoritarian
Change from baseline to 3 months (95% CI) –0.052 (–0.184 to 0.081) 0.011 (–0.076 to 0.097) 0.431
Change from baseline to 12 months (95% CI) –0.072 (–0.182 to 0.039) –0.028 (–0.084 to 0.140) 0.204
PSDQ permissive
Change from baseline to 3 months (95% CI) –0.030 (–0.258 to 0.198) –0.010 (–0.166 to 0.146) 0.884
Change from baseline to 12 months (95% CI) –0.205 (–0.391 to –0.016) –0.147 (–0.360 to 0.065) 0.684
FFH, Families for Health; UC, usual care.
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FIGURE 6 Scatterplot showing the correlation of BMI z-score change from baseline to 12 months with an
authoritative parenting style at (a) baseline; and (b) 12 months. FFH, Families for Health; UC, usual care.
TABLE 40 Sample sizes and time point averages in child–parent relationship (CPRS)
CPRS subscale
Time point average (95% CI)
Baseline 3 months 12 months
FFH (n= 63) UC (n= 65) FFH (n= 47) UC (n= 50) FFH (n= 45) UC (n= 42)
Overall 3.93
(3.77 to 4.09)
4.11
(3.95 to 4.27)
4.05
(3.85 to 4.24)
4.18
(3.98 to 4.37)
3.98
(3.77 to 4.20)
4.12
(3.93 to 4.31)
Conflicts 3.44
(3.22 to 3.66)
3.80
(3.57 to 4.03)
3.63
(3.36 to 3.90)
3.81
(3.54 to 4.08)
3.54
(3.23 to 3.85)
3.76
(3.49 to 4.03)
Closeness 4.49
(4.36 to 4.62)
4.47
(4.30 to 4.63)
4.53
(4.39 to 4.67)
4.60
(4.45 to 4.75)
4.49
(4.34 to 4.64)
4.53
(4.36 to 4.71)
FFH, Families for Health; UC, usual care.
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Parents completed the questionnaire for themselves and for the children. Higher numerical scores reflect
less appropriate eating patterns in all subscales. Table 42 shows the mean scale scores for children at each
time point and Table 43 shows the mean scores (median for the eating related to hunger subscale)
for parents.
Changes from baseline in the child scales were not significantly different between treatment groups
(Table 44). There was a significant improvement in activity level in the children in the usual-care group
both from baseline to 3 months and from baseline to 12 months (see Table 44), which is in agreement
with the usual-care group results in the accelerometer analysis (see Tables 33 and 34).
On the parent scales, the change in activity level from baseline to 12 months was significantly different
between the Families For Health group and the usual-care group (and within the usual-care group)
(Table 45). Using Fisher’s exact test to compare differences in the Likert scale, the ‘eating related to
hunger’ subscale yielded non-significant differences (p= 0.974 and p= 0.866, respectively).
TABLE 41 Longitudinal changes in child–parent relationship (CPRS)
CPRS subscale
Treatment group
p-valueFFH UC
Overall
Change from baseline to 3 months (95% CI) 0.059 (–0.053 to 0.171) 0.011 (–0.114 to 0.136) 0.569
Change from baseline to 12 months (95% CI) 0.024 (–0.111 to 0.159) –0.009 (–0.126 to 0.108) 0.714
Conflicts
Change from baseline to 3 months (95% CI) 0.078 (–0.104 to 0.260) –0.113 (–0.315 to 0.088) 0.161
Change from baseline to 12 months (95% CI) 0.038 (–0.169 to 0.244) –0.117 (–0.301 to 0.068) 0.267
Closeness
Change from baseline to 3 months (95% CI) 0.045 (–0.056 to 0.145) 0.149 (–0.041 to 0.339) 0.331
Change from baseline to 12 months (95% CI) 0.014 (–0.130 to 0.158) 0.106 (–0.063 to 0.275) 0.405
FFH, Families for Health; UC, usual care.
TABLE 42 Sample sizes and time point averages in FEAHQ subscales for children
FEAHQ
subscale
Time point average (95% CI)
Baseline 3 months 12 months
FFH (n= 63) UC (n= 65) FFH (n= 47) UC (n= 49) FFH (n= 45) UC (n= 42)
Activity level 8.16
(3.96 to 12.37)
9.09
(5.59 to 12.59)
6.91
(3.18 to 10.64)
3.79
(0.44 to 7.14)
7.09
(2.56 to 11.61)
4.73
(–0.42 to 9.87)
Stimulus
exposure
17.33
(14.68 to 19.99)
17.26
(14.52 to 20.00)
14.45
(11.90 to 17.00)
16.08
(12.68 to 19.48)
13.78
(11.94 to 15.61)
15.79
(12.74 to 18.84)
Eating related
to hunger
5.67
(5.19 to 6.14)
5.58
(5.17 to 6.00)
5.21
(4.67 to 5.76)
5.57
(5.07 to 6.08)
5.36
(4.83 to 5.88)
5.48
(4.91 to 6.04)
Eating style 16.43
(14.83 to 18.02)
14.37
(13.03 to 15.71)
13.85
(12.35 to 15.35)
12.90
(11.54 to 14.26)
14.42
(12.62 to 16.22)
13.31
(11.59 to 15.03)
FFH, Families for Health; UC, usual care.
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TABLE 45 Longitudinal changes in FEAHQ subscales for parents
FEAHQ subscale
Treatment group
p-valueFFH UC
Activity level
Change from baseline to 3 months (95% CI) –0.021 (–5.086 to 5.044) –0.060 (–4.823 to 4.702) 0.991
Change from baseline to 12 months (95% CI) 1.719 (–2.319 to 5.757) –4.793 (–8.259 to –1.327) 0.016
Eating style
Change from baseline to 3 months (95% CI) –1.549 (–3.310 to 0.212) –0.038 (–1.872 to 1.797) 0.236
Change from baseline to 12 months (95% CI) –1.840 (–3.398 to –0.282) –0.196 (–1.533 to 1.925) 0.081
FFH, Families for Health; UC, usual care.
TABLE 43 Sample sizes (number of parent reporting) and time point averages in FEAHQ subscales for parents
FEAHQ
subscale
Time point average (95% CI)
Baseline 3 months 12 months
FFH (n= 64) UC (n= 73) FFH (n= 50) UC (n= 52) FFH (n= 50) UC (n= 46)
Activity level 2.77
(–1.28 to 6.81)
1.45
(–3.19 to 6.08)
3.21
(–2.18 to 8.60)
2.61
(–2.04 to 7.27)
5.37
(–0.41 to 11.15)
–0.10
(–5.21 to 5.01)
Eating related
to hungera
0 (0 to 3) 0 (0 to 3) 0 (0 to 3) 1 (0 to 3) 0 (0 to 3) 1 (0 to 3)
Eating style 23.89
(22.22 to 25.57)
21.33
(19.45 to 23.21)
22.18
(20.15 to 24.20)
21.34
(19.32 to 23.36)
21.74
(19.51 to 23.97)
21.24
(19.12 to 23.36)
FFH, Families for Health; UC, usual care.
a Row shows median with (minimum–maximum).
TABLE 44 Longitudinal changes in FEAHQ subscales for children
FEAHQ subscale
Treatment group
p-valueFFH UC
Activity level
Change from baseline to 3 months (95% CI) –1.285 (–5.843 to 3.273) –5.640 (–9.985 to –1.295) 0.167
Change from baseline to 12 months (95% CI) –2.590 (–7.826 to 2.648) –6.813 (–11.176 to –2.450) 0.218
Stimulus exposure
Change from baseline to 3 months (95% CI) –1.021 (–3.804 to 1.761) –2.102 (–5.581 to 1.377) 0.627
Change from baseline to 12 months (95% CI) –1.690 (–4.112 to 0.734) –2.571 (–5.820 to 0.677) 0.662
Eating related to hunger
Change from baseline to 3 months (95% CI) –0.532 (–1.122 to 0.058) 0.020 (–0.547 to 0.587) 0.178
Change from baseline to 12 months (95% CI) –0.511 (–0.997 to –0.025) –0.191 (–0.720 to 0.339) 0.370
Eating style
Change from baseline to 3 months (95% CI) –1.681 (–3.111 to –0.250) –1.020 (–2.258 to 0.217) 0.483
Change from baseline to 12 months (95% CI) –0.933 (–2.229 to 0.363) –0.429 (–2.231 to 1.374) 0.648
FFH, Families for Health; UC, usual care.
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Parents’ body mass index
Parents’ BMI was measured at baseline and at the 3- and 12-month follow-up assessments. Mean parent
BMI measurements for each group at each time point, apart from the 12-months follow-up in the
usual-care group, are > 30 kg/m2, which is the World Health Organization threshold for being classified
as obese. Mean parent BMI values in Table 46 are unadjusted. The analysis of change in parent BMI in
Table 47 is adjusted for parent age and sex. No statistically significant changes within or between
treatment groups were observed.
Parents’ body fat percentage
Mean parent per cent body fat values in Table 48 are unadjusted. The analysis of parent per cent body fat
change from baseline in Table 49 is adjusted for age and sex. No significant changes within or between groups
were observed. Point estimates are smaller (favourable) for all longitudinal changes in the usual-care group.
TABLE 46 Time point averages in parents’ BMI
Secondary
outcome
Time point average (95% CI)
Baseline 3 months 12 months
FFH UC FFH UC FFH UC
BMI (kg/m2) 31.88
(30.03 to 33.73)
32.01
(30.08 to 33.94)
30.20
(30.04 to 33.96)
31.07
(29.11 to 33.03)
31.82
(29.92 to 33.72)
29.66
(27.67 to 31.64)
FFH, Families for Health; UC, usual care.
TABLE 47 Sample sizes and longitudinal changes in parent BMI (kg/m2)
Secondary outcome, parent BMI
Treatment group
Treatment effect p-valueFFH UC
Sample size (n)
Baseline 64 73
Change from baseline to 3 months 49 49
Change from baseline to 12 months 50 42
Longitudinal changes
Change from baseline to 3 months (95% CI) –0.030
(–0.379 to 0.319)
0.006
(–0.276 to 0.287)
–0.036
(–0.478 to 0.406)
0.872
Change from baseline to 12 months (95% CI) –0.238
(–0.944 to 0.467)
–0.161
(–0.681 to 0.359)
–0.078
(–0.968 to 0.813)
0.858
FFH, Families for Health; UC, usual care.
TABLE 48 Time point averages in parents’ percentage fat
Secondary
outcome
Time point average (95% CI)
Baseline 3 months 12 months
FFH UC FFH UC FFH UC
Percentage
body fat
38.48
(36.11 to 40.85)
39.21
(37.10 to 41.32)
39.52
(37.27 to 41.79)
38.72
(36.22 to 41.21)
38.36
(36.05 to 40.67)
36.89
(34.06 to 39.72)
FFH, Families for Health; UC, usual care.
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Ancillary analysis
Subgroup analysis
The difference in treatment effects between subgroups was initially assessed by interaction tests. These were
performed via significance tests of interaction terms in the hierarchical model used for the primary outcome
analysis. Each interaction has been fitted separately in a model with the individual fixed effect of this
subgroup covariate also included (if it was not already included). Finally, variables that have been categories
for subgroup analyses (age, parent BMI) were also investigated as covariates on their original scale. Table 50
shows that none of the interaction effects was significant. Therefore, there is no evidence of a differential
treatment effect between prespecified subgroups for any of the subgroup-generating covariates.
The treatment effects in terms of BMI z-scores estimated separately within each subgroup are provided in
Appendix 3.
Harms
No harmful effects were reported in either randomised group.
TABLE 49 Sample sizes and longitudinal changes in parent percentage fat
Secondary outcome, body fat
Treatment group
Treatment effect p-valueFFH UC
Sample size (n)
Baseline 64 73
Change from baseline to 3 months 47 49
Change from baseline to 12 months 46 41
Longitudinal changes
Change from baseline to 3 months (95% CI) 0.394
(–0.268 to 1.055)
–0.182
(–0.779 to 0.416)
0.575
(–0.303 to 1.453)
0.197
Change from baseline to 12 months (95% CI) –0.517
(–1.527 to 0.493)
–0.695
(–1.473 to 0.083)
0.178
(–1.102 to 1.457)
0.779
FFH, Families for Health; UC, usual care.
TABLE 50 Type III test of fixed effects for interaction of subgroups with treatment in primary outcome model,
adding interaction effect
Effect F-value p-value
Treatment × sex 0.54 0.467
Treatment × age 0.01 0.983
Treatment × age group 0.35 0.557
Treatment × parent BMI 2.61 0.110
Treatment × parent BMI group 0.45 0.640
Treatment × SES four classes 1.07 0.369
Treatment × locality 0.27 0.761
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Discussion
In this chapter the data obtained from parents and children during the Families for Health RCT were
analysed. Based on the statistical analysis it cannot be concluded that the Families for Health programme is
effective in reducing children’s BMI z-score relative to usual care. The estimated difference in BMI z-score
between the treatment groups is 0.114 (95% CI –0.001 to 0.229; p= 0.053) in favour of the usual-care
group. Furthermore, the within-group analysis showed that BMI z-score was significantly reduced in the
usual-care arm from baseline to 12-month follow-up (–0.118, 95% CI –0.203 to –0.034; p= 0.007),
whereas there was no significant change in the Families for Health arm (–0.005, 95% CI –0.085 to 0.078;
p= 0.907). This finding is consistent with the analysis of anthropometric child secondary outcomes
(waist z-score, waist circumference, percentage body fat and BMI), all of which showed a more beneficial
outcome in the usual-care group. This indicates a trend that children allocated to Families for Health
did worse than children randomised to the usual care available locally at the three sites in terms of the
management of their obesity. This trend was not observed for the parent anthropometric measures of BMI
and body fat; however, neither usual care nor the Families for Health programme is intended to affect
parent weight management directly.
In contrast, most self-reported parenting and well-being outcome measures analysed showed a more
positive result in the Families for Health arm than in the usual-care arm, albeit without any statistically
significant between-group differences. This suggests that the Families for Health programme has some
impact on parenting attitudes and behaviour, but this does not translate sufficiently into a weight
reduction as hypothesised. According to the PSDQ50 analysis, most parents were already classed as having
a primarily authoritative parenting style (the desired style) at the start of the trial. It could be hypothesised
that Families for Health programme would be more effective in families with primarily permissive or
authoritarian parenting style; unfortunately, the number of families in the trial parenting in this way was
too small to carry out an informative subgroup analysis.
A notable exception in the analysis of questionnaire data (showing favourable Families for Health group
outcomes) was the activity level subscale in the FEAHQ.44 This subscale showed a significant improvement
from baseline to 12-month follow-up in children receiving usual care, and a markedly higher improvement
than in the Families for Health arm, though the between-group difference was not significant (p= 0.167).
This is consistent with an increase in physical activity according to the accelerometer data analysis.
Although the sample size in the accelerometer data analysis was small, and, therefore, the statistical tests
are likely to be underpowered, all point estimates suggest an increase in physical activity in the usual-care
group and no effect, or even a reduction in activity, in the Families for Health group. In contrast, the
PedsQL45 physical domain shows a more positive effect in the Families for Health group.
Even though the difference in the primary outcome analysis is not significant, and the 95% CI for the
treatment effect is consistent with no true difference between the Families for Health programme and
usual care, there is little reason to distrust the point estimate. As mentioned above, the result of the
primary analysis is consistent with results of other anthropometric secondary outcomes. Furthermore,
sensitivity analyses have been conducted in the form of (multiple) imputation analyses. All of those led to
estimates of a similar magnitude as the primary outcome analysis. Moreover, a repeated measures model
has been fitted to the data using all available data (rather than just complete cases) and allowing for the
fact that actual measuring time points varied widely. This model also showed a (significant) improvement
over time in the usual-care arm relative to the Families for Health programme. Some tests have been
conducted to explore whether or not the observed differences might be related to dropouts (see Table 9)
and no relationship has been identified. Nonetheless, the dropout rate was high and differed between
groups. Therefore, the possibility that the observed differences between groups is because of dropouts
rather than a true underlying difference cannot be excluded.
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Chapter 5 Economic evaluation
Introduction
A prospective economic evaluation was conducted alongside the RCT with the aim of assessing the
cost-effectiveness of the Families for Health programme, in comparison with usual care, in the treatment of
overweight and obese children aged 6–11 years. Two main analyses of incremental cost-effectiveness were
conducted. The first analysis was a cost–utility analysis calculating the incremental cost per QALY gained
attributable to the Families for Health programme, whereas the second was a cost-effectiveness analysis
calculating the incremental cost per unit change in BMI z-score (the primary clinical outcome).
The analyses were conducted from two perspectives: (1) a NHS and Personal Social Services perspective;73
and (2) a wider societal perspective that additionally included costs incurred by education or broader
services, or by children’s families.
Methods
Measurement of resource use and costs
A comprehensive strategy was adopted to estimate the incremental costs associated with the Families for
Health programme. This encompassed two broad strands of research: (1) estimation of costs associated
with the experimental and usual-care programmes targeted at overweight and obese children; and (2)
estimation of broader health and Personal Social Service resource inputs and broader societal resource inputs.
Costing of Families for Health and usual-care programmes
A particular focus of the economic evaluation was the assessment of the cost of delivering the Families for
Health programme in community settings, including the costs of programme development, training of
facilitators, staff-related expenses, and revenue and capital overheads. This primarily involved asking each
of the Families for Health facilitators to complete a detailed proforma outlining the cost of delivering each
Families for Health programme, including costs associated with preparation time, programme delivery time,
travel, parking, refreshments and miscellaneous expenditures; these costs were subsequently converted
into programme-specific estimates of cost per session per attending child using separately collected
attendance data. The cost of delivering the alternative usual-care programmes [e.g. One Body One Life,36
Change4Life and Wolverhampton Inspiring and Supporting Health (WISH; Royal Wolverhampton NHS
Trust, Child Healthy Lifestyle Services, Wolverhampton, UK),74 see Chapter 2, Usual-care control group] was
also estimated using the same primary research methods.
Collection of broader resource-use data
Data were also collected about all health and Personal Social Service and broader societal resource inputs
over the 12-month time horizon of the study (i.e. the period between randomisation and 12 months
post randomisation). The main parent was asked to complete detailed resource-use questionnaires via
researcher-administered interviews at baseline and at 3 and 12 months. The questionnaires administered
at 3 months covered the period between baseline and 3 months post randomisation, whereas the
questionnaires administered at 12 months covered the period between 3 and 12 months post randomisation.
The data collected from the main parent at each time point included their child’s use of hospital care services,
community-based health care, community-based social care, and medicines and drugs. Information was also
collected regarding educational support, family expenditures and parental lost productivity attributable to
the child’s health status, over the relevant time horizons. The use of hospital-based services included
hospital inpatient admissions, hospital day-care services, paediatric outpatient department appointments,
other outpatient department appointments, and visits to accident and emergency units. The use of
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community-based health care included contacts with GPs, dentists, opticians, dietitians, psychiatrists,
psychologists and general practice nurses. It also included contacts with child development centres, child
guidance units, family therapists and individual therapy or counselling sessions. The use of community-based
social care included contacts with social workers and after-school activities. A list of all medications prescribed
was also included in the resource-use questionnaires and items were identified for inclusion in the economic
analyses. Medications were categorised by chemical entity, mode of administration, dosage and duration of
use. Educational support included contacts with school nurses, educational psychologists, educational welfare
officers and special education needs co-ordinators. Family expenditures accounted for changes in expenditure
attributable to the child’s weight-related problems. They also covered direct non-medical costs borne by
families, for example travel costs and child-care costs, associated with the study child’s use of health and
social care services. Parents were asked to report the number of days they had been absent from work during
the relevant time horizons as a result of the child’s weight-related problems. The resource-use questionnaires
had been piloted to assess their acceptability and parents’ comprehension levels of the resource-use
questions. The categories of cost included in analyses from the NHS and Personal Social Services perspective
were hospital care, community-based health care, community-based social care and medication use. Analyses
from a societal perspective additionally encompassed educational support, additional family expenditures, lost
productivity and travel costs.
Valuation of resource use
Resource inputs were valued using a combination of primary research, based on established accounting
methods, and data collated from secondary national tariff sets (NHS Reference Costs 2013/14, Unit
Costs of Health and Social Care;61 £, 2013–14 prices). Inpatient admissions over this time horizon were
delineated by type and duration, and valued using per-diem costs extracted from the NHS Reference Costs
2013/14.61 Use of other hospital-based care was valued by applying unit costs extracted from national
tariffs.62 Costs for the community-based services were calculated by applying unit costs from national tariffs
to resource volumes. NHS net prices per mg for the medications were obtained from the British National
Formulary for Children.63 Costs for individual children were estimated based on their reported doses and
frequencies if these were available, or otherwise on an assumed daily dose based on British National
Formulary for Children recommendations.63 The costs to parents of taking time off work to care for the
child(ren) were estimated by applying sex-specific median earnings data64 to occupational classifications
derived from self-reported work status information. Other family-borne costs were valued using data
reported by the parents as part of the follow-up resource-use questionnaires. Unit costs were inflated,
where necessary, to 2013–14 prices (£) using the NHS Hospital and Community Health Services Pay and
Prices Index75 or Consumer Price Index.75 No discounting of costs or benefits was applied as the time
horizon was < 12 months. Table 51 shows a list of resource valuations and their sources.
Calculation of utilities and quality-adjusted life-years
The economic evaluation made use of QALYs to measure preference-based health outcomes. The
health-related quality of life of the study children was assessed using the EQ-5D-Y51,53 obtained from both
parents and children at baseline and 3 and 12 months after randomisation as secondary outcomes of the
trial. The standard UK (York A1) tariff values52 were applied to these responses at each time point to obtain
health utility scores. QALYs were calculated using linear interpolation between baseline and follow-up utility
scores and form the main health outcome measure of the economic evaluation. The baseline analysis was
conducted using the self-reported EQ-5D-Y data completed by the child.
Missing data
Multiple imputation was used to impute missing data and avoid biases associated with complete-case
analysis. Missing data were a particular issue for costs and health utility scores collected at the 3- and
12-month follow-up time points. Multiple imputation using chained equations78 and predicted mean
matching was carried out on the two main outcome measures, the BMI z-score and EQ-5D-Y self-reported
by the child, as well as cost estimates, at both the 3- and 12-month follow-ups. Predicted mean matching
is a semiparametric imputation approach and generally performs better than linear regression despite the
similarities in method.79 Age group, sex, SES and location were included as explanatory variables in
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TABLE 51 Sources of unit costs for resource values
Resource input Unit cost (£) Source
Hospital care
Inpatient admissions Based on HRG code NHS Reference Costs 2013/1461
A&E visits (mean) 115.20 aPSSRU 2011/1276
Outpatient department visits (mean) 189.00 PSSRU 2013/1462
Day hospital visits (mean) 157.00 PSSRU 2013/1462
Consultant (per contact) 35.00 PSSRU 2013/1462
Dietitian (per contact) 9.25 PSSRU 2013/1462
Eye clinic (per contact) 35.00 PSSRU 2013/1462
Occupational therapist (per contact) 9.00 PSSRU 2013/1462
Physiotherapist (per contact) 9.25 PSSRU 2013/1462
Psychiatrist (per contact) 35.50 PSSRU 2013/1462
Dermatologist/skin specialist (per contact) 48.75 PSSRU 2013/1462
Walk-in centre (mean) 42.16 aPSSRU 2011/1276
Community-based health care
GP at surgery (per contact) 46.00 PSSRU 2013/1462
Practice nurse (per contact) 13.70 PSSRU 2013/1462
Dentist (per contact) 43.30 PSSRU 2013/1462
Optician (per contact) 35.00 PSSRU 2013/1462
Dietitian (per contact) 9.30 PSSRU 2013/1462
Child development centre (per contact) 42.20 PSSRU 2013/1462
Community nurse (per contact) 16.50 PSSRU 2013/1462
Children’s centre (behaviour one to one)
(per contact)
35.50 PSSRU 2013/1462
Occupational therapist (per contact) 9.00 PSSRU 2013/1462
Orthodontist (per contact) 35.00 PSSRU 2013/1462
Physiotherapist (per contact) 9.00 PSSRU 2013/1462
School nurse (per contact) 13.69 PSSRU 2013/1462
Family therapist (per contact) 12.50 PSSRU 2013/1462
Individual therapy (per contact) 12.50 PSSRU 2013/1462
Psychiatrist/psychologist (per contact) 35.50 PSSRU 2013/1462
CAMHS (mean) 22.75 PSSRU 2013/1462
School counsellor (per contact) 9.00 PSSRU 2013/1462
Base 25 – one-on-one counselling (per contact) 9.00 PSSRU 2013/1462
Personal activities for young people (per contact) 12.50 PSSRU 2013/1462
Children’s centre mental health (mean) 35.50 PSSRU 2013/1462
Community-based social care
Social worker at home (per contact) 19.80 PSSRU 2013/1462
Social care other (per contact) Various PSSRU 2013/1462
Prescribed medication Various aBNF 201363 and NHS
PCA 201377
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the imputation models. In addition, the baseline BMI z-score was included as an explanatory variable in the
models predicting BMI z-scores at the follow-up points; the baseline EQ-5D-Y utility score was included as
an explanatory variable in the models predicting EQ-5D-Y utility scores at the follow-up points; and
baseline costs were included as an explanatory variable in the models predicting costs at the follow-up
points. Five imputed data sets were generated, as this is deemed sufficient to obtain valid responses.80,81
Siblings within families (n= 24) were treated as clusters in the analyses and reflected in the multiple
imputation. Twenty-three per cent (30/128) of the 3-month BMI z-scores and 31% (40/128) of the
12-month BMI z-scores were imputed. With respect to the EQ-5D-Y, 23% (30/128) of the 3-month
EQ-5D-Y utility scores and 34% (44/128) of the 12-month EQ-5D-Y utility scores were imputed with
the identical method of chained equations and predicted mean matching. Fifteen per cent (20/128) of the
3-month costs and 31% of the 12-month costs were also imputed.
Analyses of resource use, costs and outcome data
Resource-use items were summarised by trial allocation group and follow-up period, and differences
between groups were analysed using a t-test for continuous variables and a chi-squared test for categorical
variables. Mean (SE) costs by cost category and mean (SE) total costs were estimated by trial allocation group
for all time periods. Total costs were estimated from both a NHS and Personal Social Services perspective,
and from a broader societal perspective. Cost comparisons were carried out using Student’s t-test.
Differences in mean total costs and their CIs were estimated. Non-parametric bootstrap estimates73 based on
1000 replications were also calculated for these differences in mean costs, and their CIs calculated.
In addition, bivariate regression was carried out for both costs and outcomes. These analyses explored the
determinants of costs and outcomes using seemingly unrelated regression, and included the prespecified
prognostic factors of trial intervention (referent: usual care), child age (referent: 6–8 years), child sex
(referent: males), site (referent: site A), family SES (referent: higher managerial) and number of siblings
within the trial population (referent: none).
Cost-effectiveness analyses
The main cost-effectiveness analyses were conducted for complete cases (i.e. those with complete cost and
outcome data) on an intention-to-treat basis. The cost-effectiveness results were expressed primarily in
terms of an incremental cost-effectiveness ratio (ICER). This was calculated as the difference in mean costs
divided by the difference in mean outcomes (QALYs or change in BMI z-score between baseline and
12 months) between the trial comparators. The primary analyses took the perspective of the NHS
TABLE 51 Sources of unit costs for resource values (continued )
Resource input Unit cost (£) Source
Educational support
School nurse (per contact) 13.70 PSSRU 2013/1462
Educational psychologist (per contact) 19.80 PSSRU 2013/1462
Educational welfare officer (per contact) 12.50 PSSRU 2013/1462
SEN co-ordinator (per contact) 12.50 PSSRU 2013/1462
Additional meetings with tutors (per contact) 12.50 PSSRU 2013/1462
Other educational support (per contact) Various PSSRU 2013/1462
Parents’ days off work Based on derived
occupational code
bONS earnings data 201264
A&E, accident and emergency; BNF, British National Formulary; CAMHS, Child and Adolescent Mental Health Services;
HRG, Healthcare Resource Group; ONS, Office for National Statistics; PCA, Prescription Cost Analysis; PSSRU, Personal
Social Services Research Unit; SEN, special educational needs.
a Inflated to 2013–14 prices using the NHS Hospital and Community Health Services Pay and Price Index.
b Inflated to 2013–14 prices using the Consumer Price Index.
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and Personal Social Services. The non-parametric bootstrapping approach was used to determine the
level of sampling uncertainty surrounding the mean ICER by generating 10,000 estimates of incremental
costs and benefits. These were represented graphically on four-quadrant cost-effectiveness planes.
Cost-effectiveness acceptability curves (CEACs) showing the probability that the Families for Health
programme was cost-effective relative to usual care, across a range of cost-effectiveness thresholds, were
also generated based on the proportion of bootstrap replicates with positive incremental net benefits.
Unless otherwise stated, all statements about cost-effectiveness are based on a £20,000 per QALY gained
threshold. The probability that the Families for Health programme is less costly or more effective than usual
care was based on the proportion of bootstrap replicates that had negative incremental costs or positive
incremental health benefits.
Secondary analyses were also conducted where the outcomes remained unchanged from the main
cost-effectiveness analyses, but for the costs a wider societal perspective was taken that included broader
economic costs.
Sensitivity and subgroup analyses
Several sensitivity analyses were undertaken to assess the impact of areas of uncertainty surrounding
components of the economic evaluation. These involved re-estimating the main cost-effectiveness
outcomes under the following scenarios: (1) conducting a per-protocol analysis where families having
participated in five or more sessions of the Families for Health programme are regarded as ‘programme
completers’ (i.e. as having complied with the protocol sufficiently); (2) multiple imputation of all missing
cost and outcomes data; (3) parent-reported EQ-5D-Y values for the study child(ren) substituted for child
self-reported values in the formulation for QALYs; and (4) incorporation of EQ-5D values reflecting the
main parent’s self-reported health within calculations of overall QALYs gained.
Subgroup analyses were conducted for the main cost-effectiveness results to explore heterogeneity in the
trial population. These were conducted by (1) age group (6–8 and 9–11 years); (2) sex (males or females);
and (3) site (site A, B or C).
Long-term cost-effectiveness model
This study focused on the short- and medium-term costs and consequences of the Families for Health
programme in the treatment of overweight and obese children in a community setting. The study
protocol82 had allowed for extrapolation of costs and consequences over a longer time horizon if the
results had demonstrated a difference in medium-term outcomes. This longer-term modelling would have
been based on the natural history of the disease and additional evidence from the literature in the event
that the trial yielded significant benefits for the Families for Health programme.
Results
Study population
A total of 128 children were randomised into the Families for Health trial, 63 to the Families for Health
programme and 65 to usual care. The 128 children were recruited from 115 families (56 allocated to
the Families for Health programme arm and 59 to the usual-care arm). A complete profile of resource use
was collected for 94 children at 3 months post randomisation (representing 73.4% of the trial population).
A complete profile of resource use was collected for 88 children at 12 months post randomisation
(representing 68.8% of the trial population). A complete QALY profile between randomisation and
12 months post randomisation was available for 79 children (representing 61.7% of the trial population).
Resource use
Resource-use measures for the period 3 months pre-randomisation are summarised in Table 52 by trial
allocation group. Over-the-counter medication purchases and additional meetings with tutors were
significantly higher for the usual-care group compared with the Families for Health group. There were no
significant differences between the trial arms across the remaining resource-use categories.
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TABLE 52 Resource utilisation for the period 3 months pre randomisation
Resource variable
Treatment group
p-valueaFFH (n= 63) UC (n= 65)
Hospital care, mean (SE)
Number of inpatient admissions 0.02 (0.02) 0 0.321
A&E visits 0.02 (0.02) 0.11 (0.04) 0.056
Outpatient department visits 0.25 (0.08) 0.35 (0.15) 0.548
Day hospital visits 0.02 (0.02) 0 0.321
Other hospital visits 0.03 (0.02) 0.11 (0.11) 0.492
Community-based health-care contacts, mean (SE)
GP at surgery 0.52 (0.11) 0.72 (0.18) 0.340
GP at home 0 0
Practice nurse 0.05 (0.03) 0.06 (0.03) 0.731
Dentist 0.30 (0.06) 0.51 (0.10) 0.085
Optician 0.16 (0.05) 0.20 (0.06) 0.613
Dietitian 0.02 (0.02) 0.08 (0.04) 0.159
Child development centre 0.02 (0.02) 0 0.321
Child guidance unit 0 0
General health (other) 0.08 (0.03) 0.06 (0.03) 0.697
Family therapist 0 0
Individual therapy 0 0
Psychiatrist/psychologist 0 0.03 (0.02) 0.159
Counselling (other) 0.16 (0.11) 0 0.159
Community-based social care contacts, mean (SE)
Social worker at office 0.06 (0.04) 0.38 (0.27) 0.243
Social worker at home 0 0
After-school club 0 0
Social care (other) 0.14 (0.13) 0.28 (0.18) 0.543
Medication usage, n (%)
Prescribed 28 (44.4) 34 (52.3) 0.373
Over the counter 30 (47.6) 43 (66.2) 0.034
Educational support, mean (SE)
School nurse 0.35 (0.09) 0.43 (0.21) 0.718
Educational psychologist 0.03 (0.03) 0.20 (0.16) 0.292
Educational welfare officer 0 0.05 (0.03) 0.182
SEN co-ordinator 0.52 (0.51) 0.11 (0.06) 0.419
Additional meetings with tutors 0 0.29 (0.14) 0.0407
Other educational support 0.27 (0.21) 0.65 (0.29) 0.291
Parents’ days off work 0.20 (0.10) 0.06 (0.05) 0.210
A&E, accident and emergency; FFH, Families for Health; SEN, special educational needs; UC, usual care.
a Analysed using t-tests for continuous variables and chi-squared test for categorical variables.
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Resource-use measures for the first 3 months post randomisation are summarised in Table 53 by trial
allocation group. The mean (SE) number of GP contacts at surgery was 0.70 (0.11) in the Families for
Health group, but was significantly lower in the usual-care group [0.28 (SE 0.07); p= 0.002]. The Families
for Health group also had more contacts with social workers at home, on average, with a mean (SE)
number of contacts of 0.09 (0.04) compared with none for the usual-care group (p= 0.044). There were
no significant differences between the trial arms across the remaining resource-use categories. For the
period 3–12 months post randomisation, there were no significant differences between the trial arms
across all resource-use categories (see Appendix 4).
TABLE 53 Resource utilisation for the period 3 months post randomisation
Resource variable
Treatment group
p-valueaFFH (n= 44) UC (n= 50)
Hospital care, mean (SE)
Number of inpatient admissions 0 0
A&E visits 0.25 (0.14) 0.12 (0.08) 0.412
Outpatient department visits 0.16 (0.06) 0.18 (0.09) 0.854
Day hospital visits 0 0
Other hospital visits 0 0.04 (0.03) 0.159
Community-based health-care contacts, mean (SE)
GP at surgery 0.70 (0.11) 0.28 (0.07) 0.002
GP at home 0 0
Practice nurse 0.07 (0.04) 0.06 (0.03) 0.874
Dentist 0.32 (0.07) 0.52 (0.08) 0.066
Optician 0.05 (0.03) 0.18 (0.06) 0.057
Dietitian 0 0
Child development centre 0 0.04 (0.04) 0.322
Child guidance unit 0 0
General health (other) 0.02 (0.02) 0.04 (0.03) 0.633
Family therapist 0 0
Individual therapy 0 0
Psychiatrist/psychologist 0 0.20 (0.20) 0.322
Counselling (other) 0.16 (0.12) 0.66 (0.46) 0.298
Community-based social care contacts, mean (SE)
Social worker at office 0 0 0
Social worker at home 0.09 (0.04) 0 0.044
After-school club 0 0 0
Social care (other) 0 0.02 (0.02) 0.322
Medication usage, n (%)
Prescribed 19 (43.2) 24 (48.0) 0.640
Over the counter 21 (47.7) 26 (52.0) 0.679
continued
DOI: 10.3310/hta21010 HEALTH TECHNOLOGY ASSESSMENT 2017 VOL. 21 NO. 1
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Robertson et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
63
Attendance rates for the Families for Health programme and a range of usual-care programmes targeted
at overweight and obese children during the first 3 months post randomisation are summarised in
Table 54. The mean number of contacts with the Families for Health programmes was higher than for
comparator usual-care programmes. This difference may be explained, at least in part, by the sources of
information for the two comparator arms. The attendance data for the Families for Health programme
were based on the recorded attendance information collected as part of the trial. In contrast, attendance
at comparator usual-care programmes was based on parent-reported attendance recorded as part of the
resource-use questionnaires. Nevertheless, the researchers administering the resource-use questionnaires
were trained to prompt parents about their children’s use of a range of services available in their locality.
The attendance rates for the comparator usual-care programmes over the period 3–12 months post
randomisation are presented in Appendix 5.
TABLE 53 Resource utilisation for the period 3 months post randomisation (continued )
Resource variable
Treatment group
p-valueaFFH (n= 44) UC (n= 50)
Educational support contacts, mean (SE)
School nurse 0.34 (0.12) 0.50 (0.17) 0.437
Educational psychologist 0.05 (0.05) 0.04 (0.04) 0.928
Educational welfare officer 0 0
SEN co-ordinator 0.05 (0.05) 0.12 (0.10) 0.505
Additional meetings with tutors 0.07 (0.05) 0.183
Other educational support 0.02 (0.02) 0.40 (0.25) 0.133
Parents days off work 0.15 (0.08) 0.02 (0.02) 0.116
A&E, accident and emergency; FFH, Families for Health; SEN, special educational needs; UC, usual care.
a Analysed using t-tests for continuous variables and chi-squared test for categorical variables.
TABLE 54 Families for Health programme and usual-care attendance (3 months post randomisation)
Attendance
Treatment group, mean (SE)
FFH UC
FFH, site A 1 7.5 (0.82) NA
FFH, site B 1 5.3 (1.36) NA
FFH, site C 1 3.9 (1.44) NA
FFH, site A 2 6.8 (1.52) NA
FFH, site C 2 4.8 (1.22) NA
FFH, site B 2 3.7 (0.62) NA
FFH, site A 3 5.2 (1.37) NA
UC, One Body One Life NA 1.14 (0.38)
UC, Change4Life NA 2.5 (0.61)
UC, WISH NA 3.3 (1.05)
UC, Weight Watchers NA 0
UC, school nurse NA 2.9 (1.01)
1, first running of the FFH programme at the three sites; 2, second running of the FFH programme at the three sites;
3, third running of the FFH programme at the three sites; FFH, Families for Health; NA, not applicable; UC, usual care.
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Costing of Families for Health and comparator usual-care programmes
The costs of developing the Families for Health programme and training staff to deliver the programme
were measured and valued. These costs are presented in Table 55. The costs directly attributable to the
delivery of the programme encompassed the value placed on staff preparation time, programme delivery
time, travel, parking, refreshments and miscellaneous expenditures. The programme delivery costs over the
duration of the trial, broken down by cost category, are presented in Table 55.
The costs of delivering the alternative usual-care programmes were also estimated using comparable
primary research methods. Estimates of cost per attending child per programme session are presented for
each programme in Table 56. The costs per attending child per programme session were variable among
the programmes and ranged from £4.58 for the Weight Watchers programme to £95.94 for Families for
Health. This is not entirely surprising because the programmes were not homogeneous in terms of their
constituent components, mode or location of delivery, or staff requirements.
Economic costs
Economic costs for the 3-month period pre-randomisation are summarised in Appendix 6 by trial allocation
group and cost category. There were no significant differences between the trial allocation groups in any
cost category. Economic costs during the first 3 months post randomisation are summarised in Table 57 by
trial allocation group and cost category. The mean total costs of GP visits, social worker contacts at home,
TABLE 55 Costs associated with the Families for Health programme
Category Cost (£)
Cost of developing the Families for Health intervention
Family links training costs 13,137
Other staff training costs 1816
Total 14,953
Cost of delivering the Families for Health programme during the trial
Staff costs 21,261
Travel 1981
Subsistence 888
Venue hire 6704
Toolkit 995
Consumables 663
Total 32,492
TABLE 56 Cost per attending child per programme session by programme
Programme Cost per attending child per programme session (£)
Families for Health 95.94
One Body One Life 40.41
Change4Life (family programme) 83.56
WISH 70.33
Weight Watchers 4.58
Change4Life (one to one) 53.71
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TABLE 57 Costs of care by cost category and trial allocation for the period 3 months post randomisation
Cost category
Treatment group (£)
p-valueaFFH (n= 44) UC (n= 50)
Hospital inpatient care, mean (SE) 0.00 0.00
Other hospital-based care, mean (SE)
A&E 28.79 (16.38) 13.82 (7.81) 0.412
Outpatient departments 30.07 (12.20) 34.02 (17.66) 0.854
Day hospital 0.00 0.00
Other 0.00 4.74 (3.97) 0.238
Total other hospital care costs 58.86 (26.00) 52.58 (21.08) 0.852
Community-based health care, mean (SE)
GP at surgery 28.36 (4.97) 9.75 (3.01) 0.002
GP at home 0.00 0.00
Practice nurse 1.00 (0.65) 0.35 (0.21) 0.350
Dentist 11.40 (3.07) 23.07 (5.90) 0.084
Optician 3.18 (2.22) 14.47 (6.35) 0.099
Dietitian 0.00 0.00
Child development centre 0.00 1.69 (1.69) 0.322
Child guidance unit 0.00 0.00
General health other 1.36 (1.36) 1.17 (0.83) 0.902
Family therapist 0.00 0.00
Individual therapy 0.00 0.00
Psychiatrist/psychologist 0.00 28.40 (28.40) 0.322
Counselling (other) 7.15 (4.36) 97.64 (81.37) 0.272
Total community-based health costs 52.46 (7.78) 176.53 (84.53) 0.150
Community-based social and other care, mean (SE)
Social worker at office 0.00 0.00
Social worker at home 1.80 (0.87) 0.00 0.044
After-school club 0.00 0.00
Social care (other) 0.00 0.09 (0.09) 0.322
Overweight- and obesity-related programmesb 562.58 (54.35) 127.29 (23.39) < 0.001
Total community-based social and other costs 564.38 (54.65) 127.38 (23.38) < 0.001
Medications, mean (SE)
Prescribed 2.85 (0.83) 6.42 (2.73) 0.216
Over the counter 0.56 (0.32) 0.36 (0.20) 0.604
Educational support, mean (SE)
School nurse 4.62 (1.95) 4.96 (1.67) 0.893
Educational psychologist 0.90 (0.90) 4.74 (4.74) 0.429
Educational welfare officer 0.00 0.00
SEN co-ordinator 1.14 (1.14) 4.50 (3.17) 0.322
Additional meetings with tutors 0.00 0.00
Other educational support 3.02 (3.02) 7.73 (4.61) 0.171
Total educational support costs 9.68 (3.49) 21.93 (10.37) 0.268
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overweight- and obesity-related programmes, and overall community-based social and other care were
significantly higher for the Families for Health group than for the usual-care group. Mean total NHS and
Personal Social Services costs, and mean total societal costs were significantly higher for the Families for
Health group than for the usual-care group [£688 vs. £385 (p= 0.007) and £792 vs. £459; (p= 0.006),
respectively]. For the period between 3 and 12 months post randomisation, there were no significant cost
differences in any cost category between the two trial allocation groups (see Appendix 7).
Economic costs from randomisation to 12 months post randomisation are presented by cost category in
Table 58 for the Families for Health and usual-care groups. The costs are presented for complete cases
(i.e. for those children for whom cost data were available at all follow-up periods). Mean total social and
other non-health community care costs, total NHS and Personal Social Service costs, and total societal costs
were significantly higher for the Families for Health group than for the usual-care group. There were no
significant differences in mean total hospital care costs, community health-care costs, medication costs,
educational support costs, family expenditures, parental lost earnings and travel costs between the trial
allocation groups. Mean (SE) total NHS and Personal Social Service costs were estimated at £998 (£72) for
the Families for Health group, compared with £548 (£73) for children in the usual-care group. The mean
NHS and Personal Social Service cost difference was £450 (bootstrap 95% CI £249 to £650; p< 0.001).
Similarly, mean (SE) total societal costs were estimated at £1311 (£100) for the Families for Health group,
compared with £882 (£112) for children in the usual-care group. The mean societal cost difference was
£429 (bootstrap 95% CI £110 to £713; p= 0.005).
Analyses of incremental costs and incremental health outcomes
A bivariate regression, in the form of a seemingly unrelated regression, was carried out with the view to
estimating the incremental costs and incremental health outcomes associated with the Families for Health
programme. The results of this bivariate regression are presented in Table 59. The adjusted incremental
costs associated with the Families for Health programme were £483.63 when NHS and Personal Social
Services costs were considered and £410.64 when societal costs were considered. These incremental
costs were statistically significant at the 0.1% and 1% levels, respectively. Children from all comparator
socioeconomic backgrounds incurred higher adjusted costs, regardless of study perspective, than the
reference category (highly managerial). Children with siblings in the trial population incurred lower
adjusted NHS and Personal Social Services costs and lower adjusted societal costs than children without
siblings in the trial population, although these cost decrements were not statistically significant.
Similarly, children aged 9–11 years incurred lower adjusted NHS and Personal Social Services costs and
TABLE 57 Costs of care by cost category and trial allocation for the period 3 months post randomisation
(continued )
Cost category
Treatment group (£)
p-valueaFFH (n= 44) UC (n= 50)
Other costs, mean (SE)
Additional family expenditures 82.84 (21.91) 55.40 (15.93) 0.314
Lost productivity 16.94 (7.92) 3.19 (3.19) 0.113
Travel costs 3.36 (0.82) 13.79 (6.34) 0.109
Total NHS and PSS costs, mean (SE) 688.24 (56.08) 384.85 (94.63) 0.007
Total societal costs, mean (SE) 791.94 (63.47) 457.58 (98.53) 0.006
A&E, accident and emergency; FFH, Families for Health; PSS, Personal Social Services; SEN, special educational needs;
UC, usual care.
a Comparisons of costs between trial allocation groups carried out using a Student t-test.
b Includes study intervention costs.
Note
Discrepancies in values in this table are attributable to rounding to two decimal places.
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lower adjusted societal costs than children aged 6–8 years, although these cost decrements were not
statistically significant. Regarding health outcome measures, the Families for Health programme was
associated with a mean increment in QALYs of 0.04 (95% CI –0.04 to 0.11), but also a difference in
longitudinal change in BMI z-score of 0.11 (95% CI 0.00 to 0.22). However, it should be noted that these
results were based on 88 children with complete data for all covariates.
Cost-effectiveness
The incremental cost-effectiveness of the Families for Health programme is shown in Table 60 for the
children with complete costs and health outcomes data over the trial follow-up period, by study perspective
and health outcome. When a study perspective of the NHS and Personal Social Services was adopted
(i.e. that adopted for the baseline analysis) and health outcomes were measured in terms of QALYs,
TABLE 59 Bivariate regression of incremental total costs and incremental health outcomes associated with the
Families for Health programme
Total costa
Costs, £ (95% CI)
NHS and PSS Societal
Intervention: Family for Health 483.63*** (270.51 to 696.74) 410.46** (121.12 to 699.80)
Sex: female –55.57 (–273.34 to 162.19) –243.50 (–539.15 to 52.15)
SES
Intermediate 165.67 (–166.31 to 497.66) 278.75 (–171.97 to 729.48)
Routine 284.16* (38.66 to 529.67) 178.67 (–154.63 to 511.99)
Never worked 179.64 (–163.21 to 522.49) 270.47 (–195.00 to 735.95)
Location
Site B 4.25 (–263.19 to 271.71) –21.77 (–384.89 to 341.33)
Site C –167.62 (–417.74 to 82.49) –366.42* (–705.99 to –26.84)
Siblings: trial siblings –179.50 (–509.63 to 150.62) –423.34 (–871.55 to 24.85)
Age: 9–11 years –41.13 (–248.98 to 166.71) –121.92 (–404.11 to 160.26)
Constant 557.93*** (255.72 to 860.14) 1173.07*** (762.77 to 1583.37)
QALYs (95% CI) BMI z-score (95% CI)
Intervention: Family for Health 0.04 (–0.04 to 0.11) 0.11 (0.00 to 0.22)
Sex: female 0.02 (–0.06 to 0.10) –0.12* (–0.23 to 0.00)
SES
Intermediate 0.07 (–0.05 to 0.19) 0.09 (–0.08 to 0.27)
Routine –0.02 (–0.10 to 0.075) 0.02 (–0.10 to 0.15)
Never worked –0.24*** (–0.36 to –0.11) 0.03 (–0.15 to 0.21)
Location
Site B –0.06 (–0.15 to 0.04) 0.09 (–0.04 to 0.23)
Site C 0.09 (–0.00 to 0.18) 0.08 (–0.04 to 0.22)
Siblings: trial siblings 0.12* (0.01 to 0.25) –0.06 (–0.23 to 0.11)
Age: 9–11 years 0.09* (0.02,0.17) –0.03 (–0.14 to 0.07)
Constant 0.72*** (0.61 to 0.83) 0.11 (–0.04 to 0.27)
Observations 88 88
*p< 0.05; **p< 0.01; ***p< 0.001.
PSS, Personal Social Services.
a Reference case: intervention – usual care; sex – male; SES – higher managerial; location – site A; age – 6–8 years;
sibling within trial population – no sibling.
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the average total cost was £1019 in the Families for Health group compared with £507 in the usual-care
group, generating a mean incremental cost of £512. The mean incremental cost-effectiveness of the
Families for Health programme was estimated at £552,175 per QALY gained. The bootstrapped mean ICERs
fell in the north-east and north-west quadrants of the cost-effectiveness plane (Figure 7). The CEAC shown
in Figure 7 indicates that regardless of the value of the cost-effectiveness threshold, the probability that the
Families for Health programme is cost-effective does not exceed 40%. If decision-makers are willing to pay
£20,000 for an additional QALY, the probability that the Families for Health programme is cost-effective is
approximately 28% (see Table 60). Broadening the study perspective to that of society as a whole had little
effect on these cost-effectiveness results. In particular, the mean ICER remained relatively static at £559,115
per QALY gained and the probability that the Families for Health programme is cost-effective at a £20,000
cost-effectiveness threshold remained unchanged at 28% (Table 60, Figure 8).
When a study perspective of the NHS and Personal Social Services was adopted and health outcomes were
measured in terms of longitudinal change in BMI z-score, the average total cost was £998 in the Families
for Health group (for those with complete data), compared with £548 in the usual-care group, generating
a mean incremental cost of £450. The mean incremental cost-effectiveness of the Families for Health
programme was estimated at –£3935 per unit change in BMI z-score. The bootstrapped mean ICERs
largely fell in the north-west quadrant of the cost-effectiveness plane (Figure 9), indicating that, on
average, the Families for Health programme is dominated by usual care in health economic terms.
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FIGURE 7 (a) Cost-effectiveness plane; and (b) CEAC for QALY outcome: complete cases from a NHS and Personal
Social Services perspective. Adapted from Robertson W, Fleming J, Kamal A, Hamborg T, Khan KA, Griffiths F, et al.
Randomised controlled trial and economic evaluation of the ‘Families for Health’ programme to reduce obesity in
children [published online ahead of print 21 December 2016]. Arch Dis Child 2016. doi: 10.1136/archdischild-2016-
311514. This is an Open Access article distributed in accordance with the terms of the Creative Commons
Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for
commercial use, provided the original work is properly cited (see http://creativecommons.org/licenses/by/4.0/). 71
– 0.15
– 1250
Incremental QALYs
In
cr
em
en
ta
l c
o
st
s 
(£
)
– 1000
– 750
– 500
– 250
250
750
1000
1250(a)
500
– 0.10 – 0.05 0.05 0.10 0.15
0
0.0
0.2
0.4
0.6
0.8
1.0
20 40
(b)
60 80 100
Cost-effectiveness threshold (£000 per QALY)
Pr
o
p
o
rt
io
n
 o
f 
si
m
u
la
ti
o
n
s
FIGURE 8 (a) Cost-effectiveness plane; and (b) CEAC for QALY outcome: complete cases from a societal perspective.
DOI: 10.3310/hta21010 HEALTH TECHNOLOGY ASSESSMENT 2017 VOL. 21 NO. 1
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Robertson et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
71
The CEAC shown in Figure 9 indicates that regardless of the value of the cost-effectiveness threshold,
the probability that the Families for Health programme is cost-effective does not exceed 2% (on the basis
of the BMI z-score). If decision-makers are willing to pay £20,000 per unit change in BMI z-score, the
probability that the Families for Health programme is cost-effective is < 1% (see Table 60). Broadening
the study perspective to that of society as a whole had little effect on these cost-effectiveness results.
In particular, the mean ICER remained relatively static at –£3748 per unit change in BMI z-score and the
probability that the Families for Health programme is cost-effective at a £20,000 cost-effectiveness
threshold remained unchanged at < 1% (Figure 10).
Sensitivity analyses
Several sensitivity analyses were undertaken to assess the impact of uncertainty on the cost-effectiveness
results. Table 61 presents our recalculations of cost-effectiveness estimates when a per-protocol analysis
was performed. These analyses defined ‘programme completers’ as families who participated in five or
more sessions of the Families for Health programme and non-completers as families who participated in less
than five sessions of the Families for Health programme. These analyses were also restricted to the baseline
NHS and Personal Social Services perspective. Of particular note is that for programme completers, the
mean incremental cost per QALY gained attributable to the Families for Health programme declined to
£27,790 and the probability that the programme is cost-effective at a £20,000 cost-effectiveness threshold
increased to 43%. For comparison, the mean incremental cost per QALY gained among non-completers
was –£6441 (indicating that usual care is dominant in health economic terms) and the probability that the
programme is cost-effective at a £20,000 cost-effectiveness threshold was 17% (Figures 11–14).
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Table 62 presents our recalculations of cost-effectiveness estimates following multiple imputation of all
missing cost and outcomes data (i.e. estimates are calculated for all 128 study children). Of particular note
is that following multiple imputation, the mean incremental cost per QALY gained (assuming a NHS and
Personal Social Services perspective) attributable to the Families for Health programme declined to £9119
and the probability that the programme is cost-effective at a £20,000 cost-effectiveness threshold
increased to 67%. Similar results were observed when a societal perspective for costs was adopted.
In contrast, when the BMI z-score was considered as the health outcome measure, the Families for Health
programme remained dominated by usual care in health economic terms and the probability that the
programme is cost-effective did not exceed 6%, regardless of the value of the cost-effectiveness threshold
(Figures 15–18).
Finally, Table 63 presents our recalculations of cost-effectiveness estimates when alternative sources and
inputs for EQ-5D utility values were incorporated into the analyses. Substituting parent-reported EQ-5D-Y
values for the study child(ren) for child self-reported values in the formulation for QALYs removed the
incremental QALY benefit associated with the Families for Health programme. The probability that the
programme is cost-effective at a £20,000 cost-effectiveness threshold declined to 23% when a NHS and
Personal Social Services perspective was adopted, and to 25% when a societal perspective was adopted.
Furthermore, the reduction in incremental QALYs associated with the Families for Health programme
increased when EQ-5D values reflecting the main parent’s self-reported health were also incorporated
within calculations of overall QALYs gained. The probability that the programme is cost-effective at a
£20,000 cost-effectiveness threshold declined to 2% (see Table 63 and Figures 19–22).
Subgroup analyses
Several subgroup analyses were conducted to explore the heterogeneity in our cost-effectiveness results.
These are summarised in Appendix 8. See Table 93, which presents the cost-effectiveness results by
subgroup when a NHS and Personal Social Services perspective is adopted for costs, and see Table 94 which
presents the cost-effectiveness results by subgroup when a societal perspective is adopted. The subgroups
considered in our analyses were (1) age group (6–8 or 9–11 years); (2) sex of child (male or female); and
(3) site (site A, B or C). The cost-effectiveness results for two particular subgroups of children are worthy of
comment. First, when the QALY measure was considered as the primary health outcome measure, the
probability of cost-effectiveness of the Families for Health programme was notably higher for girls than for
boys: 67% versus 15% at a £20,000 cost-effectiveness threshold from a NHS and Personal Social Services
Perspective and 63% versus 16% at a £20,000 cost-effectiveness threshold from a societal perspective.
Second, when the QALY measure was considered as the primary health outcome measure, the probability
of cost-effectiveness of the Families for Health programme was notably higher in site A than in site B or C:
61% versus 11% versus 36% at a £20,000 cost-effectiveness threshold from a NHS and Personal Social
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FIGURE 15 (a) Cost-effectiveness plane; and (b) CEAC for QALY outcome: imputed analyses from a NHS and Personal
Social Services perspective. The cost-effectiveness plane is based on 1000 bootstrap replicates of the data set.
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FIGURE 16 (a) Cost-effectiveness plane; and (b) CEAC for QALY outcome: imputed analyses from a societal
perspective. The cost-effectiveness plane is based on 1000 bootstrap replicates of the data set.
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FIGURE 17 (a) Cost-effectiveness plane; and (b) CEAC for BMI z-score outcome: imputed analyses from a NHS
Personal Social Services perspective. The cost-effectiveness plane is based on 1000 bootstrap replicates of the
data set.
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Services perspective, and 64% versus 7% versus 35% at a £20,000 cost-effectiveness threshold from a
societal perspective. These patterns were not replicated for the BMI z-score outcome measure.
Discussion
This chapter summarises the methods and results of the economic evaluation that was conducted as part
of the Families for Health RCT. The economic evaluation was conducted in accordance with national
methodological standards with a comprehensive analytical strategy adopted to handle missing data and
various forms of uncertainty, including sampling, decision and methodological uncertainty. The mean
incremental cost-effectiveness of the Families for Health programme was estimated at £552,175 per
QALY gained, and the probability that the Families for Health programme is cost-effective at a £20,000
cost-effectiveness threshold was estimated to be approximately 28%. When health outcomes were
measured in terms of longitudinal change in BMI z-score, the mean incremental cost-effectiveness of the
Families for Health programme was estimated at –£3935 per unit change in BMI z-score (indicating
that, on average, Families for Health is dominated by usual care in health economic terms), and the
probability that the Families for Health programme is cost-effective did not exceed 2% across a range of
cost-effectiveness thresholds held by decision-makers. These findings remained relatively robust to a range
of sensitivity analyses, although it is noteworthy that the probability of cost-effectiveness of the Families for
Health programme increased when the analyses were restricted to programme completers, and separately
following multiple imputation of missing cost and health utility data. It is conceivable that family-based
group interventions containing the key components of the Families for Health programme could
represent a cost-effective use of public resources for the treatment of overweight status or obesity during
mid-childhood, if strategies are in place to enhance programme adherence. Nevertheless, the incremental
costs associated with enhancements to the programme would need to be factored into future analyses.
Analyses of heterogeneity in the cost-effectiveness results revealed that the probability of cost-effectiveness
of the programme was notably higher among girls and in one of the three trial sites, although this pattern
was not replicated when cost-effectiveness estimates were based on the primary clinical outcome.
A number of caveats to the results of the economic evaluation should be noted. First, there was
considerable stochastic uncertainty surrounding our cost-effectiveness estimates, which were addressed
through the use of CEACs, and sensitivity analyses to handle uncertainty surrounding individual
components of the economic evaluation. Second, a complete profile of resource utilisation, cost and health
utility data over the study time horizon was available for only 79 of 128 (61.7%) children, despite intensive
efforts to follow up the study children and their families. In response, multiple imputation techniques for
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FIGURE 19 (a) Cost-effectiveness plane; and (b) CEAC for QALY outcome: proxy-reported EQ-5D-Y values, NHS and
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FIGURE 20 (a) Cost-effectiveness plane; and (b) CEAC for QALY outcome: proxy-reported EQ-5D-Y values,
societal perspective.
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handling missing values were applied. A third caveat is that our cost estimates are largely based on parental
reports of their children’s use of health, social and broader services, and their own incremental expenditures
over extended recall periods (3 and 9 months at the two follow-up points). Previous research has indicated
that parents may underestimate their children’s use of some categories of services (e.g. community service
utilisation) over extended recall periods.83 If this was the case for our study, our absolute costs for some
categories of services may be underestimates. Nevertheless, there is no evidence to suggest that our
estimates of incremental cost-effectiveness of the Families for Health programme are biased by this
concern.84 A fourth caveat is that lost productivity in this study was measured on the basis of parents’ time
off work, and this approach does not value the time losses of the non-working population, which may be
relevant. Finally, in several analyses a societal perspective was applied to costs, but only health benefits
accruing to the children were considered. Future research we are planning will additionally incorporate
parents’ health outcomes and use a dyad approach to measuring health benefits for the family.
In conclusion, our study results indicate that the Families for Health programme is unlikely to represent
a cost-effective use of resources targeted at overweight or obese children. Data from our economic
evaluation can be used to inform future health economic studies in this area.
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Chapter 6 Process evaluation
Introduction
This chapter reports the process evaluation of the Families for Health trial. Process evaluation is an
important adjunct to the reporting of RCTs of complex interventions, and is particularly necessary in trials
that involve multiple sites because the intervention may be delivered or received differently across sites.85
Guidance from the UK MRC for the conduct of process evaluations has recommended that process
evaluations should examine how the intervention was delivered (e.g. the structures, resources and processes
through which intervention delivery is achieved) and what is delivered in terms of quantity and quality.86
Although the protocol for this process evaluation82 was finalised before the MRC guidance was published,
this process evaluation has similar aims. The protocol for this process evaluation was developed using Linnan
and Steckler’s87 framework to address issues of recruitment, reach, dose delivered, fidelity and dose received.
Methods
Design
Table 64 shows the topics covered by the process evaluation, together with a definition of the component
in the context of this trial and the associated research question.
Three members of the research team (WR, JF and AK) collected both quantitative and qualitative data from
parents, children and facilitators. Table 65 shows the data used to assess each component. Interviews with
families took place at baseline, and at the 3- and 12-month follow-ups. In addition, weekly feedback forms
during the seven Families for Health programmes, attendance registers, focus groups with facilitators and
hours worked by facilitators were also collected. Follow-up family visits were conducted by a researcher
who was blinded to treatment allocation.
TABLE 64 Definition of components covered by the process evaluation and related research questions
Component Component definition Associated research question
Recruitment Success of methods used to approach and
recruit participants
What is the best method of recruiting families?
Reach Degree to which the intended population
participated in the intervention
To what degree did the intended population
participate in the intended interventions?
Dose delivered The ‘amount’ of intervention provided by the
intervention team
How much of the intervention was delivered in terms
of quantity and quality?
Fidelity The extent to which the intervention was
delivered as planned (i.e. as prescribed in the
handbook and as intended)
Was the FFH intervention delivered as intended in
terms of the structures, resources and processes?
Dose received Extent of engagement with the intervention by
the target population
How was the intervention (FFH and UC) received by
families, including which aspects (if any) of a healthier
lifestyle the FFH and UC programmes enabled?
FFH, Families for Health; UC, usual care.
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Data collection methods
This section describes the data collection methods that were used solely for the process evaluation,
grouped by the five components. Other data used were collected as described in Chapter 2.
Recruitment
At first contact, parents were asked to indicate how they heard about the trial. Subsequently, once
recruited, parents completed a recruitment questionnaire, which included the question, ‘Where did you
hear about the research study?’ with the following response options: GP, school nurse, health visitor,
paediatrician, school, media, flyer/leaflet, friends/family, letter from NCMP, other. In cases where there was
a discrepancy between the questionnaire response and the response given at first contact, the first contact
response was used.
Reach
Data on family composition, ethnicity, sex, age of participating child(ren), employment details of parents,
and height and weight measurements of parents and children were used to explore reach, and were
collected as described in Chapter 2.
Population-level data for each site were obtained from 2011 census data for England and Wales,88 English
Indices of Deprivation 201089 and the National Child Measurement Programme.90 Baseline characteristics of
families recruited to the Families for Health trial were compared with these data, to examine reach.
TABLE 65 Data collection plan for the process evaluation
Component Data sources Timing of data collection
Recruitment of
participants
Record of expression of interest
Parent self-report questionnaire
Recruitment stage: baseline
Reach Parent self-report questionnaire
Child height and weight measurements
Baseline
Dose delivered Attendance data
Facilitators focus groups
Facilitator evaluation forms
Weekly
One mid-programme and one at the end of
programme
Weekly
Fidelity Fidelity visits (FFH)
Facilitators focus groups (FFH)
3–4 sessions per programme
Family registers and baseline recruitment details
Facilitator training records, pay claim forms and
expenses
One mid-programme FG
One end-of-programme FG
Dose received Parent one-to-one interviews (FFH and UC)
Parent end-of-session feedback form (FFH)
Parent end-of-programme questionnaire (FFH)
3 months
Weekly (FFH)
End of FFH programme
FFH, Families for Health; FG, focus group; UC, usual care.
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Dose delivered
Family attendance for the Families for Health intervention was recorded each week by the facilitators.
Self-reports of attendance at the 3- and 12-month follow-up visits were recorded using the CSRI. This asked
families which services they had accessed (social worker, after school or homework club, Families for Health
programme, usual care, other) and the number of contacts and average duration of each contact their
child had with each service in the last 3 months (3-month follow-up) or 9 months (12-month follow-up).
Further attendance information was obtained from the 3- and 12-month follow-up interviews, as parents
were asked to confirm attendance information provided in the CSRI form.
Weekly evaluation forms with closed and open-ended questions were completed by parent and child
facilitators at the end of each Families for Health session. The open-ended questions were: ‘How receptive
were the group, how were the group dynamics and was everyone able to contribute?’; ‘Which topics
worked well in the session?’; ‘Which topics did not work well in the session?’; ‘What do you think could
improve this session?’; ‘How do you feel about today’s session?’; and ‘What are your thoughts about how
you did this session?’.
One researcher (WR) conducted two focus groups with each group of Families for Health facilitators, one
between weeks 3 and 6 and one after the last session of the programme. The focus group topics for the
mid-programme were ‘How did the session go in relation to the session guide?’, ‘Were all the families there
that you expected?’ and ‘How were the group dynamics at this stage of the programme?’. WR prompted
facilitators in relation to timing issues, programme content and feedback from families. The end-of-programme
schedule session topics were ‘What aspects worked and did not work on the programme and why?’, ‘What
were the main facilitators and barriers to change in the families’, ‘How were the group dynamics’ and
‘Whether or not they felt the training equipped them to deliver the programme’. The mean duration of focus
groups was 43 minutes (range 21–57 minutes).
Fidelity
The fidelity of delivery of the Families for Health programme was assessed by WR during visits to the
Families for Health sessions, when she checked the materials and flip charts used during the Families for
Health session. WR also collected facilitators’ weekly evaluation forms and data from transcripts of the
facilitators’ focus groups were also used. Details of the length of each Families for Health programme
(in weeks), half-term breaks, follow-up sessions delivered, number of facilitators at each session and
continuity of facilitators across each programme were collected. The number of families allocated to a
programme and the number of families that attended were noted, as was the number of families waiting
> 3 months for a programme to start. WR/AK determined which changes to the programme affected the
fidelity of delivery and which were minor adjustments.
Dose received
Parents attending a Families for Health programme completed weekly feedback forms. The feedback form
asked parents to answer the questions ‘How do you feel about today’s session?’ and ‘How do you feel
about the programme?’ using a 5-point Likert scale with responses ranging from ‘awful’ to ‘great’.
They were asked for a written response to the questions ‘What did you find useful or enjoyable this
week?’ and ‘What did you NOT find useful or enjoyable this week?’ and were given the opportunity to
share further ideas or comments – ‘We would be glad to have any other ideas or comments’.
At the end of each Families for Health programme, parents were asked to complete an end-of-programme
feedback form. The feedback form asked parents to answer the following questions using a 5-point Likert
scale: ‘How do you feel about the programme?’ (with responses ranging from ‘awful’ to ‘great’);
‘How helpful have these parenting skills topics been?’, ‘How helpful have these healthy lifestyle physical
activity topics been?’ and ‘How helpful have these healthy lifestyle food topics been?’, with responses
for each topic ranging from ‘not helpful’ to ‘very helpful’; and ‘Do you think your child has enjoyed the
programme?’, ‘Have you noticed any changes in your child as a result of the programme?’, ‘Do you
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think the programme has helped you and your child tackle his/her weight difficulty?’, ‘Do you think the
programme has helped the rest of the family?’ and ‘Would you recommend the programme to other
families?’, with responses ranging from ‘no’ to ‘a lot’.
One-to-one interviews were conducted with parents and children in both arms (Families for Health and
usual care) of the trial by a member of the research team (JF or AK). These interviews were conducted at
the 3-month follow-up visit, after the outcome measures had been collected, or at a family’s first interview
after accessing a Families for Health programme. In some cases this interview took place longer than
3 months from recruitment, because the family had waited for a programme to start. All families were
asked to consent to an interview at the recruitment stage, and one family declined. Consecutive sampling
from those families who consented was used to ensure that representation of all Families for Health
groups and of the various usual-care options, and diversity of age, ethnicity and sex of the children,
family size and whether or not they completed the intervention. There were different interview schedules
for parents allocated to the Families for Health programme and usual care at both 3 (see Appendix 9) and
12 months (see Appendix 10) and for children at the 3- and 12-month follow-ups (see Appendix 11).
The Families for Health and usual-care parent interview schedules asked ‘Has anything changed in the life
of your family/household since we first visited you?’, ‘Which intervention did you attend?’ and ‘Can you
tell me a bit about what was involved?’ (usual care only), ‘How did you feel when you were approached
to take part/saw or heard the advert?’, ‘What motivated you to take part?’ and ‘Why did you decide to
join?’. Early in the interview parents were asked what they had got out of the programme they had
attended. Parents were encouraged to tell us as much as they wanted to about this and then prompted to
reflect on each aspect of the programme, such as diet and physical activity (Families for Health and usual
care) and family relationships (Families for Health). Finally, the interviewer drew on the data from the
parents’ end-of-programme feedback form to ask the parents to expand on their written feedback
(Families for Health only). The mean duration of parent interviews was 20 minutes. Although the longest
interview took 55 minutes, most (54/63) interviews lasted less than 30 minutes (range 3.5–55 minutes).
Children’s interviews included a drawing activity as well as discussion about the programme. Children were
asked to draw three pictures: (1) ‘Draw a picture of your family including yourself’; (2) ‘Draw a picture of
the things you liked about the usual-care activity/Families for Health activity’; and (3) ‘Draw a picture of the
things you did not like about the usual-care activity/Families for Health activity’. Children were asked to
explain each of the pictures they had drawn: ‘Tell me about what you have drawn?’ (pictures 1, 2 and 3);
‘Why did you like this?’ and ‘What other things did you like about the activity?’ (picture 2); and ‘Why did
not you like this?’ and ‘What other things did not you like about the activity?’ (picture 3). Children had
completed questionnaires during the visit and these were also used as prompts to encourage children to talk
about any changes they had made to their diet, activity levels and to discuss their feelings and relationships
with family and friends. The mean duration of child interviews was 14 minutes (range 2.5–35 minutes).
Data management and analysis
Quantitative data
Data were entered into Microsoft Excel 2013 (Microsoft Corporation, Redmond, WA, USA) and SPSS
version 22 (IBM SPSS Statistics, Armonk, NY, USA) and were analysed using SPSS. Numerical responses on
Families for Health parent weekly evaluation forms to the questions ‘How do you feel about today’s
session?’ and ‘How do you feel about the programme?’ were summed to indicate parents weekly ratings
of the programme for each response option: ‘awful’, ‘bad’, ‘OK’, ‘good’ or ‘great’. Facilitators’ written
responses on the weekly evaluation forms and end-of-training evaluation form were entered into Microsoft
Excel and coded into categories by WR and MT.
Qualitative data
Focus groups and interviews with facilitators, parents and children were digitally recorded, subject to
permission from each participant. The interviews were transcribed verbatim and all transcripts were
anonymised and checked for accuracy against the initial recording. The transcripts were coded using
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NVivo 10 (QSR International, Warrington, UK). Coding was thematic based on the interview schedules,
with the addition of emergent themes.91 Table 66 describes the codes that were used.
The qualitative team (FG, WR, MT, JF and AK) met to discuss and agree the coding framework for
facilitators’ focus groups. The framework was drafted according to the process evaluation framework
components. Owing to issues surrounding blinding (researchers AK and JF may have been unblinded to
families by reading facilitators’ transcripts), the coding of facilitators’ focus group and interview data was
carried out by WR, MT and FG.
At the early stages of coding parent and child interview data, FG, WR, JF and AK met to review the coded
interviews. Initially, 16 parent and child transcripts were reviewed to identify any refinements needed to
the coding scheme. FG, WR, AK and JF read four parent and child interviews each, with each transcript
reviewed by two researchers. Discussions included defining the parameters of each code, for example to
exercise caution when coding the way families talk about their motivations as this may steer away from
their experience of the intervention, and adding new codes to the coding scheme, as required. AK and JF
carried out the coding of parent and child interview data with regular meetings with FG to ensure coding
reliability and to ensure any discrepancies were reconciled.
Focus group data coded at ‘Dose delivered’ and ‘Environment’ were combined. These combined data
were coded at the following codes, which were identified from the focus group schedule: adjustments
(e.g. content/timing issues); what facilitators thought went well or less well; the impact of group behaviour
on delivery; size and composition of group; improvements; and any additional emerging themes. The data
for each of these codes were extracted. Codes were then developed into potential themes and reviewed
to ensure that the themes worked in relation to the coded extracts.92 Facilitators’ weekly evaluation forms
were checked to identify any additional information that challenged or supported the themes identified.
Constructed variables
Information about how parents heard about the trial was categorised into active and passive recruitment
methods. Passive recruitment methods (where participants identify themselves as potential participants)
included the media (e.g. adverts in newspapers and radio) and distribution of flyers. Active recruitment
methods (where eligible participants are identified and targeted directly) included sending letters to
TABLE 66 Codes used for facilitator, parent and child qualitative data
Qualitative data Code Definition
Facilitators’
focus groups
Dose delivered The ‘amount’ of intervention provided by the intervention team
Deviation from 10 sessions?
Changes made to the programme content?
What worked well/did not work well
Comparisons with other programmes
Environment Physical environment (e.g. venue)
Social environment (e.g. group dynamics)
Parent interviews Got or not got from
intervention unprompted
What they got from the intervention/did not get from the intervention
(using unprompted text, i.e. data which are the same for FFH and UC)
Child interviews Child like or dislike about
intervention unprompted
What they liked or disliked about the intervention (using unprompted
text from the drawing activity for both FFH and UC)
FFH, Families for Health; UC, usual care.
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families with an overweight or very overweight child who had been recently measured in the NCMP and
referrals from health-care professionals.
Quality checks
Data entry for the weekly evaluation forms and parent end-of-programme feedback forms was checked
against the raw data for accuracy (WR).
Interview transcripts were independently coded and at least 10% of the coded interview data ere
cross-checked by another member of the research team to minimise researcher bias. The draft coding
framework for facilitators’ focus groups was piloted by FG, using two focus groups. MT and WR coded the
same two focus groups and discussed agreement. There was reasonable agreement that the broad coding
framework worked, but there were discrepancies in relation to dose received and dose delivered.
These discrepancies were discussed and resolved by defining dose delivered as facilitators’ experiences of
the programme and dose received as facilitators’ perceptions of families’ experiences of the programme.
Twenty-six parent and child interview transcripts were cross-checked. JF and AK independently coded and
checked 12 transcripts. JF and AK coded all 12 interview transcripts using the same codes. An additional
researcher (TS) cross-checked 14 transcripts that had been coded by JF or AK. There was reasonable
agreement and any discrepancies were discussed and resolved by checking the original definition of each
code, which resulted in retaining the original coding (JF and AK).
Unprompted parent and child data were used to inform the following research questions:
1. What are the differences/similarities in experience of parents and children in Families for Health
compared with usual-care interventions? (Dose received.)
2. Given that Families for Health has a greater emphasis on parenting skills, to what extent is this aspect
of the intervention mentioned? (Dose received.)
Results
The process evaluation presented here was carried out prior to the effectiveness data being available from
the trial, to avoid bias in interpretation.85
Seven Families for Health programmes were delivered, and 255 weekly parent feedback forms and
36 parent end-of-programme feedback forms were completed (Table 67). Of the 56 families who were
allocated to the intervention arm, 35 completed at least five sessions or more, all of whom completed an
end-of-programme parent questionnaire. There were 120 interviews conducted with parents and children
during the 3-month follow-up visit from 41 families who attended Families for Health and 21 families who
attended usual care (see Table 67).
Some of the facilitators’ weekly evaluation forms from five of the programmes were not completed: site A,
second running of the Families for Health programme (FFH2) (missing weeks 5–7 and 9–10) and third
running of the Families for Health programme (FFH3) (missing weeks 9–10); site B, first running of the
Families for Health programme (FFH1) and FFH2 (missing weeks 9–10 and 5–10, respectively); and site C,
FFH1 (missing week 2 and weeks 5–10). Thus, there were 101 completed forms. Twelve (of a possible 14)
facilitators’ focus groups and one end-of-programme telephone interview were conducted. Two
mid-programme focus groups were not conducted (see Table 67).
Recruitment
There were 194 families who expressed interest in the trial and were sent further information. Of those,
115 (59.3%) went on to be recruited and randomised (Figure 23 and Table 68). Active recruitment yielded
85 potential participants, with 43 recruited; passive recruitment yielded 99 potential participants,
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Expressed interest 
and sent information
(N = 194)
Recruited and randomised
(N = 115)
• Unable to contact, n = 18
• Not eligible, n = 14
• Cannot attend Saturday FFH session, n = 10
• No reason given, n = 8
• Child/family does not want to take part, n = 7
• Time commitment, n = 5
• Receiving other support, n = 3
• Other issues for family, n = 3
• Will manage themselves, n = 3
• Distance, n = 2
• Unwilling to be randomised, n = 2
• Other commitments, n = 2
• Do not want to be a study participant, n = 1
• ‘Not for them’, n = 1
Active methods 
(N = 85) 
• School nurse / nurse referral, n = 21
• UC referral (site A), n = 15
• UC referral (site B), n = 17
• UC referral (site C), n = 3
• Special letter via NCMP, n = 9
• Dietician referral, n = 8
• Targeted letter from GP, n = 6
• Obesity clinic referral, n = 4
• Social worker referral, n = 1
• Targeted letter from one-to-one advisor, n = 1
Passive methods 
(N = 99) 
• School (poster, newsletter, flyer, teacher), n = 30
• GP/hospital (flyer, poster), n = 24
• Public event, n = 17
• Media, n = 9
• Word of mouth, n = 7
• Flyer (unspecified), n = 7
• Flyer/poster (in community), n = 5
Unknown 
(N = 10)
Not recruited
 (N = 79)
• Site A, n = 50
• Site B, n = 31
• Site C, n = 34
FIGURE 23 Flow chart of participant recruitment to the FFH study. FFH, Families for Health; UC, usual care.
TABLE 68 Participant recruitment to Families for Health study
Project
months Actual month
Numbers
recruited Key recruitment methods useda
4–6 March 2012–May 2012 19 l Flyers distributed to GP practices
l Three radio interviews
l Letters with NCMP measurements
l Posters to children’s centres
l Media – one radio interview
l All schools contacted for first time. E-mail with
newsletter sentences and/or flyer attached
7–9 June 2012–August 2012 23 l Three public events (one per site)
10–12 September 2012–November 2012 6 l All schools contacted for a second time
l Letters with NCMP measurement (September–
December)
l Flyers distributed to GP practices for second time
l One public event (one site)
l Advert in local football match day programme
13–15 December 2012–February 2013 14 l Media
l Posters to children’s centres
l Start of monthly attendance (4 months) to obesity
clinic at local hospital
l Start of direct referrals from school nurses and
dietitians (one site)
l Posters to community venues (e.g. libraries,
leisure centres)
PROCESS EVALUATION
NIHR Journals Library www.journalslibrary.nihr.ac.uk
90
with 72 recruited (Table 69). A higher proportion of enquires from families recruited passively resulted in
recruitment to the study (72.7% vs. 50.6%; p= 0.002). The most productive active method of recruitment
was a referral from a health professional, with 69 ‘expressions of interest’ resulting in 30 families being
recruited to the study. Information seen at school or the GP surgery accounted for 55 enquiries and over
one-third (37.4%) of final recruitment. Media-generated enquiries were few, but all nine resulted in
recruitment. Further details of the recruitment to the trial via passive and active methods have been
published, alongside examples of the materials.93
What were the reasons for not participating in the trial?
The most common reason for families not participating in the trial was that the research team were unable
to contact the family after they expressed interest (n= 18, 22.8%). Another important reasons was that
the family did not meet the inclusion criteria (n= 14, 17.7%) (see Figure 23). Some of the families (n= 10,
12.7%) were unable to attend on a Saturday when the Families for Health intervention groups were to
be run.
Reach
The intended audience for this trial was families with an overweight or obese child aged 6–11 years.
All participating children were overweight or obese, mostly obese (Table 70). There was no significant
relationship between site and the proportion of obese and overweight children (p= 0.420), but there was
a significant difference in baseline BMI z-scores, with site C having the highest mean BMI z-score [site A:
mean 2.57 (SD 0.62); site B: mean 2.64 (SD 0.66); site C: mean 2.99 (SD 0.71); p= 0.010]. Asian, black
and mixed ethnicity children were a higher proportion of the children recruited than would have been
expected from census data for the three sites. However, the prevalence of obesity is higher for Asian,
black and mixed ethnicity children in England in the NCMP.3
The families recruited to the trial approximately reflected the local population for SES. By contrast, it was
clear that a higher proportion of single-parent families were recruited than would have been expected from
2011 census data88 (site A, 46% recruited vs. 9.6% in the census; site B, 25.8% vs. 6.1%; site C, 44.1% vs.
9.4%). In addition, the number of families in which the parents were unemployed was higher than
expected from the census data (site A, 16% vs. 7.4%; site B, 6.5% vs. 3.4%; site C, 32.4% vs. 10%).
Dose delivered
Seven Families for Health programmes were delivered: three of them ran for the full 10 weeks and four for
9 weeks. Session cancellations were because of bad weather (two programmes), shortage of facilitators
(one programme) and poor attendance (one programme).
TABLE 68 Participant recruitment to Families for Health study (continued )
Project
months Actual month
Numbers
recruited Key recruitment methods useda
16–18 March 2013–May 2013 14 l Media
l One public event
19–21 June 2013–August 2013 15 l Two public events (one site)
l One public event (2 days) (one site)
22–24 September 2013–November 2013 13 l GP lists searched for eligible children and letters sent
out (Primary Care Research Network)
l All schools in one locality contacted for a third time
25–27 December 2013–February 2014 11 l One public event
a Approximate time at which key recruitment methods were implemented/reimplemented. However, a variety of
recruitment methods were used on several occasions and with much overlap.
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TABLE 69 Details and success rate of recruitment methods used
Recruitment
method Amount/number of times
Numbers
expressing
interesta
Number of
families
recruited
% interest
to recruitment
Active recruitment
Referral from
health professional
65 health professionals contacted research team
via telephone with family details
On four occasions a researcher attended an
obesity clinic where the doctor referred the family
to speak to the researcher. This resulted in one
referral per visit
69 30 43.5
Targeted letter from
health professional
Information provided with approximately 600
NCMP letters to overweight/obese children
50 letters to children identified on GP lists
50 letters by one-to-one advisor to families on
their records
16 13 81.3
Subtotal 85 43 50.6
Passive recruitment
School (poster,
newsletter, flyer)
All primary schools in sites B and C contacted
twice, site A three times (telephone call plus
e-mail first time, e-mails only second/third time).
Flyers sent out on request. Text for school
newsletter sent to all. No record available of
which were published
30 24 80
GP/hospital
(poster, flyer)
Two mail outs 25 19 76
Community
(poster, flyer)
Posters sent to community venues (e.g. library,
children’s centres, leisure centres) across all
sites – three times
5 4 80
Flyer (unspecified) – 6 2 33
Public event Nine events (10 days) 17 9 52.9
Media (newspaper,
radio, internet)
Four radio interviews
Two paid newspaper articles
Five free newspaper/magazine articles
Families for Health website
City council website
Local telegraph twitter
Three Primary Care Research Network adverts
in newsletter
9 9 100
Word of mouth – 7 5 71.4
Subtotal 99 72 72.7
Total 184 115 62.5
a Ten unknown (not included in figures).
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TABLE 70 Baseline characteristics of families
Baseline characteristics Total
Number of families 115
Number of children 128
Family type, n (%)
Two parent 67 (58.3)
Single parent (mother) 46 (40.0)
Single parent (father) 0 (0)
Other 2 (1.7)
Parents SES, n (%)
Class 1 39 (33.9)
Class 2 19 (16.5)
Class 3 36 (31.3)
Never worked/long-term unemployed 21 (18.3)
Children’s ethnicity, n (%)
White 79 (61.7)
Black 10 (7.8)
Mixed 16 (12.5)
Asian 22 (17.2)
Other 1 (0.8)
Chinese 0 (0.0)
BMI
Children’s mean BMI, kg/m2 (SD) 25.86 (4.36)
Mean BMI z-score (SD) 2.71 (0.68)
Number of overweight children (%) 22 (17.2)
Number of obese children (% of total at each site) 106 (82.8)
Age (years)
Children’s mean age (median) 9.44 (9.58)
Age range 5.77–11.78
5a (%) 2 (1.6)
6 (%) 10 (7.8)
7 (%) 12 (9.4)
8 (%) 25 (19.5)
9 (%) 24 (18.8)
10 (%) 29 (22.6)
11 (%) 26 (20.3)
a Child aged 5 years at recruitment but turned 6 years at start of programme.
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Attendance of families
Families allocated to the Families for Health programme were more likely to have attended at least one
session than those allocated to usual care (75.0% vs. 40.7%; p< 0.001) (Table 71).
Adequate attendance for the Families for Health programme was defined as a family attending at least five
sessions. It is not possible to define completion for the usual-care group because the number of sessions
that were offered is not known for some programmes. Moreover, despite strenuous efforts, attendance
data for families in the usual-care arm were available from the service provider for only one area. Two of
the usual-care interventions were cancelled during the trial. Self-reported attendance is available for all but
seven of the families in the usual-care arm. The other seven families either withdrew from the study or
were lost to follow-up. Table 71 shows a breakdown of the attendance of families; 25% of families in
the intervention arm and 47.5% of families in the usual-care arm did not attend any sessions. In the
intervention arm, 62.5% of families completed at least five sessions (see Table 71).
TABLE 71 Attendance data for Families for Health and usual care
Programme
Attendance of families (n)
Did not
attend
Completed
at least
one session
Started but later
dropped out
of interventiona
Completed
at least five
FFH sessionsa
Completed
all sessions
offeredb
Did not
complete five
sessions but did
not drop outa Unknown
FFH
Site Ac
(n= 26)
5 21 1 20 7 0 –
Site Bc
(n= 13)
2 11 4 6 1 1 –
Site Cc
(n= 17)
7 10 1 9 3 0 –
Total (%)
(n= 56)
14 (25) 42 (75) 6 (10.7) 35 (62.5) 11 (19.6) 1 (1.8) 0
UC
Site Ad
(n= 26)
18 7 – – – – 1
Site Be
(n= 16)
7 8 – – – – 1
Site C groupe
(n= 5)
1 4 – – – – 0
Site C groupe
(n= 6)
1 2 – – – – 3
Site C school
nursee (n= 6)
1 3 – – – – 2
Total (%)
(n= 59)
28 (47.5) 24 (40.7) – – – – 7 (11.9)
FFH, Families for Health; UC, usual care.
a Further details of families who completed at least one session.
b Further details of families who completed ≥ 5 FFH sessions.
c Source of data – FFH registers.
d Source of data – UC register.
e Source of data – parent interview data and CSRI form.
Note
The first site C group refers to WISH and the second to Weight Watchers.
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Facilitators’ perceptions of the delivery of intervention
Both the facilitators’ completed evaluation forms and the transcriptions of the facilitators’ focus groups
were used to address two questions: ‘From the perspective of the Families for Health facilitators,
what components of the intervention were delivered (or not) as intended by the intervention designers?’
and ‘What group factors (if any) impacted on the delivery of the Families for Health programme?’.
Components of the intervention that were delivered as intended by facilitators
Dietary sessions were delivered as intended across all seven programmes. Snack time, shopping,
marketplace, the healthy eating habits quiz, advertising and food labelling were reported to have worked
well, promoting discussion and providing the opportunity for parents to share ideas and strategies:
Being able to share experiences and having the opportunity to share recipes on food that parents had
made for the celebration.
Site A FFH1, week 10
The snack-time activity encouraged children to taste a range of healthier alternatives and enabled parents
to observe their child eating food they do not usually eat. This activity also gave parents the opportunity to
apply some of the parenting skills, such as guiding children’s choices and praising positive behaviour:
The snack time was very positive. The children really enjoyed making healthy wraps for their parents.
Some children did try new fillings.
Site A FFH1, week 2
. . . I was observing parents . . . they were saying things like ‘you don’t have to eat them all you know’
and things like that . . .
Site B FFH1, week 9
. . . then it’s easier for the parents to say, ‘Oh well done, I’ve never seen you eat that before I’m really
pleased,’ she had some blueberries as well and her mum said, ‘oh that’s really good’. And she hugged
mum and said, you never say nice things like that to me.
Site A FFH2, week 9
Delivering programme content in a concrete manner, such as creating visual measures of a numerical
value, aided parents’ and children’s understanding of food labelling:
. . . they all switched on when I explained that 6 g is a teaspoon, and then they looked and they think,
oh three teaspoons, four teaspoons, it made some sense. Because what is 12 g of what, is that good,
is it bad, they don’t know.
Site C FFH1, week 9
Two of the venues, sites A and C, had on-site, purpose-built gyms that families had access to as an
‘activity taster’ session, which proved successful and popular. Gym sessions guided children through a
different experience of physical activity:
The [site A] gym and given children the chance to experience something new in an environment they
feel is safe.
Site A FFH1, week 7
The [site A] gym, we had full attendance that day. They were all there for that . . . they absolutely
loved it. It was that difference, and that confidence going through and the parents coming through to
see that . . . It was taking them through and saying ‘you just pay and it costs this much and it is this
many sessions and they can come as much as they like’ that was a real positive thing.
Site A FFH1, week 10
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Other physical activities, such as the parachute game, badminton, volleyball, basketball and outdoor
activity taster sessions, were delivered as intended across four programmes (site A, FFH1; site B, FFH1;
site C, FFH1, FFH2). These sessions promoted discussion around what constitutes sufficient physical activity
and that some activities do not require any equipment or resources.
The parenting skills and emotional well-being sessions were delivered, as intended, across all seven
Families for Health programmes. Facilitators felt that the sessions on stress and feelings prompted helpful
discussion, were relevant to parents and children and had a solution-focused approach:
Discussing feelings openly – parents comments that this helped lots.
Site C FFH2, week 6
Yes, because we were talking about you know, one of the questions obviously, do you eat around
the table as a family, you know, and there was questions around that. And [Mum] was saying my
daughter takes food to the bedroom, so she eats up in her bedroom. And I said, well how could you
address that? And she said, well first of all she needs to come down and eat with us doesn’t she?
Well she’s answered her own question, you know.
Site C FFH1, week 4
I think it gives families a new way of thinking about things as well doesn’t it? . . . It is just new
information and new perceptions of just how they cope with each other and perhaps rewarding
certain behaviours, giving each other praise.
Site A FFH1, week 10
In one programme, one session on feelings had to be held jointly with parents and children because of a
lack of space at the venue. Facilitators reported that this combined session was particularly successful:
And didn’t that work well with the children in the room that week, because dad, a couple of dad’s
said . . . ‘I’ve just realised, I don’t listen to my kids. I never ask them how they’re feeling. Might say,
have you had a good day, yes, OK, see you later. I never say, how are you feeling today, and how do
you feel about school and your teachers, do you like them’ . . . Because the kids were in here saying it
in front of their parents . . .
Site C FFH1, week 9
Components of the intervention that were not delivered as intended by facilitators
In four out of seven programmes (site A, FFH1, FFH2; site, B FFH1; site C, FFH1) facilitators experienced
difficulties delivering some of the Families for Health activities. These included games for children that were
not age appropriate and activities perceived as patronising by parents:
Balancing Act felt like familiar ground to two parents.
Site A FFH2, week 1
Not sure if snacks/lunchboxes/breakfast healthy options is needed as most parents in the group
seemed to know and were a bit bored with it.
Site B FFH1, week 4
Portion sizes – complaints at the lack of information relating to portion sizes throughout the day/week.
Site B FFH1, week 5
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In one programme there was a particularly strong feeling that some parts of the programme
were patronising:
. . . they said that they felt that the parent side of it has been written . . . what has happened is it has
been written for children and they adapted the parents bit from the children’s section. They felt that it
was aimed at a child’s level by doing things like the attention grabbers. They didn’t like those at all
and they felt it was patronising.
Site B FFH1, week 9
The lack of continuity of facilitators at one site was felt to have had negative effects as it prevented
facilitators from developing a rapport with parents and children:
And the parents were saying that as well. ‘We have had so many different people.’ And they kind of
get used to the individual and their style.
Site B FFH1, week 9
. . . unfortunately the facilitating, you know, I haven’t been able to do them all and we’ve had to swap
facilitators, and I think that does disrupt the, sort of the settlement of the children into the groups, in
my eyes, you know.
Site B FFH2, week 9
What group factors (if any) impacted on the delivery of the Families for
Health programme?
Size and composition of groups
The Families for Health programme was delivered to groups with varied levels of diversity, including
children of different ages and educational needs and families from different ethnicities, financial
circumstances and sex:
. . . we’ve got a Latvian, a lad from Holland, Asian, you know, really cross mixture there. But what
was also obvious I think as well is the support they gave each other . . . And I think because their
association, you know, they all had eating . . . bad eating habits or didn’t make necessarily positive
choices, I think they could associate with each other, they didn’t feel as if they were being
singled out.
Families for Health (site deliberately omitted)
Facilitators experienced difficulties delivering the Families for Health programme to children across a broad
age range (6–12 years) and range of behaviour issues in four programmes (site A, FFH1, FFH3; site B, FFH1,
site C, FFH1):
We had children who were six coming in. It takes them a bit longer to talk. We had two children with
autism so therefore you couldn’t pressure them. And if they got on a roll and needed to talk about
something, you had to sit and you could almost feel yourself going ‘Oh my God, I am going to have
to rush you now’. . . . You have to let these children speak else there is no point. . . . I feel we had to
let something go each week. I don’t think we ever got everything in fully . . .
Families for Health (site deliberately omitted)
Group dynamics varied and included family members with negative behaviours (site A FFH1, FFH3; site B,
FFH1; site C, FFH1). Facilitators employed a range of strategies to manage dominant group members and
where groups had members displaying two extremes of behaviour.
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Negative, dominating individuals stifled the group and limited discussion, whereas positive characters, such
as confident children, encouraged others to participate in activities:
. . . and we had really, really good laughs, positive feedback from the three families. Within seconds of
this lady coming in, I’ve done it, she sat there, they basically withdrew. You could see them . . .
Site C (site deliberately omitted)
He’s quite confident and they follow his lead with the joining in, he’s not at all scared, you know, or
embarrassed to sort of join in . . .
Site A FFH3, week 6
A small group size was a barrier to delivering the intervention in three out of seven programmes (site B,
FFH1, FFH2; site C, FFH1). Facilitators found it difficult to deliver sessions with a small number of children
and to encourage participation among quieter children. Small group sizes also restricted the number of
ideas and strategies parents and children could employ to engage in a healthier lifestyle:
Struggled due to only three children
Site C FFH1, week 3
. . . do feel that it would be better if more children attended to cause more discussion.
Site B FFH1, week 3
. . . it doesn’t help in the games and things like that because a lot of it is about confidence building
and getting to know other members of the group, and when there’s only two or three children it’s
difficult to do that.
Site B FFH2, week 9
Fidelity
As described in Methods, a number of fidelity checks were carried out. The programmes varied in the
extent to which they were delivered as prescribed (Table 72). Three Families for Health programmes (site A,
FFH1, FFH2; site B, FFH1) had only very minor changes, including adapting songs and games for children
so that they were age-appropriate and giving parents as well as children pedometers.
Partial adjustments to programme delivery included incorporating activity taster sessions across the
entire programme instead of during weeks 7–9 for one Families for Health programme (site A, FFH3).
In one programme the parent and child sessions were combined because of poor attendance and one
programme added visual aids to support content delivery (site C, FFH1).
Two Families for Health programmes varied the way in which programme content was delivered.
One programme (site C, FFH2) adapted content delivery to include a theory hour followed by a more
structured physical activity hour because there was a gym available on the site. This adjustment to
programme content appeared to work well:
Gym sessions have enhanced the weight loss and motivated the group lots.
Facilitator weekly evaluation form, site C, FFH2, week 6
Another programme (site B, FFH2) adjusted delivery because of poor attendance, by combining parent and
child sessions and facilitating whole-group discussions instead of small-group activities. Activity taster
sessions were also brought forward in this programme in the hopes of improving attendance, but this failed.
All facilitators who delivered the Families for Health programme attended the 4-day training programme,
with the exception of one facilitator who joined the programme as a facilitator after the training workshop
had been delivered. The training they received was perceived positively (see Appendix 1). Almost all
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facilitators delivered more than one Families for Health programme and facilitators’ confidence increased
as they became more experienced in the delivery of Families for Health programmes (site A, FFH2, FFH3;
site B, FFH1, FFH2; site C, FFH2). They found they could modify games easily and avoid issues they
encountered previously:
It seemed to run a lot smoother this time than it did last time, and I think because that we had so
many negatives the last time we’ve kind of turned it into a positive this time.
Site C, FFH2, week 10
The Families for Health programme is designed to be delivered in a group setting with a minimum of eight
families not waiting more than 3 months to join a programme, and four facilitators (two for parents and
two for children) delivering each session. This was not always achieved (Table 73). Three Families for
Health programmes (site B, FFH1 and FFH2; site C, FFH2) could not be delivered as intended because of
small numbers of families starting the programme and subsequent poor attendance. Two Families for
Health programmes (site B, FFH1 and FFH2) lacked continuity of facilitators and one session (site B, FFH1)
had to be cancelled because of a lack of facilitators.
Delivering the programme as a single facilitator for the parents group for one programme that had a small
number of families restricted interaction with families as the facilitator was too busy delivering the
programme activity to attend to other issues, such as families that were experiencing problems, late arrivals
or preparing for the next activity (site B, FFH1).
Of the 56 families that were randomised to the Families for Health intervention, 21 (37.5%) waited more
than 3 months before starting a Families for Health programme (see Table 73). Other issues that were
encountered included external service providers for the physical activity tasters undermining the message
of the programme by rewarding children with chocolate (site B, FFH1), room booking issues at one venue,
resulting in there being no suitable rooms to deliver one of the children’s sessions (site A, FFH3), shorter
activity sessions because of the late arrival of the coach for one of the activity tasters (site A, FFH3) and
cancelling one session because of snow (site A, FFH2; and site C, FFH1).
Only one Families for Health programme (site A, FFH1) was considered to have delivered entirely as
intended (see Table 73). The programme started with eight families, there was good continuity of trained
facilitators and 10 sessions were delivered.
In conclusion, although the delivery of the programmes varied, all programmes were delivered at a level
that is at the top of the range of what could be expected if such an intervention were being routinely
delivered by local authorities. The problems encountered were no greater than could be expected.
The outcome data from each site were analysed individually, but there were no significant differences in
outcome. Thus, there is no evidence to suggest that variations in adherence to the intended delivery had
affected outcomes.
This was a pragmatic trial, aiming to test effectiveness in a routine setting rather than efficacy in an ideal
setting and, as such, variation in delivery should be expected.
Dose received: parents
The Families for Health programme was generally well received by those families who attended. Over 90%
of responses from parents rated the weekly sessions as ‘good’ or ‘great’ (Table 74). The topics that
received the most positive comments were ‘Food labels: what do they mean?’, ‘Stress – and what we can
do about it’ and ‘Building self-esteem’ (Table 75). At the end of the programme, parents were similarly
positive, with > 80% of those who completed the end-of-programme questionnaire rating the programme
as ‘good’ or ‘great’. Parents rated physical activity and food topics particularly highly. Three topics were
rated as 4 or 5 by > 90% of respondents: ‘Food groups: Eatwell plate’ (90.6%), ‘Shopping: surviving at the
supermarket’ (93.8%) and ‘Portion sizes’ (90.6%).
DOI: 10.3310/hta21010 HEALTH TECHNOLOGY ASSESSMENT 2017 VOL. 21 NO. 1
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Robertson et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
101
TA
B
LE
73
Pr
o
g
ra
m
m
e
an
d
fa
m
ily
d
et
ai
ls
to
as
se
ss
if
ea
ch
p
ro
g
ra
m
m
e
w
as
d
el
iv
er
ed
as
in
te
n
d
ed
FF
H
g
ro
u
p
D
el
iv
er
ed
as
in
te
n
d
ed
?
Le
n
g
th
o
f
m
ai
n
p
ro
g
ra
m
m
e
H
al
f-
te
rm
b
re
ak
?
N
u
m
b
er
o
f
fo
llo
w
-u
p
se
ss
io
n
(s
)?
Ti
m
in
g
N
u
m
b
er
o
f
fa
m
ili
es
ra
n
d
o
m
is
ed
(a
tt
en
d
ed
)
N
u
m
b
er
o
f
fa
m
ili
es
w
ai
ti
n
g
>
3
m
o
n
th
s
fo
r
p
ro
g
ra
m
m
e
to
st
ar
t
N
u
m
b
er
an
d
co
n
ti
n
u
it
y
o
f
fa
ci
lit
at
o
rs
Si
te
A
FF
H
1
Y
es
.
N
o
fa
m
ily
w
ai
tin
g
fo
r
>
3
m
on
th
s;
ei
gh
t
fa
m
ili
es
st
ar
te
d
th
e
pr
og
ra
m
m
e
10
w
ee
ks
Y
es
2
Sa
tu
rd
ay
m
or
ni
ng
8
(8
)
0
Si
x
fa
ci
lit
at
or
s
in
to
ta
la
cr
os
s
10
w
ee
ks
G
oo
d
co
nt
in
ui
ty
of
fa
ci
lit
at
or
s
w
ith
lit
tle
va
ria
tio
n
ea
ch
w
ee
k
Si
te
A
FF
H
2
Pa
rt
ia
l.
O
f
th
e
ei
gh
t
fa
m
ili
es
ra
nd
om
is
ed
,
fiv
e
fa
m
ili
es
ha
d
be
en
w
ai
tin
g
>
3
m
on
th
s
an
d
si
x
at
te
nd
ed
9
w
ee
ks
(o
ne
w
ee
k
ca
nc
el
le
d
be
ca
us
e
of
sn
ow
)
Y
es
1
Sa
tu
rd
ay
m
or
ni
ng
8
(6
)
5
Fi
ve
fa
ci
lit
at
or
s
in
to
ta
la
cr
os
s
10
w
ee
ks
G
oo
d
co
nt
in
ui
ty
w
ith
sa
m
e
pa
re
nt
fa
ci
lit
at
or
s
ev
er
y
w
ee
k
an
d
lit
tle
va
ria
tio
n
of
ch
ild
fa
ci
lit
at
or
s
Si
te
A
FF
H
3
Pa
rt
ia
l.
O
f
th
e
10
fa
m
ili
es
ra
nd
om
is
ed
,
fo
ur
fa
m
ili
es
ha
d
be
en
w
ai
tin
g
>
3
m
on
th
s
an
d
se
ve
n
at
te
nd
ed
10
w
ee
ks
N
o
1
Sa
tu
rd
ay
m
or
ni
ng
10
(7
)
4
Fi
ve
fa
ci
lit
at
or
s
in
to
ta
la
cr
os
s
10
w
ee
ks
G
oo
d
co
nt
in
ui
ty
w
ith
lit
tle
va
ria
tio
n
of
fa
ci
lit
at
or
s
ea
ch
w
ee
k
Si
te
B
FF
H
1
N
o.
O
f
th
e
si
x
fa
m
ili
es
ra
nd
om
is
ed
,
on
e
fa
m
ily
ha
d
be
en
w
ai
tin
g
>
3
m
on
th
s
an
d
fiv
e
at
te
nd
ed
.
Sm
al
lg
ro
up
fr
om
th
e
st
ar
t
th
at
be
ca
m
e
le
ss
vi
ab
le
9
w
ee
ks
(o
ne
w
ee
k
ca
nc
el
le
d
be
ca
us
e
of
sh
or
ta
ge
of
fa
ci
lit
at
or
s)
Y
es
0
Sa
tu
rd
ay
af
te
rn
oo
n
6
(5
)
1
Si
x
fa
ci
lit
at
or
s
in
to
ta
la
cr
os
s
10
w
ee
ks
La
ck
of
co
nt
in
ui
ty
of
pa
re
nt
fa
ci
lit
at
or
s.
La
ck
of
fa
ci
lit
at
or
s
so
ha
d
on
e
fa
ci
lit
at
or
fo
r
pa
re
nt
s
gr
ou
p
(a
ls
o
be
ca
us
e
of
lo
w
nu
m
be
r
of
fa
m
ili
es
)
PROCESS EVALUATION
NIHR Journals Library www.journalslibrary.nihr.ac.uk
102
FF
H
g
ro
u
p
D
el
iv
er
ed
as
in
te
n
d
ed
?
Le
n
g
th
o
f
m
ai
n
p
ro
g
ra
m
m
e
H
al
f-
te
rm
b
re
ak
?
N
u
m
b
er
o
f
fo
llo
w
-u
p
se
ss
io
n
(s
)?
Ti
m
in
g
N
u
m
b
er
o
f
fa
m
ili
es
ra
n
d
o
m
is
ed
(a
tt
en
d
ed
)
N
u
m
b
er
o
f
fa
m
ili
es
w
ai
ti
n
g
>
3
m
o
n
th
s
fo
r
p
ro
g
ra
m
m
e
to
st
ar
t
N
u
m
b
er
an
d
co
n
ti
n
u
it
y
o
f
fa
ci
lit
at
o
rs
Si
te
B
FF
H
2
N
o.
O
f
th
e
se
ve
n
fa
m
ili
es
ra
nd
om
is
ed
,t
w
o
fa
m
ili
es
ha
d
be
en
w
ai
tin
g
>
3
m
on
th
s
an
d
si
x
at
te
nd
ed
.P
oo
r
at
te
nd
an
ce
.
Fo
r
3
w
ee
ks
,o
nl
y
on
e
fa
m
ily
ca
m
e
9
w
ee
ks
(s
ho
rt
en
ed
be
ca
us
e
of
la
ck
of
at
te
nd
an
ce
)
N
o
0
Sa
tu
rd
ay
af
te
rn
oo
n
(p
er
ce
iv
ed
to
be
an
is
su
e
fo
r
at
te
nd
an
ce
by
fa
ci
lit
at
or
s)
7
(6
)
2
Se
ve
n
fa
ci
lit
at
or
s
in
to
ta
l
ac
ro
ss
10
w
ee
ks
La
ck
of
co
nt
in
ui
ty
in
ch
ild
re
n’
s
fa
ci
lit
at
or
s
Si
te
C
FF
H
1
Pa
rt
ia
l.
O
f
th
e
se
ve
n
fa
m
ili
es
ra
nd
om
is
ed
,
fiv
e
ha
d
be
en
w
ai
tin
g
>
3
m
on
th
s
an
d
on
ly
fo
ur
fa
m
ili
es
at
te
nd
ed
.
Sm
al
l
nu
m
be
rs
fr
om
th
e
st
ar
t.
Sm
al
ln
um
be
rs
fr
om
th
e
st
ar
t,
so
di
ff
ic
ul
t
to
sp
lit
in
to
su
bg
ro
up
s
fo
r
ac
tiv
iti
es
9
w
ee
ks
(o
ne
w
ee
k
ca
nc
el
le
d
be
ca
us
e
of
sn
ow
)
N
o
1
Sa
tu
rd
ay
m
or
ni
ng
7
(4
)
5
Fi
ve
fa
ci
lit
at
or
s
in
to
ta
la
cr
os
s
10
w
ee
ks
G
oo
d
co
nt
in
ui
ty
of
fa
ci
lit
at
or
s
w
ith
vi
rt
ua
lly
no
va
ria
tio
n
ea
ch
w
ee
k
Si
te
C
FF
H
2
Pa
rt
ia
l.
O
f
th
e
10
fa
m
ili
es
ra
nd
om
is
ed
,
fo
ur
ha
d
be
en
w
ai
tin
g
>
3
m
on
th
s
an
d
si
x
fa
m
ili
es
at
te
nd
ed
10
w
ee
ks
N
o
1
Sa
tu
rd
ay
m
or
ni
ng
10
(6
)
4
Fo
ur
fa
ci
lit
at
or
s
in
to
ta
la
cr
os
s
10
w
ee
ks
G
oo
d
co
nt
in
ui
ty
of
fa
ci
lit
at
or
s
w
ith
vi
rt
ua
lly
no
va
ria
tio
n
ea
ch
w
ee
k
FF
H
,
Fa
m
ili
es
fo
r
H
ea
lth
.
DOI: 10.3310/hta21010 HEALTH TECHNOLOGY ASSESSMENT 2017 VOL. 21 NO. 1
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Robertson et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
103
TABLE 74 Weekly evaluation of parents after each Families for Health session
Week Total
How do you feel about today’s session? How do you feel about the programme?
Awful
☹ Bad
OK
K Good
Great
☺
% good
or great
Awful
☹ Bad
OK
K Good
Great
☺
% good
or great
1 36 0 0 2 17 17 94.4 0 0 3 20 13 91.7
2 34 0 0 5 14 15 85.3 0 0 4 15 15 88.2
3 32 0 0 2 16 14 93.8 0 0 2 16 14 93.8
4 31 0 0 5 11 15 83.9 0 0 1 16 14 96.8
5 31 0 0 4 17 10 87.1 0 0 2 17 12 93.5
6 22 1 0 3 9 9 81.8 0 1 1 7 13 90.9
7 25 0 0 0 10 14 100 0 0 0 10 15 100
8 28 0 0 0 14 14 100 1 0 2 12 13 89.3
9 13 0 0 0 4 9 100 0 0 0 4 9 100
Total (%) 1
(0.4)
0 21
(8.4)
112
(44.6)
117
(46.6)
91.2 1
(0.4)
1
(0.4)
15
(6.0)
117
(46.4)
118
(46.8)
93.2
Note
Evaluation forms were not completed by parents in week 10, and there were fewer forms completed in week 9 when this
became the last session (in programmes which were shortened to 9 weeks).
TABLE 75 Parents’ perception of the main weekly topics after each Families for Health session
Week Total Main weekly topics
Times (%) mentioned as
‘useful or enjoyable’
Times (%) mentioned as
‘not useful or enjoyable’
1 36 What is health? 3 (8) 0 (0)
Balancing act 1: energy in, energy out 2 (6) 1 (3)
Let’s look after ourselves 0 (0) 0 (0)
2 34 Discipline (including setting limits
and praise)
12 (35) 0 (0)
Balancing act 2: food our bodies need 15 (44) 1 (3)
3 32 Family guidelines and rewards 10 (31) 0 (0)
Finding our power for health (focus on
physical activity)
9 (28) 0 (0)
4 31 Our eating habits 12 (39) 1 (3)
Children’s choices 9 (29) 0 (0)
5 31 How much we eat (portion sizes) 12 (39) 2 (7)
Building self-esteem 18 (58) 0 (0)
6 22 Thinking about feelings 10 (46) 1 (5)
Active alternatives to staring at the screen 0 (0) 0 (0)
7 25 Stress – and what we can do about it 13 (52) 0 (0)
Coming to our senses 1 (4) 0 (0)
Surviving at the supermarket 4 (16) 0 (0)
8 28 Food labels: what do they mean? 21 (75) 2 (7)
Labelling our children 0 (0) 0 (0)
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In the written responses to open-ended questions, it was clear that meeting other parents was valued by
many participants. In the first week of the programme, three-quarters of parents (27/36) mentioned this as
a positive aspect of the session:
Getting ideas how other parents do certain things. Tips to learn from.
Lots of thoughts and advice from others and realising your not alone!
Giving some ideas. Finding other people with the same problems.
Getting to know other parents and realising we all feel the same. Can’t wait for next week.
Nearly two-thirds (61.8%) of parents felt that the programme had helped their children tackle their weight
difficulty ‘definitely’ or ‘a lot’, and a similar proportion (63.7%) felt that the programme had helped the
rest of the family ‘definitely’ or ‘a lot’. When asked whether or not they had noticed changes in their child
as a result of the programme, 70.6% responded ‘definitely’ or ‘a lot’.
Thematic analysis of parents’ response to the unprompted question ‘What did you get out of it?’ revealed
similarities and differences in parents’ experiences of the Families for Health and usual-care programmes.
Many parents talked about their experience of food topics, physical activity and gaining ‘no new
experiences’ as a result of the programme. Parents attending a Families for Health programme also
discussed getting support from other parents and raising their child’s awareness.
Food topics
Parents attending Families for Health identified information on food labelling as particularly useful in
making informed choices, for example realising that foods they had previously thought of as being
‘healthy’ were not necessarily so and learning which foods were in fact ‘healthy’:
I found it very beneficial. Um, food portion sizes, um food value. Sometimes some of the labels and
design packaging was very misleading . . . you think, oh yes that looks healthy, and then I think, no it’s
not. And I don’t buy it.
F112, site C, Families for Health, eight sessions attended
Parents attending Families for Health were also positive about being introduced to new recipes and
learning about correct food portion sizes:
I found out my portion sizes were just too big for children their age. So I learnt reference points and I
have cut down on my portion sizes although when I did do them to exactly what they said they just
TABLE 75 Parents’ perception of the main weekly topics after each Families for Health session (continued )
Week Total Main weekly topics
Times (%) mentioned as
‘useful or enjoyable’
Times (%) mentioned as
‘not useful or enjoyable’
9 13 From problem to solution 4 (31) 0 (0)
A healthy lifestyle or a life of diets? 1 (8) 0 (0)
Meeting the challenge of special occasions 0 (0) 0 (0)
10 3a Scaling the ladder to health 0 (0) 0 (0)
We are stars 1 (33) 0 (0)
Party celebration 0 (0) 0 (0)
a Low numbers because this was a party week and the forms were not given out, plus some groups did not have a week 10.
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looked so tiny and I was thinking, ‘my kids are never going to eat this, they are going to eat that and
they’re going to be ravenous afterwards’. So I still probably give a little bit more but it is probably half
of what they used to have.
F84, site B, Families for Health, five sessions attended
For parents attending two ‘usual-care’ community group-based programmes in sites A and B, there were
similar discussions, with parents gaining an increased awareness of what was in food and making more
informed choices over the types of food they now chose and bought:
Full-fat coke [Coca-Cola®: The Coca-Cola Company, Atlanta, GA, USA]. I drink it by the tin load. And
they did a session on how much sugar was in fizzy drinks and your chocolate and stuff that I tell you
what . . . I was very surprised. It was an eye opener. Admittedly, I have cut right down and I am
actually on diet coke now.
F22, site A, usual care
Site B usual-care provision offered a one-to-one service whereby an advisor would advise families on how
to swap meals to healthier alternatives:
You know, she [usual-care advisor] tells us about different meals, how you can swap things.
F82, site B, usual care
Physical activity
Unlike parents attending a Families for Health programme, parents attending a usual-care intervention
were more likely to talk about exercise and physical activity when discussing their experience of
the programme:
But yeah the exercise was good. At times he really did enjoy it, sometimes I even joined in for one or
two sessions if I didn’t have [younger son] with me, yeah they played dodge ball and whatever.
F27, site C, usual care
The importance of exercise was stressed and how to be active without the need to spend money, for
example going for a walk or exercising at home:
. . . and it was just about trying to be more active really from the [usual-care programme] that we got
that. You know even just at home you know he could be at home here doing his running up and
down and, like we’re at home and I’ll say to him, oh come on let’s do some star jumps or something.
F49, site C, usual care
Similar to being able to offer practical advice on what foods to eat, the one-to-one advisor at site B was
able to give usual-care parents specific details of exercise classes that were available in the local area,
such as dance classes, or exercises which families could do at home.
Nothing new
Four parents claimed to have learnt nothing new from the Families for Health programme, and a further
two felt that they already knew a lot of the information they were given, but they did not necessarily want
to change their behaviour:
Because the problem was never that I didn’t know what to eat, and the problem was never I couldn’t
afford the right foods or, you know, because I didn’t go to the right supermarket, and that was never
the issue. The issue was I just didn’t want to eat those kinds of foods and that hasn’t changed, I still
don’t want to eat wheat and nuts and fruits and dried apricots and, you know, prunes.
F57, site C, Families for Health, five sessions attended
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For the parents who had accessed usual care and the programme had run, no-one thought they had learnt
nothing new.
Support from others
Parents attending a Families for Health programme often talked about the positive experience of meeting
other parents who were in a similar situation, and being able to talk about common problems and
sharing ideas:
But it was interesting, other parents saying things about their children and you think, you know, that’s
what [child A]’s like, so that was interesting. It made it feel like it wasn’t just you.
F59, site B, two sessions attended
I liked when people shared ideas about what they do and I could say what I do and, you know, that
was nice.
F100, site A, Families for Health, 10 sessions attended
Raising child’s awareness
Some parents spoke of how attending the Families for Health programme had made their child more
aware of themselves in relation to healthy eating and exercise, and more aware of the choices they
are making:
And he’s [son] been more aware of . . . conscious of foods that he’s eating and doing a little bit more
exercise and stuff like that . . .
F109, site A, Families for Health, seven sessions attended
Overview of sessions
One parent described how they felt they got something from each session, and that the programme
was ‘complete’:
We got a lot, didn’t we? We just got . . . it was mind boggling because it was just making you aware
of the labels on foods, cooking of foods . . . Food content, just . . . I mean we went out and bought
a halogen oven because we found it would be better cooking. Just portion size . . . Snacking yes,
snacking was one of the things that we’ve . . . I mean like even down to praising your child,
self-esteem, it was a complete . . .
F99, site C, Families for Health, six sessions attended
Parents who attended a usual-care programme did not discuss group support, raising child’s awareness or
a positive overview of all sessions.
Parenting skills
A unique feature of the Families for Health intervention was the incorporation of a parenting theme.
A few parents discussed how their parenting had been influenced by attending the Families for Health
programme, including knowing what to say to their child and being stronger at saying no:
. . . it helped me think about [child A] a bit more what to say and what not to say around him and
maybe just tweaking, bettering my parenting skills, it was really good for that.
F109, site A, Families for Health, seven sessions attended
. . . it’s made it a bit easier for me to be stronger at saying to her [daughter], no.
F26, site A, Families for Health, nine sessions attended
Parenting skills were not spontaneously discussed by families attending a usual-care intervention.
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Dose received: children
Children’s unprompted comments on the Families for Health programme and
usual-care intervention
Many children (17 from Families for Health and two from usual care) reported enjoying all of the
programme they attended:
I just put, I enjoyed all of it and like . . . it was really fun.
F61, FFH3, site A, 10 sessions attended
I’ve written that I loved everything. I didn’t dislike anything that we done there because it was all fun
and stuff, it wasn’t boring.
F47, FFH1, site C, nine sessions attended
I didn’t not like anything about the [usual-care] programme really.
F33, usual-care group, site C
Some children did not enjoy the programme they attended because of the age difference between
themselves and the other children attending:
I didn’t really like anything because like I felt that I was like a bit of an odd one out because I was like
the oldest and I felt a bit like enclosed and that over things because they were like all younger kids
that liked the same things . . .
F79, FFH2, site B, one session attended
Well they were all a bit too young and they treated us a bit like babies . . . And because they were
young they treated you like everyone was young.
F28, FFH1, site B, four sessions attended
One child felt uncomfortable because he was the only child present at a usual-care support service in site C:
. . . it was only me as a child there. They were all women really . . . and I felt uncomfortable with that.
Because . . . being the only child is quite weird.
F25, usual-care group, site C
Food topics
With the exception of two usual-care services in site C (school nurse or group programme with adults),
children in all programmes talked about their experience of learning new dietary information as a fun and
useful activity. This included getting information on ingredients in snacks that one child described as
‘shocking’ and another child described as the ‘. . . secrets in the food’ (F8, usual-care group, site C):
Well we played the shopping game and she brought lots of food in and it is like unhealthy and
healthy and me and my friend, we each had a big bag and we had to put . . . there was lots of stuff
on the table and everything we thought was a good choice we had to put in the bag but you could
put anything in the bag you liked and would be a good choice. And we put all the unhealthy stuff in
and the healthy stuff! But that was probably the best game.
F28, FFH2, site B, four sessions attended
. . . each week there was a target sheet to do with it and we would talk about what is going wrong
with our health, how we can improve it. One week we had a task we had to do . . . we were given
labels of bad food products and we had, through label reading, and we looked at them and we read
the amount out and we matched them to the amount of salt and sugar. And Doritos have 58 g of
sugar . . . I was shocked.
F40, usual-care group, site C
PROCESS EVALUATION
NIHR Journals Library www.journalslibrary.nihr.ac.uk
108
Children attending a Families for Health programme had enjoyed drawing activities that required children
to apply their new dietary knowledge on the creation of a healthy cereal including food labelling
considerations for the packaging, shopping games and the Eatwell plate activity. Opportunities to try
different food were received positively by children attending a Families for Health programme and the
group-based usual-care intervention at site C. Children tried food they had never previously consumed,
which one child explained resulted in healthier snack consumption:
I liked it at break time we got to try new stuff . . . Tomato juices and other juices . . . I’ve eating a lot
more fruit.
F57, FFH1, site C, five sessions attended
. . . we tried like loads of fruit and stuff and vegetables that I’d never had before.
F100, FFH3, site A, 10 sessions attended
I like the [usual-care] programme because it was fun and I like meeting people and playing games and
trying new food.
F33, usual-care group, site C
Making snacks and developing cooking skills were also popular in the Families for Health programme:
I enjoyed making the snacks, especially the week when we made the puff pastry pizzas. And on the
last week we did like the party and stuff, everyone had to bring something and we made the pizzas
and everyone loved them . . . I liked all of it, but that was the bit that I liked the most.
F61, FFH3, site A, 10 sessions attended
Because it was near lunch the children most of time got to make snacks like yoghurt and fruit and
then we’d also have like a kind of fake shopping trip where you’d look at the prices and what’s inside
of them. And then we’d actually taste what we’d made.
F56, FFH3, site A, seven sessions attended
Physical activity
Children who had attended a Families for Health programme or the group-based usual-care intervention at
site C were more likely than other children to talk positively about physical activity. They talked positively
about a range of sports activities including football, trampolining, dodgeball and gym activities:
I liked the gym . . . The equipment and how you get to like go on them.
F8, FFH1, site C, six sessions attended
I liked all the guests that came in because they were teaching us different sports and different games
and I didn’t know how to play them before and then they taught us how to play them.
F26, FFH2, site A, nine sessions attended
I liked it how the children could choose what we’re going to do, all the sports . . . We did badminton,
tennis, um . . . I think it’s called, and volleyball I think.
F86, FFH2, site C, 10 sessions attended
Children that attended a usual-care one-to-one support service in site B did not mention engaging in
physical activities during the intervention, but were positive about the resources they received that
encourage physical activity:
Well once my friend came over and [advisor] gave us this wheel thing, and when you wheel it there’s
like some games that you have to play or dares, like run about or something with them. I did it with
my friend and we played it outside in the garden . . . It was good.
F83, usual-care, site B
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Children also talked about negative experiences of different physical activities, which mainly depended on
whether they found the game easy or difficult. Children also commented not having enough time to use
all of the gym equipment when this was an option. One child explained that he disliked other children,
commenting on his ability to take part in the running and star jumps activity:
. . . there’s some stuff that I cannot do and there’s some stuff they cannot do. And say if I cannot do it
they are sort of, ‘ah he’s too fat’ and all that to do it, and that was kind of annoying.
F27, usual-care group, site C
Balloon races . . . it is hard and not using the equipment that much . . . it was only 2 days. The first and
second week that we used them and that was it really. I think the problem was the machines weren’t
working properly.
F40, usual-care group, site C
There was not enough time and um we didn’t get much on the gym . . . To like do everything because
there was that many stuff in the gym we could get around quick enough.
F72, FFH2, site C, three sessions attended
Children attending a Families for Health programme talked about feeling disappointed that they were
unable to access the gym as they were too young, and children who did access the gym did not enjoy
sharing the gym facilities with children who were not attending the Families for Health programme:
And there was one session where we were supposed to go out of the room and into the gym and we
couldn’t do it because the age limit was 8–15 but some people were . . . two people were under that
age, so we missed out on that one . . . We felt let down.
F56, FFH2, site A, seven sessions attended
I didn’t like the different exercise machines up in the fitness room because we had to do it with
different children that we didn’t know so we had to talk to them even though we didn’t know them
. . . I thought we were just going to do it with just the people in the programme but we didn’t.
F75, FFH2, site C, nine sessions attended
Social
The social aspect of making new friends was a positive experience for children attending a Families for
Health programme and a group-based intervention at site C:
My friends from what I met in, the children . . . I like to have the friends because that means that I
don’t have to do it on my own. And I have people to play with.
F26, FFH2, site A, nine sessions attended
Meeting new people there, friends and stuff. And having fun and playing games.
F33, usual-care group, site C
Having something to do on a Saturday . . . [would normally] . . . Sit at home, watch TV or we’d go
shopping, and that’s it.
F56, FFH2, site A, seven sessions attended
Some children attending a Families for Health programme talked about feeling anxious or isolated as they
did not know other group members, which limited their level of interaction:
. . . at first there was one where I felt a bit isolated because I didn’t know anyone . . . until about the
third or fourth session. I did start to open up but I didn’t really talk during the sessions.
F56, FFH2, site A, seven sessions attended
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I get quite shy sometimes, so I didn’t like it just myself because I got quite shy. Because if I’m alone
with kids like that it’s quite scary for me.
F59, FFH2, site B, two sessions attended
Structure of sessions
Some children found some of the sessions boring, overlong and included too much talking. Children
attending a Families for Health programme and the group-based usual-care intervention at site C did not
enjoy the activities that involved sitting and writing, and children accessing the usual-care intervention in
site B felt that too much talking was involved:
I didn’t like it because it was a bit too long . . . It’s just its 2 hours and a half, which is . . . just under
half a quarter of your day wasted.
F102, FFH2, site B, four sessions attended
I got a lot bored with the [usual-care] programme because you just sit there until the end because
it was too long hours, it is 3 and a half hours . . . so I’d rather stay at home, play outside or do
something like that. Or go to the gym or something.
F27, usual-care group, site C
I know you have to talk like to explain stuff, but the thing is . . . it’s too much talking.
F83, usual care, site B
Current knowledge was not taken into consideration for one child accessing a usual-care intervention that
involved a one-to-one advisor:
. . . it was boring . . . The lady was just going on about the same thing. And she was . . . she wasn’t
really taking in that I knew the stuff already because I said that I know about the cycle thing and I
could tell my Mum . . . Like I knew about this from my school . . . And I already had this [showed
two resources].
F48, usual care, site B
Discussion
All Families for Health programmes were delivered broadly as planned and any deviations to programme
delivery did not deviate from the intended aims of the original programme. Attendance at most Families
for Health programmes was reasonable, and better than usual care in terms of the ‘did not arrive’ rate,
and most of the parents and children who attended felt positive about the programme.
Families recruited to the trial broadly reflected the target population at each site, but the overall slow
recruitment and the number of families who could not manage a Saturday morning session indicate some
of the problems in providing any group-based intervention to families with young children.
Activities that did not work well when delivering the Families for Health programmes included games that
were not age appropriate for children and activities that some parents perceived as patronising. Small
group sizes, because of the difficulties in recruitment and subsequent poor attendance, were a barrier to
successful programme delivery as many activities did not work well when there were not enough families.
This process evaluation revealed the importance of consistent, trained and experienced facilitators for
programme delivery. A lack of continuity of facilitators had a negative impact on dose delivered, as this
was disruptive for parents, children and facilitators. Beidas and Kendall94 critically reviewed studies
exploring the factors involved in the training of therapists that are required to adopt and implement
interventions, and found that appropriate training should emphasise the ‘underlying spirit’ of the
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treatment rather than solely focus on techniques.94 Most Families for Health facilitators were positive about
the programme. As facilitators became more experienced in delivering the Families for Health programmes,
they became more confident and experienced fewer difficulties when delivering the programme.
This process evaluation demonstrates that parents and children attending a Families for Health programme
enjoyed interactive sessions in relation to diet, which enabled children to develop cooking skills and
provided parents with an opportunity to practise parenting skills learnt during the programme. Parents
reported increased confidence and being stronger at saying no to their child as a result of attending the
Families for Health programme, which is similar to parents’ perceptions of the Webster-Stratton parenting
programme.95 Other similarities include parents’ perception that the programme was unsuitable because
nothing new was learnt and that the course would have been more effective if partners had attended the
programme. Parents who attended a usual-care programme talked about food topics and physical activity
positively, but did not talk about improvements in parenting skills.
There were similarities in children’s experiences of attending a Families for Health programme and
community group-based usual-care services. Children talked about learning new dietary information,
accessing gym facilities and making new friends as positive features of the programmes. Older children’s
experiences of having younger children in Families for Health groups were negative, as games were
modified to accommodate the needs of younger children. This is consistent with facilitators’ challenging
experiences of delivering the programme to a varied group of children ranging from 6 to 11 years.
Facilitators’ experiences in the Hunter Illawarra Kids Challenge Using Parent Support (HIKCUPS) trial
suggested that future programmes should specifically cater to children of similar age or same sex.96
Facilitators of the Families for Health programme experienced similar difficulties delivering the programme
to a wide age range of children, but did not encounter difficulties with mixed-sex groups. In this trial it
proved difficult to assemble groups of adequate size even with this wide range of child ages, and small
group size had a negative impact on the functioning of some groups. A narrower band of child ages
would have made this situation worse, but might be practical in a non-trial setting where half the number
of families need to be recruited to launch each group.
In conclusion, the Families for Health programme was implemented reasonably well and pretty closely to
what was planned to the intended population, and any adjustments to programme activities did not
deviate widely from the original aims of the handbook activities. Facilitators’, parents’ and children’s
experiences of the Families for Health programme were largely positive.
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Chapter 7 Discussion and conclusions
Summary of findings
The Families for Health programme focuses on a parenting approach, designed to help parents develop
their parenting skills to support lifestyle change within the family and to help children manage their
weight. Within the care pathway for weight management services, Families for Health is a level 2 targeted
weight management service.8 The logic model97 shown in Figure 24 was developed prior to analysis of
data, to demonstrate how the Families for Health intervention is intended to work.
In this RCT there was no statistically significant difference in the change in BMI z-score at the 12-month
follow-up between the usual-care and Families for Health arms (0.114, 95% CI –0.001 to 0.229; p= 0.053;
model 1). However, the within-group analysis showed that BMI z-score was significantly reduced in the
usual-care arm (–0.118, 95% CI –0.203 to –0.034; p= 0.007), whereas there was no significant change in
the Families for Health arm (–0.005, 95% CI –0.085 to 0.078; p= 0.907). The measurements of waist
circumference z-scores and percentage fat are consistent with the BMI findings. This indicates a trend that
children allocated to the Families for Health arm did worse than children randomised to the usual care
available locally at the three sites in terms of the management of their obesity.
Apart from a significant improvement in activity level in parents44 in the usual-care arm compared with the
Families for Health programme, there were no other significant differences between groups for the other
secondary outcome measures (objective or self-reported). Children’s quality of life, parents’ well-being
and the child–parent relationship scores were all better (but not significantly different) in the Families for
Health group than in the usual care group. Thus, there is some indication that the Families for Health
programme may have influenced parenting and family relationships, as predicted in the logic model,
although the BMI z-score change was worse than in the usual-care group.
Other studies focusing on the treatment of obesity using a parenting approach have found mixed results.
Lifestyle Triple P (Positive Parenting Program®, University of Queensland, Brisbane, QLD, Australia) is a
general parenting programme that is aimed at lifestyle, targeting parents of overweight and obese
children, from which contrasting results have emerged. In a RCT in children aged 4–11 years in Australia,
Parents more able
to implement
changes in child’s
lifestyle
authoritatively
Child more receptive
Child more self-aware
and confident
BMI
falls
FFH
Parent and child more
knowledgeable about causes 
of obesity and how to support
physical activity/healthy
eating 
Parents more self-aware
and confident
Parenting skills
developed
FIGURE 24 Logic model for the FFH intervention. FFH, Families for Health.
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BMI z-score in the Lifestyle Triple P group was lower by –0.11 at the end of the 12-week programme and
by –0.19 at 1-year follow-up, compared with a reduction of –0.01 in the wait-list control group (who then
started the intervention at 12 weeks).98 However, a study in the Netherlands of overweight and obese
children aged 4–8 years found no significant intervention effects in children’s BMI z-score, waist
circumference or skinfold thickness between Lifestyle Triple P and the control intervention (comprising
printed material) at 4 and 12 months after baseline.99 In general, replication studies of the Triple P suite of
programmes have shown less effect than observed in the original trials,100 and in this case there was also a
difference in the control intervention between these two trials, with the wait-list control trial showing more
effect. A systematic review of general parenting interventions to prevent or treat childhood obesity, which
included the Triple P study by West et al.98 and the Families for Health pilot study,24 found only limited
evidence but did find a small positive effect on weight-related outcomes.16
Economic evaluation
Not only was Families for Health less effective than usual care in terms of BMI z-score, it was also
significantly more costly to deliver. The increased costs were mainly because the Families for Health
programme ran separate parallel groups for parents and children with two facilitators in each, whereas
the group-based interventions in the usual-care arm were delivered with parents and children attending
the same group. The mean incremental cost-effectiveness of Families for Health was estimated at
£552,175 per QALY gained, and the probability that Families for Health is cost-effective at a £20,000
cost-effectiveness threshold is approximately 28%. When health outcomes were measured in terms of
longitudinal change in BMI z-score, the mean incremental cost-effectiveness of Families for Health was
estimated at –£3935 per unit change in BMI z-score (indicating that, on average, Families for Health is
dominated by usual care in health economic terms) and the probability that the Families for Health
programme is cost-effective does not exceed 2% across a range of cost-effectiveness thresholds. These
findings leave little doubt that the Families for Health programme is not a cost-effective intervention.
Process evaluation
An uncontrolled pilot study of the Families for Health programme had demonstrated proof of principle for
the programme showing a long-term reduction in BMI z-scores,24,25 so a question to be answered by the
process evaluation is whether the lack of effectiveness of the Families for Health programme in this trial
was because of the intervention itself or poor implementation.86 Problems with implementation that could
have impacted on effectiveness included issues with recruiting a sufficient number of families to form
viable Families for Health groups (minimum of eight families) at each site. Recruitment to group-based
interventions is more challenging than to one-to-one interventions and becomes doubly so in the context
of a trial, as approximately half of the families recruited were randomised to the usual-care intervention.
This meant that many families had to wait more than 3 months to receive the Families for Health
intervention. Furthermore, some programmes were delivered with an insufficient number of families some
weeks, owing to a combination of starting a group with a relatively small number recruited and low
attendance, impacting on effectiveness. However, based on the quantity and quality of what was
delivered, the process evaluation indicates that the intervention was implemented reasonably well,
probably as well as could be expected if the programme were to be scaled up further. There were no
major adaptations across the seven programmes and where activities were replaced or modified, the
original aims of the handbook activity were upheld. This supports a conclusion that the Families for Health
programme was delivered as planned or as well as would be possible when scaled up over three sites, and
is ineffective at reducing BMI z-score.
The process evaluation indicates that the majority of families had a positive experience and found the
Families for Health programme useful and enjoyable. This was particularly so in relation to food topics,
with an increased knowledge and understanding of food labelling being documented. The opportunity to
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take part in various forms of physical activity, particularly gym sessions, was valued by both parents and
children. Parents also felt that they gained a lot from meeting other parents facing similar challenges. It is
important to acknowledge these aspects of the Families for Health programme that were perceived to
work well. These could be built on in new interventions to tackle childhood obesity.
Our over-riding conclusion from the Families for Health trial is that the combining of support for parenting
and family relationships with learning about healthy eating and physical activity in this intervention did not
help families manage their children’s overweight or obesity, at least in the medium term.
Why not effective?
The Families for Health programme may have been ineffective for a number of reasons. It may be that the
approach to parenting in this intervention, while perceived as offering valuable insights and skills by
parents in the process evaluation, may not have helped families to manage the family diet and physical
activity participation. It may be that the dietary advice based on the Eatwell plate is not adequate. Some
childhood obesity authorities now recommend a zero-sugar approach rather than an attempt to reduce
sugar. The latter approach may be more difficult and less effective than the former. The Families for Health
programme may also have had an insufficient emphasis on physical activity.
Although the uptake of the programme varied and few families attended all the sessions, this is likely to
be the reality of any roll-out of such a programme. It is not possible from the results of this trial to
estimate what might have been a ‘sufficient’ dose, but there was active recruitment into this trial. It might
prove very difficult in routine delivery of such an intervention to achieve any greater uptake.
It remains true that the Families for Health version 1 programme produced a result in the pilot that was
not replicated in the trial. Reductions in BMI z-score of –0.18 (95% CI –0.30 to –0.05) at the end of the
programme, –0.21 (95% CI –0.35 to –0.07) at the 9-month follow-up and –0.23 (95% CI –0.42 to –0.03)
at the 2-year follow-up were shown.24,25 The conclusion from the pilot was that the Families for Health
intervention merited testing in a RCT. Changes between version 1 and version 2 of the Families for Health
programme made between the pilot and the trial included reducing the number of sessions from 12 to 10,
but adding two follow-up sessions that had been requested by parents in the pilot process evaluation.
Follow-up sessions were, however, poorly attended and usually only one follow-up session was achieved
by the facilitators. Other changes to the Families for Health programme between version 1 and version 2
were minor.
Families for Health is not alone as an intervention showing promise in a pilot but showing no difference
at the trial phase. Other interventions in the UK on the topic of childhood obesity, physical activity and
healthy eating have shown a similar pattern. For example, in the Active for Life year 5 school-based
intervention the pilot study showed that it might be effective, whereas in the cluster RCT the three
specified primary outcomes of physical activity, sedentary behaviour and fruit and vegetable consumption
showed no difference between the intervention and control schools.101 Furthermore, in a pilot of the
‘Family-Based Behavioural Treatment’ intervention, a reduction in BMI z-score of –0.15 (p< 0.001) was
observed, whereas in the main trial, although the early change in BMI z-score was similar to the pilot
within the intervention group (–0.16), there was no overall change from 0 to 12 months.14
Speculation of possible explanations between the different results between the uncontrolled pilot and the
main trial results is warranted. One possible reason is that scaling up a pilot study can attenuate the
effectiveness. The intervention was delivered very well in a small pilot in site A comprising two Families for
Health groups in a non-trial setting, without a control group, so families did not wait long before starting
the group.24 The two pilots were delivered by a small team of four quite experienced facilitators, one of
whom was involved with the development of the intervention. Scaling up the pilot study to running the
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intervention across three sites in the trial, delivered by 17 facilitators mostly delivering the intervention for
the first time after only 4 days’ training, may have attenuated the effect.
The piloting of the Families for Health intervention was done using a pre–post study, and maybe this was
an inadequate study design to inform the decision to proceed to a full-scale trial. A pilot RCT would have
been more rigorous and would have highlighted the difficulties in recruiting families and running the
Families for Health intervention in a trial setting in which families had to wait longer for a viable number of
families for a group to start.
The logic model for the Families for Health programme assumes capacity to improve parenting style, and
then improve lifestyle. According to the PSDQ50 results, however, most parents were already mainly
adopting an authoritative parenting style, maybe reflecting who enrols for these types of interventions.
Given the relatively high level of optimal parenting at the start of the trial, there was perhaps less scope for
change with this parenting intervention, which may be related to the lack of effect. Furthermore, some
parents found the parenting aspects patronising. It could be hypothesised that the Families for Health
programme would be more effective for families with primarily permissive or authoritarian parenting styles.
The Family Links Nurturing Programme is the basis for the parenting components of the Families for Health
intervention.27 A RCT of the Family Links Nurturing Programme was completed while the Families for
Health trial was in progress.102 The results have not found evidence of clinical or cost utility for the Family
Links Nurturing Programme when run as a universal early-years parenting programme for the 2–4 years
age group, although there were contamination issues with the trial. Thus, the parenting programme
that the Families for Health programme has as its base is not itself of proven effectiveness under trial
conditions. This is not necessarily a weakness of the trial methodology, but is a potential weakness of the
Families for Health intervention.
The point has been made in the context of this latter Family Links Nurturing Programme trial, as well as
in the context of other public health interventions, that the trial setting itself could interfere with the
effectiveness of interventions, particularly those involving personal development.103 This may have also been
a factor in the current trial with families having to wait longer to access the Families for Health intervention
while a viable group was formed, potentially affecting engagement. However, non-randomised designs
comprising historical controls or non-randomised concurrent controls are prone to selection bias, and others
advise that they should be used only when RCTs are not feasible or are unethical.104
Another explanation that must be considered is that the positive result in the pilot study could just be
regression to the mean in the uncontrolled pilot. Even if the Families for Health programme is not
effective, there is a 1 in 20 chance of a positive result in the pilot, and of course it is exactly those
interventions that give such a result that go on to a full RCT.
Strengths and weaknesses of the study
The strengths of the study are the randomised design and the inclusion of a comprehensive process
evaluation, alongside the effectiveness and cost-effectiveness components. The economic evaluation was
conducted in accordance with national methodological standards, with a comprehensive analytical strategy
adopted to handle missing data and various forms of uncertainty. The process evaluation used a specified
framework and mixed-methods data collection across a wide range of sources enabling triangulation
of results.
A weakness of the study is the differential follow-up of the Families for Health and usual-care arms, with
lower follow-up of usual care at 12 months (Families for Health 78.6% vs. usual care 66.1%). If the
assumption is made that those who did worse in terms of BMI were more likely to drop out, this could
have influenced the trial results by ‘improving performance’ in the control arm. Imputation analyses
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suggest that our results are robust to differential loss to follow-up, but cannot rule out the possibility that
this influenced results to the detriment of the Families for Health programme.
A further weakness is the lack of detailed attendance data from all usual-care providers, and thus
attendance data for the usual-care arm are not directly comparable with the Families for Health attendance
data. Additionally, the fact that different trial sites had different usual-care provision, and in site C this
changed part-way through the trial, may be a weakness. However, variation in the control group
treatment is a reflection of the pragmatic nature of the trial. Rather than being a limitation, this could be
viewed as an advantage as it does reflect the real world.
On reflection, greater attention should have been paid to the participants in the control arm, which may
have improved follow-up rates. Furthermore, increased involvement of the research team with the
usual-care providers would have given us better information on both the usual-care provision and the
attendance of families, including the number of sessions attended.
A difficulty in the trial was the length of time it took to recruit families. Recruitment of the planned
120 families was intended to be completed in 12 months, but instead took 24 months, eventually
recruiting 115 families. Only 40 families were required to be recruited from each of the three study sites,
but even then recruitment was difficult. At the time of study recruitment, there were more than
600 children in each of the three sites in year 6 alone (aged 10–11 years) who were eligible to take part,
but despite extensive active and passive recruitment methods, recruitment was problematic. The gap
between receiving feedback that their child is overweight via the NCMP and subsequent behaviour change
is recognised, helping to explain the disconnect between the number of potential children who were
eligible and those who actually came forward to participate in the Families for Health trial.105 As a
consequence of the slow recruitment, some families had a long wait until the number of families
randomised to the Families for Health arm was sufficient for their group to run. Some groups also started
with a suboptimal number of families, which impacted on the delivery of the programme and group
dynamics. Both of these factors could have impacted on effectiveness.
The plan was also to develop a long-term cost-effectiveness model to estimate the lifetime clinical and
economic consequences of the Families for Health intervention, but this was no longer relevant when the
programme was shown to be ineffective. This is a deviation from the protocol.
Recommendations for future research
Duggan et al.106 argue for broader reporting of negative outcomes from psychological treatments, to
include the negative effect of treatment on primary outcomes. In the current study, response, in terms of
change in children’s BMI z-score from baseline to the 12-month follow-up, ranged from –0.746 to 0.895
across the two groups, indicating that some children experienced a clinically significant benefit,65 whereas
in others treatment resulted in a negative outcome. Further exploration of these extreme cases by
treatment group is warranted, analysing psychosocial variables, attendance and qualitative data to help
explain the change in BMI z-score. Further exploration of the trial data is necessary to obtain an in-depth
understanding of why, in some children, treatment seemed to have an adverse effect.
Further research in the UK into a parent-only intervention for the treatment of obesity is warranted.
This would be much cheaper than the parallel-group model comprising separate groups for children
and parents (as in the Families for Health intervention). A recent Cochrane review has indicated that
parent-only interventions are as effective as treatment programmes for childhood obesity that involve both
parents and children.107 Alternatively, rather than a focus on the treatment of obesity, shifting attention
to the role of parents in the prevention of obesity, alongside school-based prevention initiatives, may be
worthy of future research.
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Furthermore, the Foresight report in 2007108 documented the large number of determinants of obesity,
many of which were beyond the control of the individual, and recognised that current interventions were
not making enough impact.108 Within this context, a whole-systems approach to tackle obesity has been
advocated by Public Health England, focusing action and policy at the individual, environmental and
societal levels, and across multiple sectors.109 Family-based programmes would then be embedded in
a social and fiscal environment, which would be supportive of behaviour change. Examining the
effectiveness of a systems approach is a very important area of research, and needs to include
the development of new evaluation methods.
Implications for public health/treatment services
In this trial usual care was shown to be effective in within-group analysis. Usual care for obesity
management has often been developed and improved over time,36 and has be optimised to suit the local
population, potentially explaining why no differences were found with the Families for Health intervention.
Anyone developing new interventions would be advised to first carefully evaluate any local initiatives to
inform local provider decisions, even if they have not been formally evaluated in a RCT. However, at least
47.5% of families did not receive the usual-care intervention, and so an alternative explanation is that
informing parents of their child’s weight is as good as a structured intervention.
Childhood obesity is hard to treat. Even treatment interventions that are shown to be effective may have
only a modest impact. For example, when MEND was implemented at scale, the mean change in BMI
z-score was –0.18, with the authors stating that the reduction in BMI was less than the trial result (but not
significantly so).21 A concern was raised that MEND had the potential to widen ethnic and socioeconomic
inequalities in the outcome of BMI. A further question is whether or not a mean change of –0.18 is
making a sufficient population impact, when a clinically significant change in individuals is considered a
reduction in BMI z-score, of at least –0.5, which results in a reduction in cardiovascular risk and improved
insulin resistance,110,111 although others suggest a reduction of 0.25 as the minimum clinically effective
change.65 So, even when interventions work, they may have only a limited impact on the number of
children who move to a healthy weight.
An alternative is to move the focus away from the individual-level determinants to the distal factors, with a
focus on changing the environment, making it more conducive to healthy family choices.112 Prevention
measures may be more effective.
Conclusion
Our over-riding conclusion from the Families for Health trial is that this intervention, combining parenting
skills and family relationships with learning about healthy eating and physical activity, was not effective in
helping families to effectively manage the weight of overweight or obese children aged 6–11 years.
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Appendix 1 Evaluation from the training of the
facilitators for Families for Health
N ineteen facilitators attended the 4-day training workshop in February 2012 run by Family Links. At theend of each day facilitators completed evaluation forms. They provided written responses to the
following questions: ‘What thoughts/ideas have been triggered as a result of today’s training?’; ‘In what
ways, if any, will today’s training enhance your professional practice?’; and ‘We would value any other
comments and suggestions’. Using the 4-point rating scale: ‘not confident’, ‘unsure’, ‘quite confident’,
‘confident’, facilitators were asked to rate: ‘How confident do you feel as a Families for Health facilitator?’.
Using the four-point rating scale: ‘extremely useful’, ‘useful’, ‘not very useful’, ‘pointless’, facilitators were
asked to rate: ‘How useful have you found it to explore the following?’ followed by a list of topics that
were covered during the training session for that particular day.
The evaluation from the training showed an increase in confidence of facilitators in delivering the
programme (Table 76). The majority of the topics covered during the training were scored as either
‘useful’ or ‘extremely useful’ (Table 77).
The written comments submitted by facilitators (n= 14) on completion of the 4-day training indicate that
the training was a positive and useful experience:
I have been trained in a number of parenting and children’s programmes and I would say that this
training was by far the most inspirational for me. No one has ever been able to get me drinking water,
having breakfast, eating more fruit. I could go on but this training has done this in a non-judgmental
way without forcing or coercion and for that I would like to thank you for your inspirational
facilitating skills.
Facilitator, training day feedback
TABLE 76 Facilitator review of their confidence as a Families for Health facilitator during the training workshop
(% of facilitators)
Day of training
Confidence level
Not confident Unsure Quite confident Confident
1 0.0 5.6 61.1 33.3
2 0.0 5.3 57.9 36.8
3 0.0 6.3 50.0 43.8
4 0.0 6.7 33.3 60.0
TABLE 77 Facilitator review of training topics (% of facilitators)
Topic
Relevance of topic
Extremely useful Useful Not very useful Pointless
FFH programme training 82.4 17.6 0.0 0.0
The programme for the parents/children you work with 75.0 25.0 0.0 0.0
FFH programme resources 76.5 23.5 0.0 0.0
FFH, Families for Health.
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Appendix 2 Essentially full completer analysis
on effectiveness
Essentially full attendance (full completer) is defined as having attended 9 or 10 Families for Healthsessions. The outcomes (BMI z-score and waist circumference z-score) in these children are compared
with the outcomes of children allocated to the Families for Health programme who have attended fewer
than nine sessions. The same model as in the per-protocol analysis is used. In total, there were 15 children
with essentially full attendance. There was no statistically significant difference between those children
who attended 9 or 10 sessions and those who attended fewer.
TABLE 78 Longitudinal changes in child BMI and waist circumference z-scores: essentially full completer analysis
(the Families for Health programme)
Period Treatment group
Outcome, mean z-score (95% CI)
BMI Waist circumference
Baseline to 3 months Full completer 0.006 (–0.192 to 0.205) –0.141 (–0.286 to 0.003)
Non-full completer –0.038 (–0.076 to 0.001) –0.068 (–0.122 to –0.015)
Treatment effect –0.044 (–0.162 to 0.074) 0.073 (–0.065 to 0.211)
p-value 0.457 0.297
Baseline to 12 months Full completer 0.007 (–0.205 to 0.218) –0.045 (–0.214 to 0.124)
Non-full completer –0.053 (–0.113 to 0.008) –0.075 (–0.156 to 0.007)
Treatment effect –0.059 (–0.277 to 0.159) –0.030 (–0.229 to 0.170)
p-value 0.572 0.768
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Appendix 3 Subgroup analyses on effectiveness
Subgroup age (6–8 and 9–11 years)
5.0
0
5
10
15
20
25
7.5 10.0 12.5
Age (years)
Pe
rc
en
ta
g
e
Normal
Kernel
FIGURE 25 Baseline distribution of children’s age.
TABLE 79 Data set split into young (6–8 years) and old (9–11 years) children according to baseline age
Time
point
Treatment
group
Number of
children
Mean child
BMI z-score
(SD)
Number of
young children
Mean young
child BMI
z-score (95% CI)
Number of
old children
Mean old child
BMI z-score
(95% CI)
Baseline FFH 63 2.69 (0.67) 25 2.70
(2.36 to 3.03)
38 2.68
(2.49 to 2.86)
UC 65 2.74 (0.70) 24 2.91
(2.55 to 3.27)
41 2.64
(2.46 to 2.82)
3 months FFH 48 2.62 (0.67) 20 2.63
(2.29 to 2.97)
28 2.62
(2.37 to 2.87)
UC 50 2.65 (0.71) 21 2.80
(2.41 to 3.20)
29 2.53
(2.32 to 2.75)
12 months FFH 45 2.72 (0.59) 18 2.68
(2.36 to 2.99)
27 2.74
(2.51 to 2.97)
UC 43 2.58 (0.68) 17 2.83
(2.46 to 3.20)
16 2.41
(2.16 to 2.66)
FFH, Families for Health; UC, usual care.
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Subgroup sex
TABLE 80 Longitudinal changes of BMI z-score by age subgroup
Period Treatment group
Mean young (6–8 years) child BMI
z-score (95% CI)
Mean old (9–11 years) child
BMI z-score (95% CI)
Baseline to 3 months FFH –0.008 (–0.156 to 0.140) –0.027 (–0.106 to 0.051)
UC –0.058 (–0.124 to 0.008) –0.031 (–0.098 to 0.036)
p-value 0.523 0.940
Baseline to 12 months FFH –0.033 (–0.203 to 0.138) 0.043 (–0.046 to 0.132)
UC –0.100 (–0.235 to 0.036) –0.103 (–0.215 to 0.009)
p-value 0.522 0.039
FFH, Families for Health; UC, usual care.
TABLE 81 Data set split by sex (boys/girls)
Time point
Treatment
group
Number of
children
Mean child BMI
z-score (SD)
Number
of girls
Mean BMI z-score
girls (95% CI)
Number
of boys
Mean BMI z-score
boys (95% CI)
Baseline FFH 63 2.69 (0.67) 36 2.63 (2.41 to 2.85) 27 2.76 (2.49 to 3.04)
UC 65 2.74 (0.70) 29 2.43 (2.19 to 2.67) 36 2.99 (2.77 to 3.21)
3 months FFH 48 2.62 (0.67) 27 2.55 (2.25 to 2.85) 21 2.72 (2.47 to 2.97)
UC 50 2.65 (0.71) 25 2.35 (2.10 to 2.60) 25 2.94 (2.66 to 3.23)
12 months FFH 45 2.72 (0.59) 26 2.68 (2.41 to 2.95) 19 2.77 (2.53 to 3.01)
UC 43 2.58 (0.68) 20 2.35 (2.06 to 2.63) 23 2.78 (2.48 to 3.08)
FFH, Families for Health; UC, usual care.
TABLE 82 Longitudinal changes of BMI z-score by sex subgroups
Period Treatment group Mean BMI z-score girls (95% CI) Mean BMI z-score boys (95% CI)
Baseline to 3 months FFH 0.005 (–0.084 to 0.094) –0.050 (–0.181 to 0.081)
UC –0.001 (–0.077 to 0.075) –0.084 (–0.137 to –0.031)
p-value 0.922 0.622
Baseline to 12 months FFH 0.081 (–0.006 to 0.168) –0.080 (–0.239 to 0.079)
UC –0.100 (–0.191 to 0.091) –0.146 (–0.247 to –0.046)
p-value 0.092 0.450
FFH, Families for Health; UC, usual care.
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Subgroup parent body mass index
Children are divided into subgroups according to their parents’ BMI at baseline. Parents’ BMI is classified
as underweight or healthy (BMI < 25 kg/m2), overweight (BMI ≥ 25 kg/m2 and < 30 kg/m2) or obese
(BMI ≥ 30 kg/m2) according to the World Health Organization classification system. Parent A BMI was used
unless parent A BMI was missing, in which case parent B BMI was used (parent B BMI used once).
One child did not have a parent providing a baseline BMI.
TABLE 83 Data set split by parent BMI classification
Time point
Treatment
group
Underweight/healthy
parent Overweight parent Obese parent
Number of
children
Mean child
BMI z-score
(95% CI)
Number of
children
Mean child
BMI z-score
(95% CI)
Number of
children
Mean child
BMI z-score
(95% CI)
Baseline FFH 10 2.32
(1.95 to 2.69)
16 2.64
(2.32 to 2.96)
37 2.80
(2.57 to 3.04)
UC 8 2.62
(2.18 to 3.06)
21 2.64
(2.38 to 2.90)
35 2.83
(2.55 to 3.10)
3 months FFH 6 2.26
(1.75 to 2.76)
15 2.67
(2.33 to 3.02)
27 2.68
(2.39 to 2.97)
UC 7 2.60
(2.05 to 3.15)
17 2.52
(2.20 to 2.84)
25 2.75
(2.42 to 3.08)
12 months FFH 5 2.39
(1.72 to 3.06)
15 2.62
(2.31 to 2.93)
25 2.84
(2.59 to 3.09)
UC 8 2.40
(1.86 to 2.95)
14 2.53
(2.14 to 2.92)
20 2.66
(2.32 to 3.01)
FFH, Families for Health; UC, usual care.
TABLE 84 Longitudinal changes of BMI z-score by parent BMI
Time period Treatment group
Measurement, mean BMI z-score (95% CI)
Healthy parent Overweight parent Obese parent
Baseline to 3 months FFH –0.099
(–0.264 to 0.066)
–0.049
(–0.122 to 0.221)
–0.040
(–0.132 to 0.053)
UC –0.074
(–0.132 to –0.016)
–0.069
(–0.13 to 0.001)
–0.009
(–0.090 to 0.071)
p-value 0.724 0.187 0.616
Baseline to 12 months FFH 0.099
(–0.034 to 0.233)
0.010
(–0.1665 to 0.186)
–0.002
(–0.118 to 0.113)
UC –0.213
(–0.448 to 0.021)
–0.142
(–0.280 to –0.004)
–0.036
(–0.168 to 0.095)
p-value 0.018 0.161 0.688
FFH, Families for Health; UC, usual care.
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Subgroup locality (site)
TABLE 85 Data set split by recruitment site (locality)
Time point
Treatment
group
Site
A B C
Number of
children
Mean child
BMI z-score
(95% CI)
Number of
children
Mean child
BMI z-score
(95% CI)
Number of
children
Mean child
BMI z-score
(95% CI)
Baseline FFH 28 2.39
(2.17 to 2.60)
16 2.89
(2.52 to 3.27)
19 2.95
(2.64 to 3.26)
UC 28 2.71
(2.47 to 2.95)
18 2.49
(2.18 to 2.79)
19 3.02
(2.64 to 3.41)
3 months FFH 24 2.39
(2.13 to 2.64)
11 2.94
(2.52 to 3.35)
13 2.80
(2.37 to 3.24)
UC 19 2.58
(2.29 to 2.86)
14 2.43
(2.08 to 2.78)
17 2.90
(2.46 to 3.34)
12 months FFH 20 2.53
(2.29 to 2.78)
10 2.85
(2.43 to 3.27)
15 2.87
(2.51 to 3.23)
UC 19 2.58
(2.31 to 2.85)
11 2.40
(1.89 to 2.91)
13 2.73
(2.24 to 3.21)
FFH, Families for Health; UC, usual care.
TABLE 86 Longitudinal changes in child BMI and waist circumference z-score by site
Site Time period Treatment group
Measurement, mean z-score (95% CI)
BMI Waist circumference
A Baseline to 3 months FFH –0.024 (–0.156 to 0.109) –0.160 (–0.274 to –0.046)
UC –0.029 (–0.104 to 0.046) 0.019 (–0.086 to 0.123)
p-value 0.947 0.023
Baseline to 12 months FFH 0.065 (–0.091 to 0.221) 0.099 (–0.115 to 0.313)
UC –0.082 (–0.227 to 0.063) –0.100 (–0.258 to 0.064)
p-value 0.157 0.138
B Baseline to 3 months FFH 0.051 (–0.090 to 0.191) 0.071 (–0.030 to 0.171)
UC 0.016 (–0.114 to 0.147) –0.038 (–0.136 to 0.059)
p-value 0.701 0.106
Baseline to 12 months FFH –0.001 (–0.180 to 0.177) –0.108 (–0.263 to 0.047)
UC –0.115 (–0.321 to 0.091) –0.169 (–0.339 to 0.000)
p-value 0.366 0.556
C Baseline to 3 months FFH –0.069 (–0.151 to 0.120) –0.175 (–0.367 to 0.017)
UC –0.106 (–0.143 to –0.069) –0.132 (–0.251 to –0.012)
p-value 0.351 0.669
Baseline to 12 months FFH –0.047 (–0.161 to 0.067) –0.055 (–0.225 to 0.115)
UC –0.119 (–0.233 to –0.004) –0.194 (–0.362 to –0.025)
p-value 0.350 0.224
FFH, Families for Health; UC, usual care.
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TABLE 88 Longitudinal changes in child BMI and waist circumference z-score by SES (four classes)
Class Time period
Treatment
group
Measurement, mean z-score (95% CI)
BMI Waist circumference
Managerial/professional Baseline to
3 months
FFH –0.038 (–0.138 to 0.062) –0.058 (–0.164 to 0.049)
UC –0.033 (–0.105 to 0.039) –0.073 (–0.186 to 0.041)
p-value 0.931 0.842
Baseline to
12 months
FFH 0.068 (–0.026 to 0.161) 0.122 (–0.063 to 0.306)
UC –0.098 (–0.263 to 0.067) –0.231 (–0.403 to –0.060)
p-value 0.053 0.009
Intermediate Baseline to
3 months
FFH –0.098 (–0.260 to 0.064) –0.148 (–0.437 to 0.141)
UC –0.108 (–0.406 to 0.191) –0.039 (–0.282 to 0.204)
p-value 0.939 0.561
Baseline to
12 months
FFH –0.165 (–0.376 to 0.046) –0.089 (–0.390 to 0.213)
UC 0.013 (–0.243 to 0.217) 0.010 (–0.389 to 0.410)
p-value 0.298 0.637
Routine and manual Baseline to
3 months
FFH 0.112 (–0.148 to 0.373) –0.099 (–0.258 to 0.060)
UC –0.021 (–0.103 to 0.061) –0.024 (–0.127 to 0.080)
p-value 0.295 0.394
Baseline to
12 months
FFH 0.067 (–0.209 to 0.343) –0.094 (–0.241 to 0.053)
UC –0.112 (–0.255 to 0.032) –0.084 (–0.240 to 0.071)
p-value 0.175 0.930
Long-term unemployed Baseline to
3 months
FFH –0.046 (–0.194 to 0.102) –0.251 (–0.539 to 0.038)
UC –0.076 (–0.180 to 0.027) –0.071 (–0.268 to 0.126)
p-value 0.689 0.226
Baseline to
12 months
FFH –0.053 (–0.391 to 0.286) –0.190 (–0.631 to 0.251)
UC 0.100 (–0.385 to 0.119) –0.215 (–0.443 to 0.014)
p-value 0.627 0.888
FFH, Families for Health; UC, usual care.
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Appendix 4 Resource utilisation
TABLE 89 Resource utilisation for the period 3 months post randomisation to 12 months post randomisation
Resource variable
Treatment group
p-valueaFFH (n= 45) UC (n= 43)
Hospital care, mean (SE)
Number of inpatient admissions 0 0
Accident and emergency visits 0.24 (0.14) 0.23 (0.09) 0.944
Outpatient department visits 0.38 (0.11) 0.26 (0.11) 0.429
Day hospital visits 0 0.02 (0.02) 0.323
Other hospital visits 0.02 (0.02) 0.02 (0.02) 0.974
Community-based health-care contacts, mean (SE)
GP at surgery 0.78 (0.17) 0.81 (0.17) 0.883
GP at home 0 0
Practice nurse 0.11 (0.07) 0.07 (0.04) 0.618
Dentist 0.84 (0.11) 0.95 (0.15) 0.563
Optician 0.42 (0.09) 0.49 (0.13) 0.674
Dietitian 0 0
Child development centre 0 0.09 (0.09) 0.323
Child guidance unit 0 0
General health (other) 0.20 (0.13) 0.07 (0.07) 0.379
Family therapist 0 0.28 (0.28) 0.323
Individual therapy 0 0.14 (0.14) 0.323
Psychiatrist/psychologist 0 0
Counselling (other) 0.35 (0.17) 0.02 (0.02) 0.066
Community-based social care contacts, mean (SE)
Social worker at office 0 0
Social worker at home 0.09 (0.06) 0.02 (0.02) 0.327
After-school club 0 0
Social care (other) 0 0.14 (0.10) 0.183
Medication usage, n (%)
Prescribed 23 (51.1) 19 (44.2) 0.516
Over the counter 24 (53.3) 29 (67.4) 0.176
continued
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TABLE 89 Resource utilisation for the period 3 months post randomisation to 12 months post randomisation
(continued )
Resource variable
Treatment group
p-valueaFFH (n= 45) UC (n= 43)
Educational support, mean (SE)
School nurse 0.31 (0.12) 1.19 (0.65) 0.190
Educational psychologist 0.53 (0.53) 0.05 (0.05) 0.368
Educational welfare officer 0 0.05 (0.05) 0.323
SEN co-ordinator 0.33 (0.27) 2.63 (1.97) 0.255
Additional meetings with tutors 0 0
Other educational support 0.09 (0.05) 1.72 (1.06) 0.130
Parents’ days off work 0.49 (0.23) 0.26 (0.11) 0.354
FFH, Families for Health; SEN, special education needs; UC, usual care.
a Comparisons of costs between trial allocation groups carried out using Student’s t-test.
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Appendix 5 Usual-care attendance
TABLE 90 Usual-care attendance over the period 3 months post randomisation to 12 months post randomisation
Programme/resource variable
Treatment group
FFH (n= 45) UC (n= 42)
One Body One Life, mean contacts (SE) NA 0.94 (0.50)
Change4Life, mean contacts (SE) NA 0.45 (0.21)
WISH, mean contacts (SE) NA 5 (5.00)
Weight Watchers, mean contacts (SE) NA 0
School nurse, mean contacts (SE) NA 0
FFH, Families for Health; NA, not applicable; UC, usual care.
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Appendix 6 Economic costs
TABLE 91 Economic costs by cost category and trial arm for the period 3 months pre-randomisation
Cost category
Treatment group (£)
p-valueaFFH (n= 63) UC (n= 65)
Hospital inpatient care, mean (SE) 9.90 (9.90) 0 0.321
Other hospital-based care, mean (SE)
Accident and emergency 1.83 (1.83) 12.40 (5.13) 0.056
Outpatient departments 48.00 (14.80) 66.88 (27.62) 0.548
Day hospital 2.49 (2.49) 0 0.321
Other 4.44 (3.12) 7.15 (7.15) 0.729
Total other hospital care costs 56.76 (15.89) 86.43 (28.23) 0.362
Community-based health care, mean (SE)
GP at surgery 21.05 (4.03) 25.50 (5.47) 0.514
GP at home 0 0
Practice nurse 1.05 (0.62) 0.43 (0.22) 0.353
Dentist 15.10 (4.99) 20.85 (4.82) 0.409
Optician 15.74 (5.93) 12.46 (4.95) 0.671
Dietitian 0.29 (0.29) 2.42 (1.35) 0.128
Child development centre 0.17 (0.17) 0 0.321
Child guidance unit 0 0
General health (other) 2.41 (1.76) 2.96 (2.23) 0.848
Family therapist 0 0
Individual therapy 0 0
Psychiatrist/psychologist 0 4.37 (3.07) 0.159
Counselling (other) 16.19 (14.81) 0 0.279
Total community-based health costs 72.01 (17.60) 68.99 (10.66) 0.884
Community-based social care, mean (SE)
Social worker at office 0 0
Social worker at home 1.24 (0.76) 7.60 (5.33) 0.243
After-school club 0 0
Social care (other) 0.21 (0.15) 33.43 (30.10) 0.274
Total community-based social costs 1.46 (0.77) 41.03 (30.44) 0.198
Medication, mean (SE)
Prescribed 2.51 (0.59) 4.01 (1.47) 0.347
Over the counter 1.21 (0.33) 1.25 (0.32) 0.930
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TABLE 91 Economic costs by cost category and trial arm for the period 3 months pre-randomisation (continued )
Cost category
Treatment group (£)
p-valueaFFH (n= 63) UC (n= 65)
Educational support, mean (SE)
School nurse 2.43 (0.67) 2.05 (0.80) 0.722
Educational psychologist 0.63 (0.63) 14.28 (12.20) 0.268
Educational welfare officer 0 2.69 (1.91) 0.163
SEN co-ordinator 5.42 (4.38) 5.77 (3.14) 0.949
Additional meetings with tutors 0 0
Other educational support 12.57 (10.41) 39.99 (19.21) 0.383
Total educational support costs 21.04 (11.60) 64.78 (26.44) 0.133
Other costs, mean (SE)
Change in family expenditure 51.65 (14.80) 54.08 (13.39) 0.903
Lost productivity 23.80 (12.59) 8.17 (6.19) 0.268
Travel costs 4.12 (0.87) 8.76 (3.80) 0.238
Total NHS and PSS costs, mean (SE) 163.68 (31.49) 265.24 (54.08) 0.108
Total societal costs, mean (SE) 244.47 (38.33) 337.50 (59.31) 0.190
FFH, Families for Health; PSS, Personal Social Services; SEN, special education needs; UC, usual care.
a Comparisons of costs between trial allocation groups carried out using Student’s t-test.
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Appendix 7 Costs of care
TABLE 92 Costs of care by cost category and trial arm for the period 3 months post randomisation to 12 months
post randomisation
Cost category
Treatment group (£)
p-valueaFFH (n= 45) UC (n= 43)
Hospital inpatient care, mean (SE) 0 0
Other hospital-based care, mean (SE)
Accident and emergency 28.15 (16.02) 26.78 (10.73) 0.944
Outpatient departments 71.40 (21.06) 48.35 (19.98) 0.429
Day hospital 3.65 (3.65) 0.323
Other 0.94 (0.94) 0 0.323
Total other hospital care costs 100.49 (30.58) 78.78 (26.34) 0.592
Community-based health care, mean (SE)
GP at surgery 28.51 (6.10) 29.48 (6.17) 0.912
GP at home 0 0
Practice nurse 2.26 (1.46) 0.45 (0.29) 0.232
Dentist 39.34 (6.56) 41.24 (11.93) 0.890
Optician 22.92 (5.87) 28.22 (9.11) 0.626
Dietitian 0 0
Child development centre 0 3.92 (3.92) 0.323
Child guidance unit 0 0
General health other 17.68 (15.68) 3.07 (3.07) 0.365
Family therapist 0 13.95 (13.95) 0.323
Individual therapy 0 3.49 (3.49) 0.323
Psychiatrist/psychologist 0 0
Counselling (other) 36.64 (18.75) 0 0.071
Total community-based health costs 147.35 (30.80) 123.82 (25.56) 0.592
Community-based social care, mean (SE)
Social worker at office 0 0
Social worker at home 1.76 (1.23) 0.46 (0.46) 0.327
After-school club 0 0
Social care (other) 1.37 (1.18) 0.249
FFH/UC costs 0 9.72 (9.72) 0.323
Total community-based social and other costs 1.76 (1.23) 11.55 (9.75) 0.325
Medications, mean (SE)
Prescribed 12.47 (3.72) 5.44 (1.58) 0.088
Over the counter 0
continued
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TABLE 92 Costs of care by cost category and trial arm for the period 3 months post randomisation to 12 months
post randomisation (continued )
Cost category
Treatment group (£)
p-valueaFFH (n= 45) UC (n= 43)
Educational support, mean (SE)
School nurse 3.69 (1.85) 8.40 (3.53) 0.242
Educational psychologist 17.56 (17.56) 4.10 (4.10) 0.459
Educational welfare officer 0 0.58 (0.58) 0.323
SEN co-ordinator 3.33 (2.46) 43.70 (35.53) 0.263
Additional meetings with tutors 0 0
Other educational support 3.91 (2.40) 35.78 (24.66) 0.205
Total educational support costs 28.49 (17.71) 92.57 (42.92) 0.173
Other costs, mean (SE)
Change in family expenditure 168.28 (50.45) 214.54 (70.79) 0.596
Lost productivity 45.32 (20.52) 31.45 (13.41) 0.573
Travel costs 7.60 (1.32) 14.41 (5.87) 0.264
Total NHS and PSS costs, mean (SE) 288.56 (46.13) 302.45 (53.85) 0.845
Total societal costs, mean (SE) 509.76 (75.01) 562.86 (94.79) 0.662
FFH, Families for Health; PSS, Personal Social Services; SEN, special education needs; UC, usual care.
a Comparisons of costs between trial allocation groups carried out using Student’s t-test.
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Appendix 8 Subgroup analyses: economic
evaluation
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FIGURE 26 (a) Cost-effectiveness plane; and (b) CEAC for QALY outcome, subgroup analyses: age group (6–8 years)
from a NHS and Personal Social Services perspective.
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FIGURE 27 (a) Cost-effectiveness plane; and (b) CEAC for QALY outcome, subgroup analyses: age group
(9–11 years) from a NHS and Personal Social Services perspective.
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FIGURE 28 (a) Cost-effectiveness plane; and (b) CEAC for QALY outcome, subgroup analyses: sex (male) from a NHS
and Personal Social Services perspective.
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FIGURE 29 (a) Cost-effectiveness plane; and (b) CEAC for QALY outcome, subgroup analyses: sex (female) from a
NHS and Personal Social Services perspective.
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FIGURE 30 (a) Cost-effectiveness plane; and (b) CEAC for QALY outcome, subgroup analyses: site A from a NHS and
Personal Social Services perspective.
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FIGURE 31 (a) Cost-effectiveness plane; and (b) CEAC for QALY outcome, subgroup analyses: site B from a NHS and
Personal Social Services perspective.
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FIGURE 32 (a) Cost-effectiveness plane; and (b) CEAC for QALY outcome, subgroup analyses: site C from a NHS and
Personal Social Services perspective.
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FIGURE 33 (a) Cost-effectiveness plane; and (b) for BMI z-score outcome, subgroup analyses: age group (6–8 years)
from a NHS and Personal Social Services perspective.
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FIGURE 34 (a) Cost-effectiveness plane; and (b) for BMI z-score outcome, subgroup analyses: age group
(9–11 years) from a NHS and Personal Social Services perspective.
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FIGURE 35 (a) Cost-effectiveness plane; and (b) for BMI z-score outcome, subgroup analyses: sex (male) from a NHS
and Personal Social Services perspective.
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FIGURE 36 (a) Cost-effectiveness plane; and (b) for BMI z-score outcome, subgroup analyses: sex (female) from a
NHS and Personal Social Services perspective.
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FIGURE 37 (a) Cost-effectiveness plane; and (b) for BMI z-score outcome, subgroup analyses: site A from a NHS and
Personal Social Services perspective.
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FIGURE 38 (a) Cost-effectiveness plane; and (b) for BMI z-score outcome, subgroup analyses: site B from a NHS and
Personal Social Services perspective.
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FIGURE 39 (a) Cost-effectiveness plane; and (b) for BMI z-score outcome, subgroup analyses: site C from a NHS and
Personal Social Services perspective.
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FIGURE 40 (a) Cost-effectiveness plane; and (b) CEAC for QALY outcome, subgroup analyses: age group (6–8 years)
from a societal perspective.
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FIGURE 41 (a) Cost-effectiveness plane; and (b) CEAC for QALY outcome, subgroup analyses: age group
(9–11 years) from a societal perspective.
– 0.40
– 1500
Incremental QALYs
In
cr
em
en
ta
l c
o
st
s 
(£
)
– 1000
– 500
1000
1500
500
(a)
– 0.30 – 0.10– 0.20 0.10 0.20 0.30 0.40
0
0.0
0.2
0.6
0.8
1.0
20 40
(b)
60 80 100
Cost-effectiveness threshold (£000 per QALY)
Pr
o
p
o
rt
io
n
 o
f 
si
m
u
la
ti
o
n
s
0.4
FIGURE 42 (a) Cost-effectiveness plane; and (b) CEAC for QALY outcome, subgroup analyses: sex (male) from a
societal perspective.
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FIGURE 43 (a) Cost-effectiveness plane; and (b) CEAC for QALY outcome, subgroup analyses: sex (female) from a
societal perspective
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FIGURE 44 (a) Cost-effectiveness plane; and (b) CEAC for QALY outcome, subgroup analyses: site A from a
societal perspective.
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FIGURE 45 (a) Cost-effectiveness plane; and (b) CEAC for QALY outcome, subgroup analyses: site B from a
societal perspective.
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FIGURE 46 (a) Cost-effectiveness plane; and (b) CEAC for QALY outcome, subgroup analyses: site C from a
societal perspective.
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FIGURE 47 (a) Cost-effectiveness plane; and (b) CEAC for BMI z-score outcome, subgroup analyses: age group
(6–8 years) from a societal perspective.
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FIGURE 48 (a) Cost-effectiveness plane; and (b) CEAC for BMI z-score outcome, subgroup analyses: age group
(9–11 years) from a societal perspective.
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FIGURE 49 (a) Cost-effectiveness plane; and (b) CEAC for BMI z-score outcome, subgroup analyses: sex (male) from
a societal perspective.
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FIGURE 50 (a) Cost-effectiveness plane; and (b) CEAC for BMI z-score outcome, subgroup analyses: sex (female)
from a societal perspective.
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FIGURE 51 (a) Cost-effectiveness plane; and (b) CEAC for BMI z-score outcome, subgroup analyses: site A from a
societal perspective.
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FIGURE 52 (a) Cost-effectiveness plane; and (b) CEAC for BMI z-score outcome, subgroup analyses: site B from a
societal perspective.
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FIGURE 53 (a) Cost-effectiveness plane; and (b) CEAC for BMI z-score outcome, subgroup analyses: site C from a
societal perspective.
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Appendix 9 Interview schedules for parents at
3-month follow-up
 
• Were approached to take part? 
• Saw/heard the advert? 
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Appendix 10 Interview schedules for parents at
12-month follow-up
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(b) Usual Care Parent Interview Schedule (Example from Site A)  
(NB. Interview Schedule tailored to other usual care programmes ) 
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Appendix 11 Interview schedules for children
(a) Interview Schedule for Children at Three Months 
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(b) Interview Schedule for Children at 12-Months 
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